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IV    Abstract 
 
Excitation-secretion coupling at nerve cell synapses is a sub-millisecond process that 
entails the transduction of an electrical stimulus into synaptic vesicle fusion. Before fusion, 
synaptic vesicles are physically docked to the presynaptic active zone membrane and 
functionally primed to become fusion competent. In response to an increase in 
intracellular calcium concentration after the arrival of an action potential, primed vesicles 
fuse with the plasma membrane and release their neurotransmitter content into the 
synaptic cleft. Recent studies combining cryo-fixation methods and three-dimensional 
electron microscopy analysis proposed that synaptic vesicle docking and priming steps 
may not reflect independent mechanisms, but rather describe the same molecular process 
namely full or partial soluble N-ethylmalemide-sensitive factor attachment protein receptor 
(SNARE) complex formation initiated by members from the UNC-13/Munc13 protein 
family. However, other studies have challenged the notion of SNARE complex assembly 
prior to the calcium triggering step in the release process.  
In the present study, a combination of organotypic hippocampal slice culture, high-
pressure freezing, freeze substitution and electron tomography was used to reinvestigate 
the role of key synaptic proteins in synaptic vesicle docking in glutamatergic hippocampal 
spine synapses. This method enables the analysis of synaptic parameters in an in-situ-like 
setting using lethal mouse mutants that do not survive birth. Loss or reduction of 
components of the molecular priming machinery, namely Munc13 or CAPS proteins, and 
of the individual neuronal SNARE proteins Synaptobrevin-2, Syntaxin-1 and 
synaptosome-associated protein of 25 kDa (SNAP25) caused severe defects in synaptic 
vesicle membrane-attachment in this experimental setting. Moreover, loss of the calcium 
(Ca2+)-sensor Synaptotagmin-1, causes a decrease in vesicle numbers in presynaptic 
terminals in comparison to control synapses and a reduction in membrane-proximal 
(loosely tethered) and docked vesicles. However, the reduction in the number of 
membrane-attached synaptic vesicles was milder than it was observed in the absence of 
the vesicular SNARE ptrotein Synaptobrevin-2, indicating that Synaptotagmin-1 might 
have a regulatory (e.g. tethering or clamping) but not essential role in synaptic vesicle 
docking in neurons. Complexin-deficient synapses exhibited no changes in the number of 
membrane-attached synaptic vesicles, a finding that supports a facilitatory rather than 
inhibitory role of Complexins prior to synaptic vesicle fusion. These findings indicate that 
synaptic vesicle membrane-attachment, synaptic vesicle priming and (partial) SNARE 
complex assembly are respective morphological, functional and molecular manifestations 
of the same process. 
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1. Introduction 
1.1.  Synaptic transmission 
 
The brain is a highly complex network composed of billions of neurons that communicate 
with each other in a regulated manner in order to control a variety of processes including 
motor control, sensory information processing, as well as learning and memory functions. 
Along a neuron, information is conveyed as electrical signals, however neurons form 
highly specialized contacts at chemical synapses that mediate information transduction 
and processing between a presynaptic and a postsynaptic compartment.  
 
An electrical signal (action potential) that arrives at the presynaptic terminal is converted 
into a chemical response by the release of messenger molecules (neurotransmitters) at 
the active zone, a process often referred to as excitation-secretion coupling (reviewed in 
Wojcik & Brose 2007). This process is very fast and works with high fidelity and 
endurance, which requires local recycling of the neurotransmitter and the molecular 
release machinery in the presynaptic terminal (reviewed in Jahn and Fasshauer, 2012; 
Südhof, 1995, 2004). Neurotransmitter molecules are stored in small, spherical, lipid-
bound organelles called synaptic vesicles. Synaptic vesicles bud off from recycling 
organelles, termed endosomes, and neurotransmitter molecules are filled into the vesicles 
by neurotransmitter transporters using the energy of a proton gradient across the vesicle 
membrane. Neurotransmitter-containing synaptic vesicles are transported to the active 
zone, a highly specialized region at the presynaptic plasma membrane, where 
neurotransmitter release takes place. At the active zone, synaptic vesicles attach to the 
plasma membrane in a process called “docking” and become fusion-competent in a 
functional “priming” process (reviewed in Wojcik & Brose 2007). The common view is that 
only a subset of the docked synaptic vesicles becomes primed, thus forming a readily-
releasable pool (RRP) of vesicles which can be released in response to the arrival of an 
action potential.  
 
The arrival of the electrical signal at the presynaptic terminal causes a change in the 
electrical potential across the plasma membrane which initiates the rapid opening of 
voltage-gated Ca2+-channels clustered at the active zone membrane. As a consequence, 
Ca2+ ions flow into the presynaptic terminal and cause a local increase in the Ca2+-
concentration. This increase in intracellular Ca2+ levels can be sensed by the molecular 
release machinery and functions as the signal to trigger fusion of synaptic vesicles with 
the plasma membrane in a process called exocytosis. The exocytosis of vesicles is 
thought to comprise multiple intermediate states (reviewed in Kasai et al., 2012): (i) 
                                                                                                            1. Introduction 
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membrane-attached vesicles hemifuse with the plasma membrane as the outer leaflet of 
the vesicular phospholipid bilayer merges with the inner leaflet of the membrane bilayer, 
(ii) a small fusion pore connecting the vesicular lumen with the extracellular space is 
formed as distal leaflets of the lipid bilayers intermingle, and (iii) the fusion pore expands 
and the vesicle collapses into the plasma membrane. As a result, the neurotransmitter 
content of fusing synaptic vesicles is released from the presynaptic terminal. 
 
The released neurotransmitter molecules diffuse through the extracellular space between 
the pre- and postsynaptic compartment, referred to as the synaptic cleft, until they reach 
the postsynaptic membrane. Upon binding to specific receptors, neurotransmitters 
activate, inhibit or modulate the activity of the postsynaptic cell. To guarantee the constant 
availability of synaptic vesicles, especially during high synaptic activity, not only 
neurotransmitter and molecular components of the presynapse, but also the synaptic 
vesicle membranes need to be recycled. The retrieval of vesicles from the plasma 
membrane is achieved by endocytosis (Heuser and Reese, 1973; reviewed in Südhof, 
1995, 2004). Different pathways of endocytosis have been proposed, with the most widely 
accepted one being clathrin-mediated endocytosis (Dittman and Ryan, 2009; Heuser and 
Reese, 1973; Hua et al., 2011a). In this process, synaptic vesicle proteins incorporated 
into the plasma membrane during vesicle fusion are recognized by specific adaptor 
proteins, which in turn recruit a local scaffold of clathrin molecules. Clathrin molecules 
induce inward curvature of the membrane (pits) which, with the concerted action of 
dynamin proteins, can be pinched off to form a new vesicular organelle. Alternative routes 
for endocytosis described include a direct coupling of exo- and endocytosis called kiss-
and-run, whereby synaptic vesicles return to the cytoplasm following neurotransmitter 
release without fully collapsing into the plasma membrane, and a process called bulk-
membrane retrieval, where large portions of membrane are internalized during high 
synaptic activity. However, these processes are less well studied and often controversially 
discussed (Aravanis et al., 2003; Cheung et al., 2010; Gandhi and Stevens, 2003; 
Granseth et al., 2006, 2009; Watanabe et al., 2013; Wenzel et al., 2012; Zhang et al., 
2009). 
 
Action-potential evoked synaptic vesicle fusion at synapses is a very fast, endurable and 
tightly-regulated process that is controlled by a wide range of proteins to secure high-
speed and reliability even during sustained activity. The active zone is characterized by a 
unique composition of cytoskeletal elements, voltage gated Ca2+-channel clusters and 
proteins that regulate synaptic vesicle fusion and therefore secure temporal and spatial 
accuracy in the release process (reviewed in Südhof 2012). 
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Figure 1.1. The synaptic vesicle cycle at excitatory synapses 
Synaptic vesicles are locally recycled in presynaptic terminals. Synaptic vesicles are filled with the 
neurotransmitter (here e.g. glutamate) (1) and translocated to the active zone. There, synaptic 
vesicles become physically attached to the plasma membrane (2) and undergo a Ca
2+
-regulated 
priming process to acquire fusion-competence (3). In response to the arrival of an action potential 
and an increase in Ca
2+
-concentration, primed synaptic vesicles can fuse with the plasma 
membrane (4) and release their neurotransmitter content into the synaptic cleft. Neurotransmitter 
molecules diffuse through the synaptic cleft to mediate receptor ion channel opening and allow ion 
influx generating an excitatory postsynaptic current (EPSC) (5). Synaptic vesicle membranes are 
recycled in a process called endocytosis (6). The best-described pathway is clathrin-mediated 
recycling, in which clathrin-coated vesicles bud off from the membrane, become uncoated and fuse 
with early endosomes (7). Kiss-and-run exocytosis and bulk membrane retrieval are possible 
alternative, clathrin-independent recycling routes. Schematic provided by Dr. B. Cooper; based on 
(Jahn and Fasshauer, 2012) 
 
1.2.   Synaptic vesicle docking and priming 
 
Studying neurotransmitter release from neurons requires well-defined settings, which 
enable the assessment of physiological and morphological parameters and an easy way 
to monitor, stimulate or pharmacological manipulate the release process. The vast 
majority of studies characterizing the physiological function of proteins in synaptic 
transmission have therefore been performed in neuronal culture systems, in which the 
experimental conditions can be precisely controlled and the electrophysiological 
properties of neurons can be measured by using the patch-clamp technique (Neher and 
Sakmann 1976). However, morphological or ultrastructural features of synaptic terminals 
require the use of a high-resolution microscopy approach, called electron microscopy 
                                                                                                            1. Introduction 
 4 
(EM) to be able to resolve presynaptic vesicles and cytoplasmic structures in the 
nanometer range (Verhage and Sørensen 2008). 
 
A special culture method is a low density culture of neurons plated on astrocytic feeder 
islands that will result in neurons that form synapses onto themselves (autapses) in the 
absence of neighboring cells (Bekkers, 1991; Burgalossi et al., 2012; Pyott and 
Rosenmund, 2002). In this experimental system, application of hypertonic sucrose 
solution has been shown in electrophysiological experiments to deplete the pool of fusion-
competent, primed synaptic vesicles (RRP) in an as yet unknown manner (Rosenmund 
and Stevens, 1996; Stevens and Tsujimoto, 1995). In these early studies, calculations of 
the measured postsynaptic electrical responses after application of hyperosmotic solution 
indicated that a depletion of the entirety of synaptic vesicles in a neuron would result in a 
much greater response than measured and that therefore possibly only a subset of 
synaptic vesicles would be released in such an experiment. It was suggested that this 
pool of synaptic vesicles would very likely be already close, or in contact with, the active 
zone membrane to ensure fast fusion after the arrival of the action potential. Using 
aldehyde-based chemical fixation methods for electron microscopic analysis of synaptic 
ultrastructure, C. Stevens and colleagues were able to confirm a tight correlation between 
the number of membrane-attached or docked synaptic vesicles and the active zone area. 
Moreover, the number of docked vesicles was found to correlate approximately with the 
calculated quantal size of the measured RRP after hypertonic sucrose solution application 
in autaptic neurons (Murthy and Stevens, 1999; Rosenmund and Stevens, 1996; 
Schikorski and Stevens, 1997).  
 
A “docked” pool of synaptic vesicles therefore describes synaptic vesicles that are in 
direct contact with the active zone membrane at synaptic release sites, as seen in 
electron micrographs. However, synaptic vesicle “priming” is a term that arose from the 
hypothesis that a multistep-molecular mechanism preceding Ca2+-triggered release would 
be much too slow to allow synaptic vesicle release at high frequency for long durations 
(reviewed in Südhof 1995). It was shown that during high-frequency stimulation for 15 
minutes, the number of synaptic vesicles observed in contact with the presynaptic release 
sites in electron micrographs from lamprey reticulospinal axon synapses did not decrease, 
whereas electrophysiologically, synaptic release slows down much earlier (reviewed in 
Südhof, 1995; Wickelgren et al., 1985). Moreover, animals that were lacking presynaptic 
proteins exhibited massive physiological defects in basic neurotransmitter release 
characteristics accompanied by an almost completely depleted RRP of primed vesicles, 
but displayed normal numbers of membrane-attached synaptic vesicles in electron 
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micrographs (Aravamudan et al., 1999; Augustin et al., 1999a; Richmond et al., 1999; 
Varoqueaux et al., 2002). These findings indicated that instead of the synaptic vesicle 
docking step, a subsequent Ca2+-dependent molecular priming step that renders the 
synaptic vesicles fusion-competent might be rate-limiting (reviewed in Südhof 1995).  
 
Conventional sample preparation techniques for EM employing aldehyde-based chemical 
fixation are subject to certain experimental constraints: (i) the speed of sample fixation is 
limited by the diffusion of chemical fixatives through the tissue (requiring minutes to 
hours), and (ii) artefacts introduced by dehydration steps at room-temperature alter the 
spatial relationships and ultracellular integrity of cellular organelles (e.g. shrinkage). 
Recent improvements in sample preparation techniques employing rapid cryo-fixation 
methods resulted in superior ultrastructural preservation coupled with a dramatically 
improved temporal resolution (milliseconds), therefore enabling a more reliable analysis of 
membrane-attached vesicles in presynaptic protein null mutants (See 1.4. Ultrastructural 
analysis of synaptic vesicle docking). Studies using these methods indicated that synaptic 
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Figure 1.2. Schematic representations of domain structures of key presynaptic proteins 
The domain structures of the SNARE (soluble N-ethylmalemide-sensitive factor attachment protein 
receptor) proteins SNAP25 (A), Syntaxin-1A (B) and Synaptobrevin-2 (C), the priming proteins 
Munc13-1 (D) and CAPS-1 (E), the Ca
2+
-sensor Synaptotagmin-1 (F), and Complexins (G). The 
number of amino acids (aa) are indicated for each protein. C1 domain in Munc13-1 (light green), C2 
domains in Munc13-1, CAPS-1 and Synaptotagmin-1 (dark green), CBD in Munc13-1 (Calmodulin-
binding domain, orange), Habc domain of Syntaxin-1 (three α-helices, yellow), MHD in Munc13-1 
and CAPS-1 (Munc homology domain, dark red) N-pep of Syntaxin-1 (amino-terminal peptide, light 
grey), PH domain (Pleckstrin homology, violet), SNARE motifs in SNAP25, Syntaxin-1, 
Synaptobrevin-2 (red; Q = central glutamine residue; R = central arginine residue),TMR 
(transmembrane region, dark grey). The domain structures are not drawn to scale. Schematic 
provided by Dr. Ben Cooper; based on (Kasai et al. 2012). 
 
1.3.   Molecular mechanisms underlying docking, priming and fusion 
 
1.3.1.   SNAREs and Munc18-1 
 
Hundreds of proteins have been described to participate in the tight regulation of the 
different steps of synaptic vesicle release. The key players in membrane-fusion reactions, 
however, are SNARE proteins that form the exocytotic core complex for membrane fusion 
(reviewed in Jahn and Fasshauer, 2012; Jahn and Scheller, 2006). The family of the 
(SNARE) proteins is characterized by a stretch of 60-70 amino acids referred to as the 
SNARE motif, which is highly conserved and undergoes regulated assembly to form 
stable ternary SNARE-complexes (Fasshauer et al., 1998; Kloepper et al., 2007, 2008). 
The family of synaptic SNARE molecules include the synaptic vesicle protein 
Synaptobrevin-2 (vesicular, v-SNARE) and the two plasma-membrane residing molecules 
Syntaxin-1 and SNAP25 (target-membrane, t-SNAREs). In the course of the fusion 
reaction, the three molecules form a parallel four-α-helical bundle by interaction of their 
respective SNARE motifs (Poirier et al., 1998; Sutton et al., 1998).  
 
Within the assembled SNARE complex, the side chains of the individual α-helices form 
hydrophobic interactions between each other, with the only exception being a central 
amino acid layer that consists of four interacting charged amino residues, one arginine (R) 
contributed by Synaptobrevin-2 (R-SNARE), one glutamine (Qa) from Syntaxin-1 and two 
glutamines (Qb, Qc) from SNAP25 (Q-SNAREs), which contributes two SNARE motifs 
(Fasshauer et al., 1998). Despite the highly conserved nature of SNARE motifs, the three 
neuronal SNAREs vary in their domain structure. Synaptobrevin-2 and Syntaxin-1 are 
anchored to the vesicle or plasma membrane by a single carboxy (C) -terminal 
transmembrane region (TMR) that is connected to the SNARE motif by a short linker. 
SNAP25, however, varies from this structure as its two SNARE motifs are connected by a 
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short, hydrophobic linker that contains palmitoylated cysteines, a post-translational protein 
modification, which allows plasma membrane-anchoring without a TMR (reviewed in 
Hong, 2005). Whereas, Synaptobrevin-2 and SNAP25 lack any additional domains, 
Syntaxin-1 contains a short amino (N)-terminal peptide and an additional N-terminal 
domain, which forms a three α-helical bundle (Habc domain) that is linked to, and folds 
onto, the SNARE motif of Syntaxin-1 and renders the molecule in a “closed”-conformation, 
most-likely by the interaction with Munc18-1 (Dulubova et al., 1999; Fernandez et al., 
1998). 
 
The most widely accepted model for SNARE complex zippering is that it starts at the N-
terminus of the SNARE motifs by interaction of the v-SNARE Synaptobrevin-2 with the t-
SNAREs Syntaxin-1 and SNAP25 in a trans conformation and progresses towards the C-
terminal membrane-anchors (reviewed in Kasai et al., 2012; Pobbati et al., 2006; Stein et 
al., 2009). This process will pull the synaptic vesicle and the plasma membrane closer 
together. Full zippering of the ternary SNARE complex has been shown to release a high 
amount of energy, which can possibly be conducted through the linkers to the TMR, 
inducing destabilization of the membrane and fusion of the bilayers (Li et al., 2007; Stein 
et al., 2009). After the membrane-fusion reaction, the assembled SNARE complex resides 
in the plasma membrane in a low energy cis conformation, which is subsequently 
disassembled by the AAA-ATPase NSF (N-ethylmaleimide sensitive factor) together with 
its SNAP (soluble NSF attachment proteins) adaptor molecules (Burgalossi et al., 2010; 
reviewed in Jahn and Scheller, 2006). In vitro studies that used reconstituted SNARE 
complex formation assays, proposed a model, according to which the two t-SNAREs 
Syntaxin-1 and SNAP25 form a highly reactive intermediate acceptor complex on the 
membrane (Fasshauer and Margittai, 2004; Pobbati et al., 2006). This complex might be 
stabilized in vivo by regulatory proteins prior to Synaptobrevin-2 engagement. 
 
Null mutant mice of the neuronal SNAREs Synaptobrevin-2 and SNAP25 die prior to birth 
(Schoch et al., 2001; Washbourne et al., 2002). Neurons lacking the v-SNARE 
Synaptobrevin-2 exhibit an 85% decrease in spontaneous synaptic vesicle fusion events, 
which is reflected by a reduced frequency of spontaneous miniature excitatory 
postsynaptic currents (mEPSC) and a 90% reduction in the size of the RRP of primed 
synaptic vesicles measured after hypertonic sucrose application (Schoch et al. 2001). 
However, action potential evoked, Ca2+-dependent release, measured in the size of the 
evoked excitatory postsynaptic current (EPSC) recorded after stimulation, is almost 
completely abolished (Schoch et al. 2001). Moreover, Synaptobrevin-2 KO mice exhibit a 
significant increase in the vesicle diameter, which was interpreted as a possible 
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endocytosis defect, although neurons showed no additional changes in synaptic 
morphology or in the number of docked synaptic vesicles in electron micrographs (Deák et 
al., 2004). Low-density cultures of neurons lacking SNAP25 exhibit neurodegeneration 
accompanied by cell death and synapse loss. However, high-density cultures were shown 
to prolong neuronal survival over three weeks’ time (Bronk et al., 2007; Washbourne et 
al., 2002). SNAP25 KO neurons are characterized by a strong reduction in the mEPSC 
frequency accompanied by a slight decrease in the mEPSC amplitude. Evoked, Ca2+-
dependent neurotransmitter release measured by field stimulation revealed that ~70% of 
the measured neurons failed to respond after stimulation and the remaining cells only 
exhibited an EPSC that was dramatically decreased in amplitude. The size of the RRP 
measured by hypertonic sucrose application was reduced to 12% of the control value. 
However no alterations in synaptic morphology or in the number of docked synaptic 
vesicles could be detected in EM analyses (Bronk et al., 2007).  
 
A mouse mutant deficient for both Syntaxin-1A and B isoforms has only recently become 
available, but mutant neurons of these mice degenerate and do not survive the first few 
days of culture (Rosenmund and Südhof, unpublished data). Proteolytic cleavage of 
Syntaxin-1 after viral expression of Botulinium neurotoxin serotype C (BoNT/C) in cultured 
neurons revealed a robust reduction in the mEPSC frequency and in the evoked EPSC 
response, with no change in the number of membrane-attached synaptic vesicles (de Wit 
et al., 2006). A recent study introduced a knock-in mouse line for Syntaxin-1B, in which 
the protein is fused to a yellow fluorescent protein (YFP) in the Syntaxin-1A KO 
background, and which exhibits a significant reduction in Syntaxin-1 levels in neurons 
(Arancillo et al., 2013; Gerber et al., 2008). The reduction of Syntaxin-1 protein levels 
causes embryonic lethality and severe physiological phenotypes with a reduction of the 
RRP size by 65% and of the EPSC size by 80% with respect to control levels in 
hippocampal autaptic neurons. Moreover, these electrophysiological alterations are 
accompanied by changes in the synaptic vesicle distribution (Arancillo et al. 2013). Of 
note, the reduction of Syntaxin-1 levels also caused a 25% reduction in the expression 
levels of Munc18-1, a neuronal protein of the Sec1/Munc18 (SM) family of trafficking 
molecules and the homologue of C. elgans UNC-18 (Arancillo et al. 2013). Munc18-1 KO 
mice die at birth and exhibit a complete loss of synaptic neurotransmission, and mutant 
neurons degenerate within days in culture (Heeroma et al., 2004; Verhage, 2000). 
Moreover, Munc18-1 KO neurons exhibit a 70% reduction of Syntaxin-1 levels, indicating 
that Munc18-1 has a role in stabilizing the t-SNARE Syntaxin-1.  
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The fact that mouse mutants lacking individual SNARE proteins exhibit massive 
physiological impairments in neurotransmission and a great decrease in the size of the 
RRP of primed vesicles measured by hypertonic sucrose solution, led to the hypothesis 
that the formation of the SNARE complex might indeed be the molecular process 
underlying synaptic vesicle priming (Arancillo et al., 2013; Schoch et al., 2001). In vitro, it 
has been shown that SNARE complex formation alone seems to be sufficient to mediate 
membrane fusion and that the fusion efficiency can further be enhanced by Munc18-1, 
indicating that most likely additional regulatory proteins are crucial for the speed of Ca2+-
evoked membrane fusion in vivo (reviewed in Rizo and Südhof, 2012; Shen et al., 2007; 
Weber et al., 1998). The role of the individual SNARE molecules in synaptic vesicle 
docking in neurons has not yet been assessed using improved cryo-preservation methods 
for EM. The outcome of such experiments could help to clarify the role of the SNARE 
complex prior to synaptic vesicle fusion. 
 
1.3.2.   Munc13s 
 
Munc13s are major components of the molecular priming machinery. They are large 
(~200 kDa) proteins that represent the mammalian homologues of C. elegans UNC-13 
proteins, which were first identified in a genetic screen for mutants with defects in synaptic 
transmission (Brenner, 1974). In C. elegans, two UNC-13 isoforms are expressed from 
the unc13 gene, termed UNC-13L (long, previously: LR) and UNC-13S (short, previously: 
MR), which have highly conserved C-termini, but differ in their N-terminal domain structure 
(Hu et al., 2013; Kohn et al., 2000). Mammals express at least five different Munc13 
isoforms, Munc13-1, bMunc13-2, ubMunc13-2, Munc13-3, Munc13-4 and brain-specific 
angiogenesis inhibitor-associated protein 3 (Baiap-3), all characterized by a highly 
conserved C-terminus (Koch et al., 2000). Munc13-1 is widely expressed throughout the 
central nervous system and is the most dominant isoform present in most synapses. 
Munc13-2 mRNA expression can be found especially throughout the cortex, hippocampus 
and cerebellum, whereas Munc13-3 is primarily expressed in the cerebellum (Augustin et 
al., 1999b, 2001). Munc13-1, bMunc13-2 and Munc13-3 are brain specific isoforms, 
whereas ubMunc13-2 is more ubiquitously expressed in a great variety of tissues 
(Augustin et al., 1999b). Munc13-4 is mainly expressed in peripheral tissues and can be 
detected in the lung, the spleen and testes as well as in cells of the immune system, 
where it functions in regulated exocytosis of granules in cytotoxic T lymphocytes. 
Mutations of the human Munc13-4 gene are linked to the familial immune disease 
hemophagocytic lymphohistiocytosis subtype 3 (Dudenhöffer-Pfeifer et al., 2013; 
Feldmann et al., 2003; Koch et al., 2000). The brain-specific molecule Baiap-3 is highly 
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expressed in the amygdala, the hypothalamus and the periaqueductal gray matter and 
has been associated with fear and anxiety pathways (Koch et al., 2000; Wojcik et al., 
2013).  
 
Characteristic of all members of the UNC-13/Munc13 protein family is the highly 
conserved C-terminal region which contains two Munc13 homology domains (MHD) 
connected by a linker (Koch et al., 2000). This region, referred to as the  MUN domain, 
has been shown to weakly interact with the N-terminus of Syntaxin-1 (Betz et al., 1997; 
Ma et al., 2011, 2013). It has been shown that the MUN domain is sufficient for the basic 
priming function of Munc13s since it can at least partially rescue the Munc13-deficient 
phenotype in neurons and chromaffin cells (Basu et al., 2005; Stevens et al., 2005). The 
binding of Munc18-1 to the N-terminus of Syntaxin-1 renders Syntaxin-1 in a closed 
conformation, which led to the hypothesis that the priming function performed by Munc13s 
is based on their ability to interact with Syntaxin-1. Munc13s could therefore induce a 
switch from the closed to an open Syntaxin-1 conformation, which would enable and/or 
accelerate SNARE complex nucleation (Ma et al., 2011, 2013; Sassa et al., 1999).  
The C-terminus of Munc13 proteins possesses a single C2 (C2C) domain, the function of 
which remains unknown (Brose et al., 1995; Shin et al., 2010). Further towards the N-
terminus, the MUN domain is preceded by accessory domains that execute important 
regulatory roles for Munc13 function. Adjacent to the MUN domain, Munc13s contain a 
second C2 domain (C2B) which is the only C2 domain of UNC-13/Munc13 proteins to bind 
phospholipids in a Ca2+-dependent manner, with a preference for phosphoinositides like 
phosphatidylinositol phosphate (PIP) and phosphatidylinositol 4,5-bisphosphat (PIP2) 
(Shin et al., 2010). The C2B domain is preceded by a C1 domain that is homologous to the 
diaglycerol (DAG)/phorbolester-binding domain of protein kinase C. Point mutations that 
disable the binding of DAG to Munc13-1 cause perinatal lethality in mice and a significant 
decrease in the RRP without changes in the EPSC amplitude, resulting in an increase in 
the vesicular release probability (Pvr) in autaptic neuron cultures (Ahmed et al., 1992; 
Aravamudan et al., 1999; Lackner, 1999; Maruyama and Brenner, 1991; Rhee et al., 
2002). Preceeding the C1 domain, members of the UNC-13/Munc13 proteins contain a 
Calmodulin-binding region, which is functionally highly conserved and mediates Ca2+-
dependent Calmodulin-binding to UNC-13/Munc13 proteins (Aravamudan et al., 1999; Hu 
et al., 2013; Junge et al., 2004; Lipstein et al., 2012, 2013; Rodríguez-Castañeda et al., 
2010). Mice which express a Munc13-1 variant that has lost its ability to bind Ca2+-
Calmodulin, are viable, develop normally and show no major changes in basic synaptic 
transmission characteristics. However, these mice exhibited a deficit in synaptic vesicle 
priming during high activity at the calyx of Held synapse, a highly specialized 
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glutamatergic synapse in the auditory pathway that is an established model to study 
plasticity characteristics (Lipstein et al., 2013).  
In contrast to the highly conserved C-termini of UNC-13/Munc13 proteins, the N-terminal 
domain structures vary significantly between isoforms. The only exceptions are UNC-13L 
in C.elegans and Munc13-1 and ubMunc13-2 in mammals, which exhibit homologous N-
terminal sequences. These isoforms contain a third C2 domain (C2A), which does not bind 
phospholipids in a Ca2+-dependent manner like the C2B domain, but mediates binding to 
the Rab3a-interacting molecule (RIM), a cytoskeletal component of the presynaptic active 
zone that has been shown to have a role in localizing Ca2+-channels to the active zone 
and in docking and priming synaptic vesicles in their vicinity (Andrews-Zwilling et al., 
2006; Betz et al., 2001; Fernández-Busnadiego et al., 2013; Han et al., 2011; Kaeser et 
al., 2011, 2012). 
Mice lacking Munc13-1 die perinatally and electrophysiological recordings from 
glutamatergic hippocampal autaptic neurons in culture revealed a severe decrease in the 
RRP size measured by hyperosmotic sucrose solution, in the spontaneous release of 
synaptic vesicles and in Ca2+-dependent evoked release (Augustin et al., 1999a). 
Augustin et al., observed no changes in the number of synaptic vesicles and in the 
number of docked vesicles in electron micrographs after chemical fixation (Augustin et al., 
1999a). Mice deficient of both Munc13-1 and Munc13-2 isoforms die prenatally and exhibit 
a complete shutdown of excitatory and inhibitory neurotransmission in hippocampal 
neuron cultures with no apparent changes in synapse density, synapse morphology, 
synaptic vesicle density and the number of membrane-attached synaptic vesicles in 
electron micrographs after chemical fixation (Varoqueaux et al., 2002).  
Taken together, it is evident that members of the Munc13 family are essential proteins in 
neurotransmission since null mutants cause a complete loss of spontaneous and evoked 
synaptic transmission. The fact that application of hypertonic sucrose solution fails to 
trigger vesicle release in these mutants implies a complete absence of readily-releasable 
fusion-competent vesicles, despite normal numbers of morphologically docked synaptic 
vesicles in electron micrographs from chemically fixed samples. These findings 
established Munc13s as proteins important for mediating a molecular priming step 
downstream of synaptic vesicle docking. However, synapses lacking UNC-13 in C. 
elegans and Munc13-1 and -2 in mice were recently shown to exhibit an almost complete 
loss in the number of docked synaptic vesicles, analyzed using improved cryo-fixation 
methods combined with electron tomography, a method permitting three-dimensional 
reconstruction of synaptic organelles with nanometer resolution (See: 1.5.3 Transmission 
electron microscopy and electron tomography) (Gracheva et al., 2006; Siksou et al., 2009; 
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Weimer et al., 2006). These findings indicated that Munc13s, major molecules in synaptic 
vesicle priming, also have a role in synaptic vesicle membrane-attachment and that the 
concept of subsequent docking and priming steps prior to synaptic vesicle fusion has to 
be revised.  
 
1.3.3.   Ca2+-dependent activator protein for secretion (CAPS) 
 
The Ca2+-dependent activator protein for secretion (CAPS) family consists of two ~145 
kDa proteins, which were originally identified as essential cytosolic factors for regulated 
Ca2+-dependent release in PC12 cells (Walent et al., 1992). CAPS proteins are highly 
conserved across species and have structural homology to members of the Munc13 
family (Koch et al., 2000). Whereas C. elegans and Drosophila only express one CAPS 
isoform (UNC-31 & dCAPS), it has been shown that mammals express two isoforms, 
CAPS-1 and -2 (Jockusch et al., 2007; Speidel et al., 2003). CAPS proteins contain a 
single Munc13 homology domain, which includes a Syntaxin-1-binding region (Betz et al., 
1997; Khodthong et al., 2011; Koch et al., 2000). Moreover, the domain structure of CAPS 
proteins contains an N-terminal dynactin-binding region, followed by a C2 domain that can 
bind phospholipids in a Ca2+-dependent manner, indicating a role of CAPS in Ca2+-
dependent membrane interactions (Grishanin et al., 2002; Sadakata et al., 2007a). The C2 
domain is followed by a pleckstrin homology (PH) domain, a structural motif that can 
associate with acidic phospholipids of the plasma membrane and that can bind to PIP2 
(Grishanin et al., 2002). A C-terminal stretch of acidic amino acids mediates binding of 
CAPS to LDCVs and seems crucial for normal CAPS function in PC12 cell secretory 
vesicle release in addition to the required Ca2+-dependent PIP2 binding to the PH domain 
(Grishanin et al., 2002, 2004). For many years, most studies had indicated a specific role 
of CAPS in LDCV priming and release in neuroendocrine tissues (Elhamdani et al., 1999; 
Grishanin et al., 2002, 2004; Liu et al., 2008, 2010; Rupnik et al., 2000; Speidel et al., 
2003, 2005, 2008; Tandon et al., 1998; Wassenberg and Martin, 2002).  
 
Western blot analysis and immunotainings for CAPS-1 reveals the presence of CAPS-1 in 
neuroendocrine tissues, for example in chromaffin cells of the adrenal medulla, in 
glucagon-containing α-cells of the pancreas, and in endocrine cells of the anterior pituitary 
(Sadakata et al., 2007b; Walent et al., 1992; Wassenberg and Martin, 2002). However, 
CAPS-1 is also strongly expressed in the brain, especially in the hippocampus and in the 
cerebellar granule cell layer, where its immunolabelling pattern co-localizes with the 
synaptic vesicle marker Synaptophysin, indicating a synaptic localization of the protein 
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(Speidel et al., 2003; Walent et al., 1992; Wassenberg and Martin, 2002). CAPS-2 
expression appears to be distinct from CAPS-1 and displays a strong level of co-
localization with neutrophin-3 and brain-derived neurotrophic factor (BDNF), both factors 
important for neurodevelopmental processes in cerebellum (Sadakata et al., 2006, 2007c; 
Speidel et al., 2003). The widespread presence of CAPS in synaptic terminals in almost 
all brain regions, including terminals which do not contain many LDCVs, raised the 
question as to whether or not CAPS proteins have a role in synaptic vesicle release 
(Jockusch et al., 2007).  
 
In Drosophila neuromuscular junction synapses, the loss of CAPS causes a severe 
reduction in LDCV release reflected by an accumulation of LDCVs in the terminals, but 
showed additional defects in the release of synaptic vesicles, with a reduction of the 
excitatory responses by 50% and a morphological accumulation of synaptic vesicles 
(Renden et al., 2001). However, the defects in glutamatergic synaptic vesicle release 
could not be rescued by genetically targeted expression of rat CAPS at the neuromuscular 
junction, leading to the interpretation that CAPS might influence fast synaptic transmission 
indirectly by preventing the delivery of components of the synaptic vesicle release 
machinery by LDCVs (Renden et al., 2001). Mice lacking both CAPS isoforms do not 
survive birth, whereas mice lacking only CAPS-2 are phenotypically indistinguishable at 
birth from wild-type mice (Jockusch et al., 2007; Speidel et al., 2003). Hippocampal 
autaptic neurons cultures from CAPS-1/2 double knock-out (DKO) mice display a complex 
phenotype. In 38% of all neurons, no evoked or spontaneous release could be detected, 
with a non-measurable RRP after hypertonic sucrose application (Jockusch et al., 2007). 
The remaining 62% of the cells exhibited a 68% decrease in the EPSC amplitude after 
stimulation and an 85% reduction in the size of the RRP. Synapse morphology and 
density as well as the number of total and docked synaptic vesicles in glutamatergic 
synapses were unchanged in electron micrographs of chemically fixed samples (Jockusch 
et al., 2007).  
 
The current model poses that CAPS may prime synaptic vesicles by regulating SNARE 
complex assembly, since CAPS stimulates formation of trans-SNARE complexes from 
Syntaxin-1/SNAP25 acceptor and Synaptobrevin-2 donor in liposomes fusion assays 
(Daily et al., 2010; James et al., 2008, 2009, 2010; Khodthong et al., 2011). However, the 
role of CAPS proteins in synaptic vesicle priming is still heavily debated as many groups 
claim that the observed physiological deficits in neurotransmission in CAPS-1/2 DKO mice 
are rather an indirect consequence of deficits in synaptic LDCV secretion (reviewed in 
Rizo and Südhof, 2012; Stevens and Rettig, 2009; Südhof, 2012). Until now, the function 
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of CAPS proteins in synaptic vesicle docking has not been assessed using improved cryo-
preservation methods for EM in any experimental setting.   
 
1.3.4.   Synaptotagmin-1 
 
The fusion of docked and primed vesicles in response to action potential-evoked 
elevations in presynaptic Ca2+ concentrations occurs within milliseconds. The neuronal 
vesicular protein Synaptotagmin-1 has been proposed to be the Ca2+-sensor to trigger 
evoked release in neurons (Brose et al., 1992; Fernández-Chacón et al., 2001; Geppert et 
al., 1994).  
 
Synaptotagmin-1 is a 65 kDa vesicular protein comprising one N-terminal TMR, which 
serves as a vesicular anchor, and two C2 domains, C2A and C2B, which are connected by 
a flexible linker and able to bind three and two Ca2+ ions, respectively (Fernandez et al., 
2001; Fernández-Chacón et al., 2001; Shao et al., 1998; Ubach et al., 1998). The C2 
domains can bind anionic phospholipids (e.g. PIP2) in both a Ca
2+-independent manner, 
through a stretch of polybasic amino acids, and in a Ca2+-dependent manner at the Ca2+-
binding pocket (Araç et al., 2006; van den Bogaart et al., 2011; Li et al., 2006; 
Radhakrishnan et al., 2009). Moreover, Synaptotagmin-1 has been shown to interact with 
t-SNAREs and the SNARE complex (Choi et al., 2010; Kim et al., 2012; Lai et al., 2011; 
Rickman et al., 2004; Zhou et al., 2013). However, whether this interaction has 
physiological relevance for the Ca2+-triggering step in neurons in vivo remains unclear 
since Synaptotagmin-1 binding appeared to be weak and transient through electrostatic 
interactions, and may actually be indirect through Syntaxin-1-bound PIP2 (Choi et al., 
2010; Honigmann et al., 2013). 
 
Early studies showed that Synaptotagmin-1 KO mice die perinatally and that neurons 
lacking Synaptotagmin-1 exhibit a severe reduction in the fast component of the Ca2+-
evoked EPSC. No changes were observed in the mEPSC frequency or in the size of the 
RRP after hypertonic sucrose application, a means of triggering release of primed vesicles 
in a Ca2+-independent manner (Geppert et al., 1994). Since then, many physiological 
functions have been proposed for Synaptotagmin-1 in addition to its ability to trigger Ca2+-
dependent synchronous neurotransmitter release. However, different organisms or culture 
systems often revealed conflicting results. Synaptotagmin-1 was proposed to have a role 
in inhibiting release by acting as a fusion clamp that can be relieved in a Ca2+-dependent 
manner during SNARE-mediated fusion, reflected by an increase in the mini-frequency of 
inhibitory and excitatory PSCs in dissociated neuron cultures and hippocampal slice 
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cultures from Synaptotagmin-1 KO mice (Kerr et al., 2008; Liu et al., 2009; Xu et al., 
2009). Moreover, in neurons of C.elegans, Drosophila and mice, as well as in chromaffin 
cells, Synaptotagmin-1 deletion results in a reduction in the number of membrane-
attached synaptic vesicles and LDCVs, respectively, indicating a role of Synaptotagmins 
in a docking process prior to Ca2+-triggering (Jorgensen et al., 1995; Liu et al., 2009; Reist 
et al., 1998; de Wit et al., 2009; Yu et al., 2013). In addition, a reduction in total synaptic 
vesicle numbers was observed in Synaptotagmin-1 KO synapses, possibly related to a 
role of Synaptotagmin-1 in vesicle recycling (Jorgensen et al., 1995; Kononenko et al., 
2013; Maritzen et al., 2010; Reist et al., 1998). In contrast to these morphological findings, 
cultured mammalian hippocampal neurons lacking Synaptotagmin-1 exhibit no, or only 
very little changes in the size of the RRP measured after application of hypertonic sucrose 
solution or during Ca2+-uncaging experiments (Burgalossi et al., 2012; Geppert et al., 
1994; Liu et al., 2009; Xu et al., 2009). These results indicate that Synaptotagmin-1 most 
likely does not play an essential role in the physiological synaptic vesicle priming step, but 
rather support a model according to which Synaptotagmin-1 has, if any, a regulatory 
function in synaptic vesicle priming, in addition to its function as a  Ca2+-sensor.  
 
In summary, the mechanism by which Synaptotagmin-1 triggers Ca2+-evoked 
neurotransmitter release and the processes in which it participates prior to Ca2+-triggering 
(e.g. inhibitory fusion clamp for spontaneous release or membrane-attachment) remains 
unclear and a point of controversy (reviewed in Chapman, 2008; Jahn and Fasshauer, 
2012; Rizo et al., 2006). The observed morphological docking phenotypes in 
Synaptotagmin-1 null mutant cells and results from recent in vitro studies indicate that the 
interaction of Synaptotagmin-1 with the plasma membrane and/or t-SNARE acceptor 
complexes might indeed be the molecular correlate of synaptic vesicle priming. This 
model challenges the idea of a (partially) assembled SNARE complex prior to fusion and 
would rather place SNARE complex zippering downstream of priming to result in 
immediate membrane fusion.  
 
1.3.5.   Complexins 
 
Another protein family called Complexins has been shown to function in the Ca2+-
triggering step of evoked neurotransmitter release in neurons (reviewed in Brose, 2008). 
In mammals, the Complexin family consists of four members (Complexin-1 to -4), each of 
around 20 kDa, with Complexin-1 and -2 being predominantly expressed in the brain and 
Complexin-3 and -4 being strongly expressed in the retina (Reim et al., 2001, 2005, 2009; 
Xue et al., 2008). Complexin-3 is also expressed to a lower extent in the brain (Xue et al., 
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2008). Complexins are small molecules (~20 kDa) that can bind with a central α-helix in 
an antiparallel orientation to the at least partially assembled SNARE complex in a groove 
between the SNARE motifs of Synaptobrevin-2 and Syntaxin-1 (Chen et al., 2002). By this 
mode of action, murine Complexin isoforms have previously been shown to facilitate fast 
neurotransmitter release in a post-priming step ('super-priming') since the EPSC 
amplitude and the vesicular release probability was drastically reduced with no 
concomitant changes in the RRP size or in the number of docked vesicles in mouse 
hippocampal neurons (Reim et al., 2001; Xue et al., 2007, 2008). According to this model, 
Complexins might stabilize partially assembled SNARE complexes in the primed state 
prior to fusion, thus enabling rapid zippering after Ca2+-triggering. However, structure-
function analyses of murine and Drosophila Complexin isoforms revealed that distinct 
domains might execute different but conserved functions, with the central and an 
accessory α-helix coordinating inhibitory effects of the fast, synchronous release and an 
unstructured N-terminal sequence facilitating Ca2+-evoked release (Cho et al., 2010; Xue 
et al., 2007, 2009, 2010). Recent studies described a drastic decrease in the RRP size 
and a massive increase in the mEPSC frequency after lentiviral knock-down of 
Complexins in mammalian neuron mass culture systems, which was not observed in 
similar knock-down experiments for Synaptotagmin-1, indicating a priming role for 
Complexins upstream of Synaptotagmin-1 function and an additional role as a fusion 
clamp for asynchronous and spontaneous release in concert with Synaptotagmin-1 (Cao 
et al., 2013; Kaeser-Woo et al., 2012; Tang et al., 2006; Yang et al., 2010). According to 
this model, Complexins would inhibit full SNARE complex zippering and therefore prevent 
synaptic vesicle fusion prior to Ca2+-triggering, suggesting a dominantly inhibitory role for 
Complexins. This model is supported by data obtained from C. elegans Complexin null 
mutants, which revealed a severe reduction in evoked release and in the number of 
docked vesicles, most likely due to an increase in spontaneous fusion events caused by 
an absence of inhibitory Complexin-mediated clamping-functions (Hobson et al., 2011). In 
Drosophila Complexin mutants, Complexin seems to regulate synchronous and 
asynchronous release with no changes in the number of membrane-attached synaptic 
vesicles at the neuromuscular junction synapse, thereby supporting the model of 
Complexins being inhibitors of spontaneous release and facilitators of evoked release, 
most likely by stabilizing partially assembled SNARE complexes and preventing 
premature synaptic vesicle fusion by preventing Synaptotagmin-1 / SNARE complex 
interactions (Jorquera et al., 2012).  
 
In summary, the functional role of Complexins in mammalian neurons is still heavily 
debated. Most of the recent discussion has focused primarily on: (1) understanding the 
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physiological relevance of a multiple role for Complexins in synaptic vesicle priming as 
well as in facilitating and inhibiting neurotransmitter release, and (2) resolving the 
molecular interactions of Complexins with the SNARE complex and with the Ca2+-sensor 
Synaptotagmin-1 (reviewed in Brose, 2008; Jahn and Fasshauer, 2012; Neher, 2010; 
Sørensen, 2009; Südhof and Rothman, 2009).  
 
1.4.   Ultrastructural analysis of synaptic vesicle docking 
 
Transmission electron microscopy is the key method in studying synaptic morphology and 
the only method permitting the distances between synaptic vesicles and the active zone 
membrane to be measured accurately. EM enables the analysis of synaptic ultrastructure 
in the nanometer range, and due to the fact that plastic-embedded EM samples can be 
cut to sections as thin as 20 nm, it has the highest z-resolution of any cellular microscopy 
techniques to date.  
 
1.4.1.   Classical aldehyde-based fixation methods for electron microscopy 
 
Classically, EM studies have employed aldehyde-based (e.g. paraformaldehyde and 
glutaraldehyde) chemical fixation methods of the tissue followed by heavy metal 
membrane contrasting, dehydration and embedding in a plastic resin that allows ultrathin 
(20 – 100 nm) sectioning (Hayat, 200; Sabatini et al., 1963). Aldehydes crosslink networks 
of proteins, thus preserving much of the ultrastructure of biological samples. In addition, 
the cell membranes are stained by heavy metals, such as osmium tetroxide (OsO4), 
uranyl acetate or lead citrate, which readily react with phospholipids in lipid bilayers, 
resulting in an electron-dense precipitate on cell membranes for excellent contrast for EM 
(Hayat 2000). However, these traditional methods cause several problems when studying 
synaptic ultrastructure and in particular synaptic vesicle docking at the active zone. First, 
fixative diffusion into the tissue is a rather slow process (minutes to hours), which results 
in gradual rather than rapid fixation of the sample (Smith and Reese, 1980). Moreover, 
aldehydes have been shown to even trigger synaptic vesicle release during the fixation 
process, which makes reliable quantification of membrane-attached synaptic vesicles 
rather difficult (Smith and Reese, 1980). Second, the crosslinking process by aldehydes 
and heavy-metal stains result in dense protein networks composed of cytoskeletal 
components as it has been described for the presynaptic active zone (“dense projections”, 
“presynaptic vesicular grid”), which appear as electron-dense, aggregated structures that 
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may not provide a realistic picture of synaptic ultrastructure (Gray, 1963; Landis et al., 
1988; Pfenninger et al., 1969, 1972; Südhof, 2012).  
 
Third, the biggest problem for studying synaptic vesicle docking is the necessity for 
samples to be dehydrated prior to embedding in plastic, which cannot polymerize 
efficiently in the presence of water (Hayat 2000) This process, whereby sample tissue 
water is substituted by organic solvents (e.g. ethanol, propylene oxide), is typically 
performed at room temperature and introduces sample shrinkage and deformation of 
membranes that make the exact analysis of synaptic vesicle distances rather ambiguous 
(Möbius et al., 2010; Murk et al., 2003; Rostaing et al., 2006; reviewed in Verhage and 
Sørensen, 2008). To take these fixation artifacts into account, many studies defined all 
vesicles within a certain distance of the active zone membrane (e.g. a vesicle diameter of 
30-40 nm) as docked. This definition enables the analysis of vesicle docking despite 
severe membrane deformations, but it clearly overestimates the number of membrane-
attached synaptic vesicles and cannot distinguish between loose tethering and actual 
membrane attachment. 
 
1.4.2.   Cryo-fixation methods for electron microscopy 
 
In recent years, it has become obvious that rapid cryo-immobilization methods for EM 
possess several advantages in comparison to classical chemical fixation methods, and 
cryo-fixation has become the method of choice to study synaptic ultrastructure and 
dynamic cellular processes such as synaptic vesicle docking (Dubochet, 1995; 
Fernández-Busnadiego et al., 2010a, 2011, 2013; Frotscher et al., 2007; Heuser et al., 
1979; Landis et al., 1988; Rostaing et al., 2006; Siksou et al., 2007, 2009; Zuber et al., 
2005). Cryo-fixation methods exploit the ability of rapid freezing to prevent destructive ice-
crystal formation and promote the formation of vitreous (amorphous) ice. Samples thinner 
than 500 nm (e.g. monolayer neuron cultures, purified synaptosomes) can be frozen 
easily by a method called plunge freezing (Fernández-Busnadiego et al., 2011). Thicker 
samples (e.g. organotypic slice cultures, acute slices) require a method called high-
pressure freezing (reviewed in Dubochet 1995). In this process, the sample is frozen 
under high pressure (~ 2100 bar) at low temperatures within milliseconds, resulting in 
vitrified samples that exhibit minimal perturbation of ultrastructure (Dubochet 2009). High-
pressure freezing can rapidly (< 10 ms) immobilize physiologically active synapses in 
cultured organotypic hippocampal slices from lethal KO mutants, providing snapshots of 
dynamic cellular processes, such as exo- and endocytosis of synaptic vesicles, to be 
captured with high temporal resolution (Fernández-Busnadiego et al., 2010; Frotscher et 
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al., 2007; Siksou et al., 2009; Zuber et al., 2005). In contrast to the room temperature 
dehydration steps typically employed in classical EM sample preparation protocols, high-
pressure frozen samples are substituted at low temperatures to minimize sample 
shrinkage in a process called freeze substitution. During this process, cellular components 
are fixed and contrasted at subzero temperatures to minimize perturbation of 
ultrastructure prior to plastic embedding (Giddings, 2003; Jiménez et al., 2009; McDonald, 
2007). Limitations of this method are that only relatively small samples are suitable for 
high-pressure freezing and that suboptimal cryo-fixation can result in artefacts (sometimes 
subtle) resulting from ice-crystal formation, such as deformed or ruptured membranes, 
that require careful evaluation of the ultrastructural preservation quality (Möbius et al., 
2010). Moreover, the high-pressure applied during the freezing process requires the use 
of an external cryoprotectant / filler in order to prevent air in the freezing chamber and to 
improve ultrastructural sample preservation (McDonald, 2007). Commonly used 
cryoprotectants include dextran or sucrose solutions, which may increase the osmolarity 
of the sample environment to over 600 mOsm and may stimulate vesicular release from 
synaptic terminals (Dubochet, 1995; Fernández-Busnadiego et al., 2010; Südhof, 2012; 
Zuber et al., 2005).  
 
As a consequence of these technical improvements, the optimized ultrastructural 
preservation for electron microscopy revealed a more accurate view of synaptic 
morphology in a near-native state. Reduced sample shrinkage, and therefore improved 
membrane preservation, enables the use of more stringent docking definitions, and 
usually exclusively vesicles in physical contact with the active zone membrane are 
considered docked (reviewed in Verhage & Sørensen 2008). However, in 2D electron 
micrographs, vesicles will only appear in direct contact with the plasma membrane if their 
midline is contained within the volume of the ultrathin section, which will lead to an 
underestimation of the number of membrane-attached vesicles using this criterion. 
Moreover, curvature of the active zone membrane can obscure small gaps between 
synaptic vesicles and the plasma membrane, leading to the false-positive identification of 
non-attached vesicles. To circumvent this problem, electron tomography (ET), a method 
permitting three-dimensional reconstruction of synaptic organelles with nanometer 
resolution, can be applied.  
 
1.4.3.   Transmission electron microscopy and electron tomography 
 
Transmission electron microscopy is a method in which a high voltage electron beam is 
transmitted through a semi-transparent, thin-sectioned specimen sample. The electrons 
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are emitted by an electron gun, in which electrons originate from a cathode and are 
accelerated by high voltage (~80-300 kV) to provide enough energy to penetrate the 
specimen. The electron beam that passes the specimen conveys information about its 
structure and the image is magnified by a magnetic lens system within the microscope 
and finally detected by a charge-coupled device (CCD) camera. Cellular electron 
tomography is a technique, which employs a rotatable sample holder in order to allow 
acquisition of an image series at different tilt angles over a large angular range (~-60° to 
+60°, in 1-2° increments). These two-dimensional projection images can be aligned (a 
process typically facilitated by application of surface fiducial markers), and then be used to 
reconstruct a three-dimensional volume, e.g. by applying a weighted backprojection 
algorithm (Koster et al., 1997). Due to technical limitations, the specimen cannot be tilted 
up to 90° in one direction as the path length of electrons traversing the specimen 
increases dramatically at high angles which leads to increased electron scattering and 
induces noise and thus results in limitations in the sample thickness for imaging. In recent 
years (cryo)-electron tomographic techniques have revolutionized the field of 
neuroscience as they enable the capture of detailed synaptic structural and functional 
information like cytoskeletal arrangements, vesicle populations, exo-and endocytotic 
events, and most importantly provided the most reliable and reproducible tool to study 
synaptic vesicle docking to the active zone release sites (Fernández-Busnadiego et al., 
2010, 2011, 2013; Liu et al., 2009; Siksou et al., 2007, 2009, 2011). 
 
1.5.   Aim of the study 
 
The aim of the first part of the present study was to address the following questions:  
(1) Do morphological synaptic vesicle docking and functional synaptic vesicle priming 
represent independent, subsequent steps prior to synaptic neurotransmitter release or are 
they indeed correlates of the same molecular process? 
(2) Does synaptic vesicle docking require trans-SNARE interactions or is it rather 
mediated by Synaptotagmin-1 t-SNARE/plasma membrane binding.  
 
The first question was primarily motivated by the fact that synapses lacking Munc13 
priming proteins are completely devoid of fusion-competent as well as membrane-
attached synaptic vesicles in cryo-preserved samples for EM (Siksou et al., 2009). My fist 
aim was to set up a similar methodological approach combining the organotypic 
hippocampal slice culture system with high-pressure freezing fixation and freeze 
substitution for electron tomographic analysis. These methods would allow me to analyze 
synaptic parameters in an in-situ-like setting using lethal presynaptic mouse mutants that 
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do not survive birth, and to apply high-resolution three-dimensional EM analysis to assess 
synaptic vesicle docking at glutamatergic, excitatory spine synapses of the hippocampus. 
 
First, I studied members of the CAPS family, which have a crucial role in synaptic vesicle 
priming, but conventional chemical fixation methods for EM have not yet been able to 
reveal a deficit in synaptic vesicle membrane-attachment (Jockusch et al., 2007). I 
therefore planned to reassess the function of CAPS proteins in synaptic vesicle docking in 
my experimental setting.  
 
Second, Munc13s and CAPS proteins are thought to initiate or regulate (partial) SNARE 
complex formation during vesicle priming. Therefore, my next aim was to elucidate the 
functions of the individual SNARE proteins Synaptobrevin-2, Syntaxin-1 and SNAP25 in 
synaptic vesicle docking. The outcome of these experiments would yield important 
information on the role of the SNARE complex in the synaptic vesicle docking/priming 
step. Moreover, it would help to answer the question whether stable trans-interactions 
between the v-SNARE Synaptobrevin-2 and the t-SNAREs Syntaxin-1 and SNAP25 
would indeed be possible prior to Ca2+-triggering in vivo.  
 
Third, I wanted to elucidate the function of the Ca2+-sensor Synyaptotagmin-1 in synaptic 
vesicle docking in my experimental system. Synaptotagmin-1 has recently been proposed 
as the vesicular molecular partner in the secretory vesicle membrane-attachment step (Liu 
et al., 2009; de Wit et al., 2009). If indeed the interaction of Synaptotagmin-1 with the t-
SNARE acceptor complex and/or the plasma membrane were the process underlying 
synaptic vesicle docking, Synaptobrevin-2 engagement and SNARE-complex formation 
would occur only downstream of synaptic vesicle docking during Ca2+-triggering and 
fusion. In this context I planned to reinvestigate the role of Complexins in synaptic vesicle 
docking in my experimental system. Complexin KO mice have been shown to exhibit a 
drastic decrease in evoked Ca2+-dependent release, with no changes in the size of the 
RRP or increase in the rate of spontaneous release. Other studies propose a role of 
Complexins in inhibiting full SNARE complex formation in concert with Synaptotagmin-1 
prior to Ca2+-triggering and in synaptic vesicle priming.  
 
The aim of the second part of the present study was to generate a Munc13-1 conditional 
KO mouse line. As mentioned above, genetic deletion of all Munc13 isoforms leads to 
complete shutdown of synaptic transmission in the majority of neuron types, with no effect 
on neuronal survival or major changes in neuron development and morphology in 
cultures. Loss of Munc13-1, the dominant isoform in most cell types, causes perinatal 
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lethality, so that analysis of the function of Munc13-1 in neuronal networks in vivo has not 
yet been possible. A conditional Munc13-1 KO mouse line will help to understand the 
function of Munc13-1 in physiological networks, at different time-points of brain 
development and in brain regions that have been proven difficult to study in culture 
systems (e.g. Calyx of Held synapse). 
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All experiments performed on mice were conducted in compliance with the guidelines for 
the welfare of experimental animals issued by the Federal Government of Germany 
(Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit 
Permission 33.9.42502-04/103/08) and the Max Planck Society. The mouse lines used in 
this study and a reference to the original publication are listed below. Munc13, CAPS and 
Complexin knock-out (KO) mouse lines were originally generated in the host laboratory of 
Prof. Nils Brose. A Munc13-1 conditional knockout mouse line was generated within this 
study and is not listed below. 
2.1.1. Mouse lines 
 
Munc13-1 KO (Augustin et al., 1999a) 
Munc13-2 KO (Varoqueaux et al., 2002) 
CAPS-1 KO (Speidel et al., 2005) 
CAPS-2 KO (Jockusch et al., 2007) 
Complexin-1 KO (Reim et al., 2001) 
Complexin-2 KO (Reim et al., 2001) 
Complexin-3 KO (Xue et al., 2008) 
Synaptotagmin-1 KO (Geppert et al., 1994), bought from “The Jackson Laboratory“ 
Synaptobrevin-2 KO (Schoch et al., 2001), bought from “The Jackson Laboratory“ 
SNAP25 KO (Washbourne et al., 2002), kindly provided by Dr. M. Loos and Dr. I. Herfort 
Syntaxin-1A KO (Gerber et al., 2008), kindly provided by Prof. C. Rosenmund 
Syntaxin-1B
YFP 
(Arancillo et al., 2013), kindly provided by Prof. T. Südhof and Prof. C. Rosenmund 
 




2.2.1.1. Chemicals and Reagents 
Product Company Cat. No. 
1 kb DNA ladder, 0.05 µg/µl Fermentas SM0311 
10× RedTaq® PCR Reaction Buffer Sigma-Aldrich B5926 
100 bp DNA ladder, 0.05 µg/µl Fermentas SM0322 
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Product Company Cat. No. 
10x Cloned Pfu DNA Polymerase Buffer Stratagene 200532 
10x rAPid Alkaline Phosphatase Buffer Roche 04 898 133 001 
1kb DNA ladder Invitrogen 15615-016 




5x Ligation Buffer Invitrogen 46300-018 
Ammonium Acetate (NH4Ac) Merck 1.011.161.000 
Ampicillin Sigma-Aldrich   
BD Bacto™ Agar BD Diagnostic Systems 214010 
Bromophenol Blue Merck 8122 
BSA (digest) New England Bio Labs B90015 
Chloramphenicol Calbiochem  220551 
Chloroform Merck 1.024.451.000 
Cloned Pfu Polymerase Stratagene 600153-81 
dNTP Set Bioline BIO-39025 
Ethylenediaminetetraacetic Acid Trisodium Salt (EDTA) Sigma E1644 
Ethanol Sigma-Aldrich 32205 
Etidium Bromide Carl Roth 2218.2 
Gel Red BIOTIUM  730-2958 
Glycerol Merck 1.040.940.500 
Hydrochloric Acid (HCL) Merck 1.003.172.500 
Isopropanol Merck 1.096.342.500 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Carl Roth 2316.4 
Kanamycin Sigma-Aldrich   
L-(+)-arabinose Sigma-Aldrich A3256 
Luria Broth Sigma-Aldrich L3522 
Lysozym  Sigma-Aldrich L6876 
MidRange PFG Marker I New England Bio Labs N3551S 
NEB buffers New England Bio Labs   
P1 buffer Quiagen 19051 
P2 buffer  Quiagen 19052 
P3 buffer  Quiagen 19053 
Phenol Carl Roth 382 
Plastikwaren Greiner, Falcon, Costar und 
Brandt 
  
Potassium chloride (KCl) Merck 1.049.361.000 
rAPid Alkaline Phosphatase Roche 04 898 133 001 
REDTaq® DNA Polymerase  Sigma-Aldrich D4309 
Restriction Enzymes New England Bio Labs   
Rnase A Roche 10109169001/11
3 
Sodium Acetate (NaAc) Merck 1.062.680.250 
Sodium Chloride (NaCl) Merck 1.076.511.000 
Tris-Base Sigma-Aldrich T1503 
                                                                                             2. Material and Methods 
 25 
Product Company Cat. No. 
T4 DNA ligase Invitrogen 15224-017 
Triton-X-100 Roche 10 789 704 001 
UltraPure™ Agarose Invitrogen 16500500 
Lysozym  Sigma-Aldrich L6876 
MidRange PFG Marker I New England Bio Labs N3551S 




BIO-RAD electroporator BIO-RAD 
BioScience Ultrospec3100pro Amersham 
Gene Amp PCR system Applied Biosystems 
Peltier Thermal Cycler 255 MJR Research 
Chef-DR II Pulsed Field Electrophoresis System Bio-RAD 
 
2.2.1.3. Media and buffer 
 
Ampicillin Stock 20 mg/ml 
Kanamycin Stock 10 mg/ml 
Chloramphenicol Stock 25 mg/ml in ethanol 
LB-Medium (25 g Luria Broth in 1 L ddH2O) 
LB Agar plates (15 g Bacto-Agar in 1 L LB Medium  
6x Loading Buffer (10 ml 1M Tris-HCl pH 7.5, 300 mg Bromphenolblau, 600 ml 87% Glycerol, 120 
ml 0.5 M EDTA; add H20 to 1000 ml) 
STET buffer (100 mM NaCl, 10 mM Tris/HCl (pH 8.0), 1 mM EDTA, 5% Triton X-100) 
TE buffer (10 mM Tris/HCl (pH 7.4), 1 mM EDTA) 
1xTBE buffer was used (89 mM Tris, 8 mM boric acid, 0.2 mM Na2-EDTA) 
1xTAE buffer (40 mM Tris, 20 mM acetic acid, and 1 mM EDTA) 
P1 buffer (50 mM TrisCl (pH 8.0), 10 mM EDTA, 100 µg/ml RNase A) 
P2 buffer (200 mM NaOH, 1% SDS (w/v)) 
P3 buffer (3.0 M potassium acetate (pH 5.5) 
Lysozyme solution (10 mg/ml in STET buffer) 
 
2.2.1.4. Vector plasmids  
 
Product Company/Institution 
pBluescript II SK +/- Stratagene, Heidelberg 
PL253 Biological Resources Branch, DCTD 
NCI-Frederick Cancer Research and 
Development Center 




Biological Resources Branch, DCTD 
NCI-Frederick Cancer Research and 
Development Center 
PL451 
Biological Resources Branch, DCTD  
NCI-Frederick Cancer Research and 
Development Center 
pCR®2.1-TOPO® vector Invitrogen 
bMQ 441 l13 (pBACe3.6) The Welcome Trust Sanger Institute 
pFUGW Salk Inst., Dr. Inder M. Verma 
pFUGW-iCre 
Provided by Prof. Dr. Richard L. Huganir (Lois et 
al., 2002) 
PACK Provided by Prof. Dr. Pavel Osten 
ENV Provided by Prof. Dr. Pavel Osten 
The pFUGWiCre vector with an insertion of IRES-iCre downstream of EGFP in the 
pFUGW vector (Lois et al., 2002) was a kind gift from Dr. R. Huganir (Baltimore, MD, 
USA). 
 
2.2.1.5. Bacterial Strains 
 
Product Company 
E. coli competent XL1-Blue cells Stratagene, Heidelberg 
E.coli competent Electro10-Blue Stratagene, Heidelberg 
EL350 
Biological Resources Branch, DCTD 
NCI-Frederick Cancer Research and 
Development Center 
SW106 
Biological Resources Branch, DCTD 
NCI-Frederick Cancer Research and 
Development Center 
 
2.2.1.6.  Kits 
 
Product Company Cat. No. 





PureLink™ HiPure Plasmid Filter Midiprep Kit Invitrogen K2100-14 
PureLink™ PCR Purification Kit Invitrogen K3100-02 
PureLink™ Quick Plasmid Miniprep Kit Invitrogen K2100-11 
QIAquick Gel Extraction Kit  Quiagen 28706 
QIAquick PCR Purification Kit  Quiagen 28106 
TOPO TA Cloning® Kit Invitrogen K4510-20 
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2.2.1.7. Oligonucleotides  
 
All oligonucleotides used in this study were synthesized in the DNA Core Facility of the 
Max-Planck Institute of Experimental Medicine. Oligonucleotide sequences are listed 
below with their Lab ID number. Restriction sites used for molecular cloning are indicated. 
The primers 27121 – 27124 were used for the genotyping of the Munc13-1 CKO mouse 
line and will be abbreviated in the following to #1 - #4.  
 
Primer ID Sequence 
Restr. 
Site 
8431 5'-AGAGCCAAAGCCAACTG-3'  
8432 5'-GACGTCCAACTTCACCTGT-3'  




19931 5'-GGGGATCCAATTGGTAGGTGGACAGACAGATG-3' BamHI 
19932 5'-AAGCGGCCGCTCCCTCACGTCATGGCTTGGTAGA-3' NotI 
19965 5'-TCCTCGAGGTGACGGACGTGCAGAACAATGGTG-3' XhoI 
19966 5'-CAGAATTCATGTAGCCAAGGATGGTCCTGTGCTCCAGATC-3' EcoRI 
19967 5'-GGGGATCCACTGGGTGGGAAACCATCGGGCTACAA-3' BamHI 
19968 5'-GACCGCGGGAAACACTGGGCAGAGGCACACG-3' SacII 
21137 5'-GAGTGCGGCCGCTGATGTCAAGTGTTCAGAATCGATG-3' NotI 
21138 5'-GAAAAAGCTTCCAAAAATAAATAATAAATAAATAACAACAAACTA-3' HindIII 
21139 5'-TGCAAAAAGCTTCAACTGTCATGTGGGTGATGGAAATC-3' HindIII 
21140 5'-CAGGGGGATCCTGAGAAGTGGGGTATGATGGT-3' BamHI 
21141 5'-TGCTGAGGTGATGTGGAGCCTATT-3'  
21142 5'-AGGTCTTGGTGACATCAGGACTTA-3'  
24607 5'-GCTGGGGATGCGGTGGGCTCTA-3'  
24608 5'-TGTGCGTAGTAGGCGTTGATGTTG-3'  
24609 5'-CCATCCGGCTTCACATCAGT-3'  
24610 5'-AGGCCTACCCGCTTCCATTG-3'  
25153 5'-CATCGCATTGTCTGAGTAGGTGTC-3'  
25154 5'-GGGTTTAGGGAGTTTGTTTTTAGA-3'  
25155 5'-GTGTGGCTAAGGACGAGTGT-3'  
27121 (#1) 5'-CTCTATGGCTTCTGAGGCGGAAA-3'  
27122 (#2) 5'-AGTTTTCATCTTGTAGCCCGAT-3'  
27123 (#3) 5'-CAACTGGCCAAGAACTAGAGGA-3'  
27124 (#4) 5'-GCACGGAATGTTGAATGGTCTT -3'  
 
 




2.2.2.1. Generation of electrocompetent E. coli cells 
 
A single colony was picked and transferred to 5 ml LB to grow for 16-18 h with shaking. 
Three ml of the culture was transferred to 60 ml of LB (1:20 dilution) and incubated to 
reach an optical density measured at 600 nm wavelength (OD600) of 0.5 - 0.6. Cells were 
immediately put into ice slush and shaken for 5 min for a fast temperature drop and then 
placed on ice for additional 10 min. Cells were collected at 3,500 rpm at 0°C for 10 min 
and washed three times with ice-cold water. Cells were resuspended in 400 μl sterile ice-
cold water and 50 μl aliquots were prepared in precooled Eppendorf tubes and stored on 
ice. For long-term storage of cells, cells were washed and resuspended with 15% glycerol 
in water. Aliquots were immediately frozen in liquid nitrogen and stored at -80°C.  
 
2.2.2.2. Inducing Recombineering Enzymes 
 
EL350 or SW106 cells grew in 5 ml LB at 32 °C for 16-18 h with shaking. 3 ml of the 
culture was transferred to 60 ml of LB (1:20 dilution) and incubated to reach an OD600 of 
0.5 - 0.6. 50 ml of the cells were split into two new flasks and shaken in a 42°C water bath 
for 15 min. The cells were immediately put into ice slush and shaken for 5 min and then 
placed on ice for additional 10 min. Cells were then prepared for deoxyribonucleic acid 
(DNA) plasmid electroporation. 
 
2.2.2.3. Excision of the Neo cassette by arabinose induced Cre expression  
 
EL350 or SW106 cells were grown in 5 ml LB at 32°C for 16-18 h with shaking. The 5 ml 
culture was then added to 250 ml LB to grow at 32°C to reach an OD600 of 0.4. A 10% 
solution of L-(+)-arabinose in ddH2O was added to reach a final concentration of 0.1% and 
cells were shaken for another hour. Cells were then prepared for DNA plasmid 
electroporation. 
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2.2.2.4. Transformation of bacterial strains  
 
Electroporation of bacterial artificial chromosome (BAC) or plasmid DNA into bacterial 
strains was performed using a BIO-RAD electroporator at 1.8 kV, 25 μF with pulse 
controller set at 200 Ω. For conventional and pCR®2.1-TOPO® ligation reactions, 1 - 2 μl 
of the sample was electroporated per 50 μl electrocompetent cells. For freshly purified 
BAC DNA, 1 μl (≈ 4 μg) was electroporated. Then, 1 ml LB was added to each cuvette, 
cells were transferred to Eppendorf or 14 ml Falcon tubes and incubated at 37°C for 1 h. 
Cells were then spread in different concentrations on LB agar plates containing 
appropriate antibiotics for selection. For plasmid retransformations, typically only 1 ng 
DNA was electroporated. Cells were not recovered, but 20 μl was plated immediately onto 
LB agar plates containing appropriate antibiotics for selection. 
 
2.2.2.5. Glycerol stocks 
 
750 μl from an overnight culture of transformed E. coli was mixed with 750 μl 30% glycerol 
in LB in a cryo-tube, incubated for 3 min at room temperature and stored at -80°C. To 
plate cells from a glycerol stock, the tube was transported to the bench on dry ice and 
cells were spread and isolated with a sterile inoculating loop. 
 
2.2.2.6. BAC DNA preparation 
 
E. coli cells with BACs were grown in 5 ml of LB containing chloramphenicol for 16-18 h. 
Cells were collected at 3500 rpm for 15 min and resuspended in 250 μl buffer P1. Cells 
were lysed in 250 μl buffer P2 for 5 min at room temperature and the sample neutralized 
by buffer P3. Tubes were spun for 4 min at 11,000 rpm. The supernatant was transferred 
to a new tube and spun again for 4 min at 11,000 rpm. The supernatant was transferred to 
a new tube and BAC DNA was precipitated for 10 min at room temperature by adding 750 
μl isopropanol. The DNA pellet was collected at 15,000 rpm for 10 min, washed once with 
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2.2.2.7. Plasmid DNA preparation 
 
To purify plasmid DNA from bacterial cultures for sequencing, the PureLink™ Quick 
Plasmid Miniprep Kit was used. In order to purify high yields of plasmid DNA from 
bacterial cultures, the PureLink™ HiPure Plasmid Filter Midiprep Kit was used. To optain 
high yields of pure, endotoxin-free plasmid DNA for ES cell electroporation and 
HEK293FT cell transfection, the EndoFree Plasmid Maxi Kit was used. For detailed 
protocols for these Kits, please refer to the product manuals. 
 
2.2.2.8. Agarose gel electrophoresis and Pulsed field gel electrophoresis 
 
Agarose gel electrophoresis is a technique, which allows separating DNA based on its 
size in an electric field. The distance between DNA bands of different sizes depends on 
the percent agarose in the gel. Usually 0.7 – 1.5% agarose gels were used and the gels 
run at a constant voltage of 80-120 V. Samples were loaded in 1x loading buffer. For 
plasmid DNA, 1 x TBE buffer was used, whereas genomic DNA required 1 x TAE buffer. 
To visualize DNA in the gel, ethidium bromide, a DNA intercalator, was added in a 
concentration of 0.5 μg/ml to the agarose gel. Alternatively, to visualize DNA fragments for 
genotyping purposes, GelRed, a nucleic acid stain, was added the agarose gel in a 
1:200,000 dilution. Both substances, ethidium bromide and GelRed, fluoresce under 
ultraviolet light. DNA fragment sizes were estimated by different ladder mixes run in 
parallel (100 bp DNA ladder (Fermentas), 1 kb DNA ladder (Fermentas, Invitrogen)). 
 
Pulsed field gel electrophoresis was used for the separation of large DNA molecules (i.e. 
BAC DNA fragments) by applying an electric field that periodically changes direction. In 
order to analyze the BAC clones by restriction enzyme digest, DNA samples were 
separated by for 24 h on a 1% agarose gel in 0,5 x TBE buffer at 6 V/cm. The interval 
length was changing from an initial 1 sec to a final 25 sec in order to separate all 
fragments. The MidRange PFG Marker I (New England Bio Labs) ladder was run in 
parallel in order to estimate the DNA fragment sizes. 
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2.2.2.9. Agarose gel extraction of DNA fragments 
 
DNA fragments were purified with the QIAquick Gel Extraction Kit. For a detailed protocol 
for this Kit, please refer to the product manual. 
 
2.2.2.10. Phenol/Chloroform Extraction for large ( ≥ 10 kb) DNA fragments 
 
The linearized Munc 13-1 cko targeting vector was extracted by Phenol/Chloroform 
extraction. In a first step Phenol/Chloroform (1:1) was added to the digestion mix and 
vortexed for 1 min. Samples were centrifuged at 15,000 x g for 15 min and the upper 
phases were transferred into fresh tube. This procedure was repeated three times. After 
the last step, 300 μl chloroform was added to the upper phases, vortexed again for 1 min 
and the samples were centrifuged at 15,000 x g for 15 min. All following steps were 
performed in a cell culture hood. The upper phases were transferred into sterile Eppendorf 
tubes. To precipitate the DNA, 2.5 μl 3M NaAc (pH 5.2) and 500 μl 100% ethanol were 
added and the samples stored at -20°C overnight. The next day, samples were 
centrifuged at 15,000 x g for 15 min, washed three times with 70 % ethanol, pooled, air-
dried and resuspended in 200 μl sterile-filtered 0.1xTE. 
 
2.2.2.11. Polymerase Chain Reaction 
 
The polymerase chain reaction (PCR) is a method to amplify specific DNA sequences in 
order to obtain a large number of copies. The main steps of the reaction are a 
denaturation step, in which the double-stranded DNA template melts into its single strand, 
an annealing step, in which short oligonucleotides (primers) can anneal to the DNA 
strands, and an elongation step, in which the DNA polymerase synthesizes a new DNA 
strand complementary to the DNA template. The duration and the temperature of the 
individual steps depend highly on the DNA polymerase used as well as on the melting 
temperatures of the individual primer pairs used. To check the PCR results, 1 μl of each 
sample was loaded onto an agarose gel.  
PCR amplifications in order to produce PCR products used for subsequent cloning 
reactions were done using the Cloned Pfu Polymerase with a proof reading function and 
were performed in the following reaction mix using a Gene Amp PCR system 2400 with 
varying annealing temperatures (X): 
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PCR Mix PCR Settings 
1 μl – BAC DNA (10ng) 
2,5 μl – primer 1 (12,5 pM) 
2,5 μl – primer 2 (12,5 pM) 
5 μl – 10x Pfu buffer 
4 μl – dNTPs 
1 μl – Pfu Polymerase 
34 μl – ddH2O 
95°C – 1 min 
30 cycles of: 
95°C – 45 sec 
X°C – 45 sec 
72°C – 60 sec 
followed by: 
72°C – 10 min 
 
PCR products were purified either with PureLink™ PCR Purification Kit or the QIAquick 
PCR Purification Kit. For detailed protocols for these Kits, please refer to the product 
manuals. 
PCR amplifications for quick genotyping PCRs or PCR screens were performed using a 
Red Taq DNA Polymerase in following reaction mix using a Peltier Thermal Cycler 255 
with varying annealing temperatures (X): 
 
PCR Mix PCR Settings 
1 μl – bacterial culture / DNA 
0.1 μl – primer 1 (0.5 pM) 
0.1 μl – primer 2 (0.5 pM) 
2 μl – 10x Red Taq Buffer 
1 μl – dNTPs 
1 μl – Red Taq Polymerase 
15,8 μl – ddH2O 
94°C – 3 min 
30 cycles of: 
94°C – 30 sec 
X°C – 30 sec 
72°C – 60 sec 
followed by: 
72°C – 7 min 
 
2.2.2.12.  Dephosphorylation of 5’DNA ends: 
 
The 5’ ends of vector DNA were dephosphorylated by incubating 1 μl (1U) rAPid alkaline 
phosphatase and 2 μl 10x rAPid alkaline phosphatase buffer with 17 μl DNA for 10 min at 
37°C and subsequent inactivation of the enzyme for 2 min at 75°C. 
 
2.2.2.13. DNA Ligation and subcloning in TOPO pCR vectors 
 
The ligation reaction mix was prepared in a 1:3 ratio of dephosphorylated vector DNA to 
insert DNA and in a total volume of 14 μl. 4 μl of 5x ligation Buffer and 2 μl of T4 DNA 
ligase were added and incubated overnight in a cold water bath. 1 μl of the ligation mix 
was electroporated into Electro10 Blue or XL1-Blue cells and spread onto LB agar plates 
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containing appropriate antibiotics for selection. TOPO TA Cloning® requires Taq 
polymerase amplified PCR products. Taq polymerase has a terminal transferase activity 
that adds a deoxyadenosine to the 3’ end of a PCR fragment. The TOPO TA Cloning® Kit 
provides a linearized pCR®2.1-TOPO® vector, which has a 3’ deoxythymidine overhang 
that allows efficient ligation of PCR product and vector, and has the cloning site in the lacZ 
gene, which encodes for the ß-galactosidase for selection. For a detailed protocol for this 
Kit, please refer to the product manual. Briefly, 1-2 µl of the TOPO reaction was 
electroporated in Electro10 Blue cells and spread onto LB agar plates containing 
ampicillin, IPTG and X-Gal for selection. 
 
2.2.2.14. Dirty Mini Prep and test digest. (Holmes and Quigley, 1981) 
 
In order to test plasmids from a large number of transformed bacterial clones by restriction 
enzyme test digests, cells from 2 ml overnight bacterial culture were harvested at 15,000 x 
g for 1 min. The pellet was then resuspended in 300 μl STET buffer. 25 μl of lysozyme 
solution was added, samples were denatured on a 100°C heat block and immediately 
centrifuged at 15,000 x g for 10 min. The pellet was removed with a toothpick and the 
DNA was precipitated by adding 100 μl 7.5 M NH4Ac and 400 μl isopropanol. The 
samples were mixed and centrifuged at 15,000 x g for 30 min at room temperature. The 
supernatant was discarded and the dried DNA pellet resuspended in 50 μl TE buffer. 5 μl 
of the sample was digested in 50 μl volume with 10 units of appropriate restriction 
enzymes and in the presence of 0.1 μg RNase A. 
 
2.2.2.15. PCR Screens 
 
PCR screen is a fast way to screen a large number of colonies. For that, a colony was 
picked and inoculated into 50 μl LB medium per well of a 96-well plate. The full plate was 
placed for 3 h at 37°C and then 1 μl bacterial culture was added into a new 96-well plate, 
containing the PCR mix. Primer pairs were designed with one primer lying in the vector 
backbone and the reverse primer in the insert sequence for the 5’ and the 3’ cloning site. 
Clones that give rise to bands of an expected size for both PCR reactions were inoculated 
into 5 ml LB to grow overnight and process furtherr 
 
                                                                                             2. Material and Methods 
 34 
2.2.2.16. Cloning strategies for constructs generated and used in this study 
 
2.2.2.16.1  BAC DNA retrieval vector PL253 
 
For generating the BAC DNA retrieval vector PL253, the 5’ and 3’ GAP repair mini arms 
were first amplified by PCR A (primer 21137/21138, Annealing 63°C, 445 bp) and PCR B 
(primer 21139/21140, 63°C, 578 bp), respectively. PCR fragment A was digested with 20 
units of NotI and HindIII and fragment B with HindIII and BamHI in 50 μl final volume for 2 
h. 3 μg of the PL253 vector was digested with 30 units of NotI and BamHI in 100 μl final 
volume for 3 h and separated on a 0.7% TAE agarose gel. 5’ ends of the vector DNA were 
dephosphorylated and the final retrieval vector was generated by ligating 2 μl of PL253, 6 
μl fragment A, and 6 μl fragment B. 1 μl of the ligation mix was electroporated into E10 
cells and Ampr colonies selected. 
 
2.2.2.16.2.  loxP-PGK-EM7-NeobpA-loxP vector PL452 
 
For cloning the 5’ and 3’ GAP repair mini arms amplified by PCR C (primers 19929/19930, 
Annealing 63°C, 450 bp) and PCR D (primers 19931/19932, Annealing 63°C, 405 bp) into 
PL452, the PCR samples were first cloned into the pCR®2.1-TOPO® vector. Fragment C 
was cut out of the vector with 20 units KpnI and EcoRI and fragment D with BamHI and 
NotI. 6 μg of the vector PL452 was each digested with EcoRI and BamHI to obtain a 1.89 
kb large fragment containing the loxP-PGK-EM7-NeobpA-loxP cassette and with KpnI and 
NotI to obtain a 2.93 kb vector backbone fragment. Vector fragments were separated on a 
0.8% agarose TAE gel, extracted and dephosphorylated. The final C-loxP-PGK-EM7-
NeobpA-loxP-D targeting vector PL452 was generated by ligating 2 μl of loxP-PGK-EM7-
NeobpA-loxP cassette, 2 μl vector backbone, 5 μl fragment C and 5 μl fragment D. 1 μl of 
the ligation mix was electroporated into Electro10 Blue cells and Ampr colonies selected. 
Ampr colonies were screened by PCR analysis (primer pairs 24607/24608 and 
24609/24610, Annealing 65°C). 
 
2.2.2.16.3.  FRT-PGK-EM7-NeobpA-FRT-loxP vector PL451 
 
For cloning the 5’ and 3’ GAP repair mini arms amplified by PCR E (primers 19965/19966, 
Annealing 63°C, 417 bp) and PCR F (primers 19967/19968, Annealing 63°C, 437 bp) into 
PL451, the PCR samples were first cloned into the pCR®2.1-TOPO® vector. Fragment E 
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was cut out of the vector with 20 units XhoI and EcoRI and fragment F with BamHI and 
SacII. 6 μg of the vector PL451 was digested each with EcoRI and BamHI to obtain a 1.89 
kb large fragment containing the FRT-PGK-EM7-NeobpA-FRT-loxP cassette and with 
XhoI and SacII to obtain a 2.94 kb large vector backbone fragment. Vector fragments 
were separated on a 0.8% agarose TAE gel, extracted and dephosphorylated. The final E-
FRT-PGK-EM7-NeobpA-FRT-loxP-F targeting vector PL451 was generated by ligating 2 
μl of FRT-PGK-EM7-NeobpA-FRT-loxP cassette, 2 μl vector backbone, 5 μl fragment E 
and 5 μl fragment F. 1 μl of the ligation mix was electroporated Electro10 Blue cells and 
Ampr colonies selected. Ampr colonies were screened by PCR analysis (primer pairs 
25153/25154 and 25155/24610, Annealing 54°C). 
 
2.2.2.16.4.  Generation of a 3’ hybridization probe for Southern Blot Analysis 
 
The PCR product for the 3’ probe (primer 21141/21142, Annealing 60°C, 291 bp) was 
cloned into the pCR®2.1-TOPO® vector and cut out of the vector by EcoRI digestion prior 
Southern Blot hybridization in order to obtain a 291 bp large fragment. 
 
2.2.2.16.5.  Generation of a 5’ hybridization probe for Southern Blot Analysis 
 
The PCR product for the 5’ probe (primer 8431/8432, Annealing 50°C, 598 bp) was cloned 
into the pBluescript psKII vector and cut out of the vector by PstI digestion prior Southern 
Blot hybridization in order to obtain a 536 bp large fragment. 
 
2.2.2.16.6. Generation of a Neo hybridization probe for Southern Blot Analysis 
 
The Neo probe was obtained by PstI and XbaI digestion of the vector PL451, containing 
the FRT-loxP-PGK-EM7-NeobpA-FRT-loxP cassette in a 630 bp large fragment. 
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2.3. Cell Cultures 
 




2.3.1.1.1.  Chemicals and Reagents  
 
Product Company Cat. No. 
Amersham Hybond™-N+ GE Healthcare RPN303B 
Amersham Rapid-hyb™ Buffer  GE Healthcare RPN1635 
Bio-Spin 30 Colums BioRad 732-6202 
Cell Culture dishes 
Greiner, Costar, Falcon, 
Nunc 
  
Cymeven (Ganciclovir-Natrium) Roche Pharma AG   
dCTP, [α-
32
P]- 3000Ci/mmol 10mCi/ml Perkin Elmer NEG513H250UC 
Dimethyl sulfoxide, Cell Culture Tested Sigma-Aldrich D-2650 




) PAA  H15-002 
ESGRO-LIF Chemicon ESG1107 
Fetal Bovine Serum (FBS) HyClone SH30070.03 
Gelatin from porcine skin Sigma-Aldrich G-1890-100 
Geneticin (G418-Sulfat) Gibco 11811-023 
Hydrochloric Acid (HCL) Merck 1.003.172.500 
Knockout D-MEM Gibco 10829-018 
Kodak BioMax MS Film Kodak 1435726 
L-Glutamin (100 x) Gibco 25030-024 
MEM non-essential amino acids (100 x) Gibco 11140-035 
Mineral oil Sigma-Aldrich M-8410-500 
Mitomycin C Sigma-Aldrich M-0503-2MG 
N-Lauroylsarcosine sodium salt Sigma-Aldrich L-5777 
Penicillin/Streptomycin (100x) Gibco 15140-122 
Prime-It II Random Primer Labeling Kit Agilent Technologies 300385 
Proteinase K (20mg/ml) Qiagen 19133 
Sodium Chloride (NaCl) Merck 1.076.511.000 
Sodium Hydroxid (NaOH) Merck 1.064.980.500 
Spermidine Sigma-Aldrich 82501 
Trypsin-EDTA (0.05%) Gibco 25300-054 
Trypsin-EDTA (0.25%) Gibco 25200-056 
β-Mercaptoethanol "cell culture tested" Sigma-Aldrich M-7522-100 
 
 





BIO-RAD Gene Pulser BIO-RAD 
Fluo-Link Biometra 
 
2.3.1.1.3.  Media and buffer 
 
ES cell and MEF medium (500 ml Knockout D-MEM, 95 ml FBS, 6 ml MEM, 6 ml diluted ß-
mercaptoethanol, 3 ml Penicillin/Streptomycin, 65 μl ESGRO-LIF) 
2x Freezing Medium (20% DMSO, 20% FBS, 60% Knockout D-MEM) 
100x G418 (360 mg active ingredient in 20 ml PBS) 
1000x Ganciclovir (2mM; 510 mg in 1 L PBS) 
Lysis Buffer (10 mM Tris, pH 7.5, 10 mM EDTA, pH 8.0, 10 mM NaCl, 0.5% N-Lauroylsarcosine 
sodium salt, 1 mg/ml PROTEINASE K 




2.3.1.2.1.  Mouse embryonic fibroblast culture 
 
Mouse embryonic fibroblasts (MEFs) were stored in liquid nitrogen in 500 μl aliquots. Cells 
were quickly thawed in a 37°C water bath, transferred to a 15 ml tube, and mixed with 10 
ml medium. Cells were centrifuged for 7 min at 900 rpm, resuspended in medium and 
plated on a gelantine-coated T75 tissue culture flask. P4 – P6 aliquots were split in ratios 
of 1:3, later passages were split (1:2) every 2 – 3 days. For passaging cells, the confluent 
culture was washed once with PBS. Enough trypsin-EDTA (0.05%) was added to cover 
the surface (3.5 ml for a T75 flask). Cells were incubated for 5 min at 37°C, an equal 
volume of medium was added and the cells were triturated. The MEFs were then 
transferred to the new tissue flasks. To inactivate MEFs, cells were incubated in 10 μg/ml 
mitomycin C for 2.5 h at 37°C and then washed three times with PBS. Trypsin-EDTA 
(0.05%) was added and the cells were triturated and finally plated on gelatinized plates. 
The number of feeder plates was calculated according to area. 1 T175 (175 cm2) plate 
was used to make 4 10 cm2 plates, 5-6 96-well plates or 3-4 6-well plates. MEFs from a 
T175 plate were frozen in two 500 μl aliquots in 1 x Freezing medium. The vials were 
placed into a freezing container and transferred to a -80°C freezer in order to obtain a 
slow freezing rate around 1°C per minute. After 24 h, cells were transferred into liquid 
nitrogen for storage. 
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2.3.1.2.2.  Embryonic stem cell culture 
 
Embryonic stem (ES) cells were stored and thawed as described for MEFs and plated 
onto 6 cm2 feeder plates. The ES cell medium was changed 1-2 times per day and 3-4 h 
before passaging. For passaging cells from confluent plates, the medium was aspirated 
off and the cells were washed once with PBS. Enough trypsin-EDTA (0.25%) was added 
to cover surface (500 μl for a 6 cm2 plate). Cells were incubated for 15 min at 37°C, an 
equal volume of ES cell medium was added and the cells were carefully triturated with a 
pasteur pipette. Cells were usually split (1:6) onto fresh feeder plates. ES cells were 
frozen in 1x Freezing medium at a density of 3.0 x 107 cells / ml, making a total of 9 x 106 
cells per 300 μl aliquot. The vials were placed into a freezing container and transferred to 
a -80°C freezer in order to obtain a slow freezing rate around 1°C per minute. After 24 h, 
cells were transferred into liquid nitrogen for storage. 
 
2.3.1.2.3.  ES cell electroporation 
 
The ES cells were passaged (1:2) 24 h before electroporation and the medium was 
changed 3 h prior harvesting. The cells were trypsinized as described earlier and 
resuspended in media. The cells were centrifuged for for 7 min at 900 rpm and 
resuspended in 10 ml PBS. The total number of cells was determined by counting 20 μl of 
a 1:10 dilution.  Cells were pelleted again and resuspended in PBS at a density of 11 x 
106 cells/ml. 900 μl aliquots of cells were prepared and (25 - 50 μg) linearized vector DNA 
was added. Electroporation into ES cells was performed using a BIO-RAD Gene Pulser at 
2.3 kV and 500 μF. The cuvette was left at room temperature for 5 min and cells were 
then plated onto 10 cm2 feeder plates. Cells were selected against G418 (positive 
selection) from 24 h post-electroporation onwards and selected against Ganciclovir 
between 3-5 days post-electroporation (negative selection). 
 
2.3.1.2.4.  Picking ES cell colonies 
 
ES cell colonies for later analysis by Southern Blot were picked 11 – 12 days after 
electroporation. 25 μl trypsin-EDTA (0.25%) was added into each well of a 96-well round-
bottom plate and kept on ice. ES cell medium was aspirated from the plate and 
substituted by PBS. Colonies were picked by sucking the colony into a 10 μl pipette tip 
and was transferred into the trypsin (1 colony per well). After completing a 96-well plate, 
the cells were incubated for 15 min at 37°C. 35 μl ES cell medium was added per well, the 
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cells were triturated and transferred to a flat-bottom feeder plate and cultured in 150 μl 
medium per well. Cells were split 1:1 after a few days to obtain a higher cell density. 
Finally, cells were split (1:3) onto two feeder plates for freezing and onto one gelantine-
coated plate for subsequent Southern Blot analysis.  
 
2.3.1.2.5.  Freezing 96-well plates 
 
To freeze 96-well plates, cells were trypsinized in 50 μl trypsin-EDTA (0.25%) for 15 min 
at 37°C. 50 μl 2 x Freezing Medium was added to each well and the cells were triturated. 
100 μl sterile filtered mineral oil was added to each well, the plate was sealed with 
parafilm and placed into a small polystyrene box and transferred to a -80°C freezer. 
 
2.3.1.2.6.  Isolating ES cell DNA on 96-well Plates 
 
ES cell clones cultured on gelantine-coated 96-well plates were washed twice with PBS 
and then lysed in 50 μl Lysis Buffer. Plates were kept for 6 - 8 h at 60°C in a humified 
chamber. Then, 100 μl of 75 mM NaCl in cold 100% ethanol was added to each well and 
the DNA was precipitated for 30 min at room temperature. The plates were briefly 
centrifuged, then washed three times with 70% ethanol and air-dried for 30 min. ES cell 
DNA was digested overnight at 37°C in 30 μl volume containing 1 mM spermidine, 100 
μg/ml BSA and 20 μl units of enzyme in 1x restriction buffer. 4 μl of loading buffer was 
added the next day to each well and samples were loaded onto a 0.8% TAE agarose gel 
and run for 5 h at 60 V.  
 
2.3.1.2.7.  Southern Blot (Southern, 1975) 
 
Southern blot analysis is a method for the detection of specific genomic DNA sequences.  
First, DNA samples are transferred of electrophoresis-separated DNA fragments to a filter 
membrane and the subsequent labeling of a specific fragment by e.g. a hybridization 
probe.  
In order to transfer the DNA samples from the 0.8% TAE agarose gel, the gel was washed 
in 0.25 M HCl for 10 min to depurinate the DNA for a better transfer.  The gel was then 
washed in 0.4 M NaOH to denaturate the DNA and to produce sDNA single strands. The 
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DNA was then capillary transferred overnight from the gel in 0.4 M NaOH blotting solution 
onto a positively charged nylon membrane. A glass plate was placed above two plastic 
containers filled with blotting solution. A long sheet of Whatman paper was soaked in 
blotting solution and placed on the plate, each end reaching the blotting solution in the 
plastic containers. Then the gel was then placed on the Whatman paper and the nylon 
membrane placed on top of the gel, followed by three sheets of wet Whatman paper. A 
large pile of tissue was added and a weight was positioned on top of the construction. The 
next day, the membrane was neutralized in 2xSSC, air-dried and the DNA was covalently 
cross-linked by exposure to ultraviolet irradiation (1.0 J/cm2; Fluo-Link).  
The hybridization of the probes was performed with the Prime It Random Primer Labeling 
Kit. For detailed protocol refer to the product manual. Briefly, 25 ng probe DNA was mixed 
with random oligonucleotide primers, [32P]dCTP labeling buffer, 50 μCi labeled nucleotide 
([32P]dCTP) and 5 units of Exo(-) Klenow polymerase in 50 μl volume. Reaction mix was 
incubated at 37°C for 30 min and purified over a Bio-Spin 30 SSC columns. The probe 
was then denatured for 5 min on a 100°C heat block and placed immediately onto ice. The 
membrane was pre-incubated in a glass bottle at 65°C with Rapid-hyb buffer for at least 
15 min and then the probe was added at a final concentration of 2 ng/ml. The membrane 
was hybridized for 2 h at 65°C and then washed once with 2xSSC, 0.1% SDS for 20 min 
at room temperature and twice with 1xSSC, 0.1% SDS and twice with 0.5xSSC, 0.1% 
SDS at 65°C. The washed membrane was wrapped in cling film and autoradiographed at -
80°C overnight. 
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2.3.2.   Mouse hippocampal Neuron Culture 
 
2.3.2.1.  Materials 
 
2.3.2.1.1  Chemicals and Reagents  
 
Product Company Cat. No. 
Albumin from bovine serum (BSA) Sigma A4503 
B-27® Serum-Free Supplement (50X) Gibco 17504-044 
Calcium chloride dihydrate  Sigma C3881 
Dulbecco's Modified Eagle Medium (DMEM) Gibco 41966-029 
EDTA Sigma E1644 
Fetal Bovine Serum (FBS) PAA A15-104 
Glutamax (200mM) Gibco 35050038 







L-Cysteine  Sigma C7352 
Millex Syringe Filter Units, 0.22 µm Gibco SLGP033RS 
Neurobasal®-A Medium (1X), Liquid  Gibco 10888-022 
Papain Worthington Biochemical LS003126 
Penicillin/Streptomycin (100x) Gibco 15140-122 
Poly-L-lysine  Sigma P4707 
Trypsin inhibitor from chicken egg white  Sigma T9253 
 
2.3.2.1.2.  Media and Solutions 
 
Papain Solution  (0.2 mg/ml cysteine, 1 mM CaCl2, 0.5 mM EDTA in DMEM and 25 units Papain 
per ml; the Papain Solution was bubbled with carbogen (95% oxygen, 5% carbon dioxide) for 20 
min and sterile filtered (0.2 µm) prior use) 
Stop Solution (2.5 mg / ml BSA, 2.5 mg/ml trypsin inhibitor, 10% FBS in D’MEM) 
Complete Neurobasal Medium (500 ml Neurobasal-A, 5 ml GlutaMAX I, 10 ml B27-supplement, 1 
ml Penicillin/Streptomycin) 
 
2.3.2.2.  Methods 
2.3.2.2.1.  Treatment of coverslips for mouse hippocampal neuron cultures 
 
Glas coverslips (32 mm) were washed first in 1 M HCl overnight, then multiple times with 
ddH2O and finally with 70% Ethanol. Coverslips were then transferred into the wells of a 6-
well cell culture plate and UV-sterilized for 1 hour. Glass coverslips were coated in a 1:12 
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dilution of Poly-L-Lysine in PBS overnight at 37°C. The coverslips were then washed twice 
with PBS and incubated with the Complete Neurobasal Medium until further use. 
 
2.3.2.2.2.  Primary mouse hippocampal neuron culture 
 
Neonatal P0 mouse pups were decapitated and the brains were placed into HBSS. The 
hippocampi were removed, transferred into 500 µl of pre-warmed Papain solution and 
incubated at 37°C with gentle agitation for one hour. Then, the supernatant was removed 
and 500 µl of pre-warmed Stop Solution was added to the hippocampal tissue and kept at 
37°C for an additional 15 minutes. Then, the supernatant was removed and the tissue was 
washed once with 500 µl Complete Neurobasal Medium. Then the tissue was triturated 
gently for 15 times in 200 µl of Complete Neurobasal Medium and the tube was kept at 
room temperature for 2 minutes and then the supernatant was transferred into a fresh 
tube containing 800 µl of pre-warmed Complete Neurobasal Medium. A second trituration 
step was perforemd to increase the number of cells for high-density cultures, if necessary. 
Cells were counted on a Naubauer Counting Chamber and approximately 100,000 to 
200,000 cells were plated per well of a six-well plate for continental cultures. The neurons 
were infected on DIV1 by adding the virus directly into the culture medium. The medium 
was changed 15-24 hours after infection to prevent neurotoxicity of the virus. The 
expression level of green fluorescent protein (GFP) was used in order to determine the 
viral titer. 
For autaptic neuron cultures, approximately 4,000 neurons were plated per well of a six-
well plate that contained small astrocyte feeder islands on glass coverslips, a method that 
results in the isolation of individual neurons (Bekkers, 1991). The preparation of the 
astrocyte microislands was performed by Ines Beulshausen and Sabine Bolte as 
published (Burgalossi et al., 2012). Electrophysiological experiments on autpaptic cultures 
in order to assess physiological consequences of Cre-mediated deletion of Munc13-1 in 
neurons were performed by Dr. Riikka Liisa Uronen.  
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2.3.3.   HEK 293FT cell culture 
 
2.3.3.1.  Materials 
 
2.3.3.1.1.  Chemicals and Reagents  
 
Product Company Cat. No. 
Amicon Ultra-15 Centrifugal Filter Unit Millipore UFC901024 
Butyric acid Sigma 303410 
DMEM, High Glucose, GlutaMAX™, Pyruvate  Gibco 31966-021 




) PAA  H15-002 
Fetal Bovine Serum (FBS) PAA A15-104 
Geneticin, G 418 Sulfate, Cell Culture Tested Calbiochem 345810 
HEK293FT cell line Invitrogen R700-07 
HEPES, 1M Buffer Solution Gibco 15630-080 
Lipofectamine® 2000 Transfection Reagent Invitrogen 11668-500 
Millex-HA Syringe Filter Units, 0.45 µm  Millipore SLHA033SB 
Neurobasal®-A Medium (1X), Liquid  Gibco 10888-022 
Opti-MEM® I Reduced Serum Medium Gibco 31985-047 
Penicillin/Streptomycin (100x) Gibco 15140-122 
Poly-L-lysine  Sigma P4707 
Trypsin-EDTA (0.05%) Gibco 25300-054 
 
 
2.3.3.1.2.  Media and buffer 
 
HEK293FT Medium (500 ml DMEM containing GlutaMAX, 50 ml FBS, 5 ml Pen/Strep) 
 
2.3.3.2. Methods  
2.3.3.2.1.  HEK293FT culture 
 
The human embryonic (HEK) 293FT cell line was used for the production of lentiviral 
particals. HEK293FT cells express the SV40 large T antigen under the human 
cytomegalovirus (CMV) promotor to facilitate lentiviral production together with the 
neomycin resistance gene from the pCMVSPORT6Tag.neo plasmid (Invitrogen). 
HEK293FT cell cultures were therefore kept in cell culture dishes in HEK293FT Medium 
containing 500 µg/ml Geneticin for selection at 37°C and 5% CO2.  
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2.3.3.2.2.  Thawing of HEK293FT cells 
 
A vial of frozen HEK293FT cells was quickly thawed and transferred into a 15 ml Falcon 
tube containing HEK293FT Medium. Cells were spun down for 5 min at 1.500 rpm and 
resuspended in HEK293FT medium and plated onto cell culture dishes. After 24 hours, 
the medium was replaced by fresh medium containing 500µg/ml Geneticin.  
 
2.3.3.2.3.  Passaging of HEK293FT cells 
 
For passaging cells, the confluent culture plate was washed once with PBS. Enough 
trypsin-EDTA (0.05%) was added to cover the surface (2 ml on a 10 cm2 dish). Cells were 
incubated briefly at room temperature, then an equal volume of medium was added and 
the cells were triturated and plated onto cell culture dishes and cultured in the presence of 
500 µg/ml Geneticin. 
 
2.3.3.2.4.  Production of lenti-viral particles in HEK293FT cells 
 
In order to produce viral particles, HEK293FT cells were split in a 1:2 ratio 24 hours prior 
transfection onto PLL-coated 15 cm2 cell culture plates. Semiconfluent HEK293FT cell 
cultures were co-transfected with the vector plasmids (pFUGW or pFUGW-iCre) together 
with a plasmid (PACK) encoding for proteins that form the viral core structure (GAG – 
group antigens) and for the reverse transcriptase and integrase (POL), as well as with a 
plasmid (ENV) encoding for the vesicular stomatitis virus glycoprotein (VSV-G) forming 
the viral envelope. For a 15 cm2 cell culture dish, 60 µl Lipofectamine2000 was added to 2 
ml of OPTI-MEM and kept at room temperature for 5 min. The transfection mix was 
prepared by adding 40 µg vector plasmid, 16 µg PACK plasmid and 16 µg ENV plasmid to 
2 ml OPTI-MEM. Then, the Lipofectamine2000 in OPTI-MEM was added to the 
transfection mix and kept at room temperature in the dark for 60 min. The HEK293FT cell 
Medium was replaced by 11 ml OPTI-MEM with 10% FCS and the Transfection Mix was 
added to the cells. 20 hours after transfection, the medium was replaced by DMEM 
containing 2% FBS and 10 mM sodium butylate. 48 hours after transfection, the viral 
particles were harvested. The supernatant of the cell culture plates was filtered through 
0.45 µm pores and concentrated using an Amicon filter system by centrifugation with 
4,300 rpm at 4°C for 10 min. The concentrated virus was then washed twice with cool 
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Neurobasal-A medium. Finally, small aliquots of virus particles inNeurobasal-A medium 
and in the presence of 100 mM HEPES were frozen in liquid nitrogen and stored at -80°C. 
 




2.3.4.1.1.  Chemicals and Reagents  
 
Product Company Cat. No. 
5-Fluoro-2′-deoxyuridine Sigma F0503 
BME (Basal Medium Eagle without Glutamin) Gibco 41010026 
Cytosine β-D-arabinofuranoside hydrochloride (Ara-C) Sigma C6645 
Glucose x H2O Fluka 49159 
Glutamax (200mM) Gibco 35050038 







Heat-inactivated horse serum (HS) Gibco 26050-088 
Kynurenic Acid Tocris 223 
Millex Syringe Filter Units, 0.22 µm Gibco SLGP033RS 
Millicell Cell Culture Inserts  Millipore PICM03050 
Millipore confetti Millipore FHLC04700 
Minimum Essential Medium (MEM) Gibco 11700-077 
razor blades Gillette   
Uridine Sigma U3750 
 
2.3.4.1.2.  Equipment 
 
 
2.3.4.1.3.  Media and buffer 
 
2xMEM (9.39g / 500ml ddH20) 
Culture Medium (22.44ml ddH20, 25 ml 2xMEM, 25 ml BME, 1 ml Glutamax, 1.56ml Glucose 40%, 
25 ml HS ) 
Cutting solution (pH 7.4; 97 ml HBSS, 2.5 ml Glucose 20%, 1 ml 100mM Kynurenic Acid) 
Inhibitor Mix (50 ml Culture Medium, 5µl of Ara-C, 5µl Uridine, 5µl 5-Fluoro-2′-deoxyuridine) 
 
Product Company 
McIllwain tissue chopper The Mickle Engineering Company Ltd, UK 




2.3.1.3.1. Preparation of organotypic hippocampal slice cultures 
 
The protocol for the preparation of organotypic hippocampal slice cultures was based on 
the “interface method” introduced by Stoppini and colleagues in 1991 (Kerr et al., 2008; 
Stoppini et al., 1991). Control and knockout mice were taken from the same mouse colony 
and from the same litters. For E18 preparations, the mothers were anesthetized, 
decapitated and the pups taken out by cesarean section. E18-P0 pups were then 
decapitated and the brains were placed into Cutting Solution. The hippocampi, still 
attached to the entorhinal cortex, were removed and transferred with a sterile Pasteur 
pipette onto the Tissue Culture Stage under a preparation hood. Excess liquid was 
removed with sterile autoclaved tissues. Slices of 300 μm thickness were cut with a 
McIllwain tissue chopper perpendicular to the longitudinal axis of the hippocampus. Then 
the stage was flooded with Cutting Solution and the slices were transferred in liquid with a 
plastic Pasteur pipette into a plastic dish. Only undamaged slices were then placed onto 
small membrane pieces (confetti) on top of the microporous cell culture membrane. 
Usually, maximally four hippocampal slices were cultured on each cell culture insert. 
Slices were maintained with culture medium. The medium was first changed 24h after 
preparation and then 2-3 times per week. Between 3-5 days in-vitro (DIV) 100 μM 
cytosine arabinoside, 100 μM uridine and 100 μM 5-fluorodeoxyuridine were added for 
24h to the culture. The slices were maintained at 37°C and in 5% CO2 for 2-4 weeks. 
High-pressure-freezing fixation for electron tomography was performed between 4 and 5 
weeks in vitro. The animals were genotyped by using tail DNA and subsequent PCR 
analysis. In addition, for most of the experiments, the rest of the brain was frozen in liquid 
nitrogen and kept for Western-Blot analysis of the genotype if necessary. 
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2.4.   Biochemistry 
 
2.4.1.  Materials 
 
2.4.1.1. Chemicals and reagents 
 
Product Company Cat. No. 
Acrylamide/N,N'-Methylene-bis-Acrylamide (37.5:1) 
(AMBA) 
National Diagnostics EC-890 
Amersham HyperfilmTM ECL GE Healthcare 28906837 
Ammonium persulfate (APS) Sigma-Aldrich A-6761 
Aprotinin Roth A162.3 
Bio-Rad Protein Assay Dye Reagent  BIO-RAD 500-0006  
Bromophenol Blue Pierce 20730 
Cell scraper Nunc 179693 
Dithiothreitol (DTT) Boehringer Ingelheim 708992 
ECL Reagent (Kit) Amersham, GE-Healthcare 
RPN2106V1 
and -2 
Ethylenediaminetetraacetic Acid Trisodium Salt (EDTA) Merck  1.084.180.250 
Glacial acetic acid Merck 1.000.632.511 
Glycine Sigma-Aldrich 33226 
Goat Serum Gibcro, Invitrogen 16210-072 
IGEPAL Sigma-Aldrich I3021 
Instant Milk Powder Granovita GmbH   
Leupeptin Pepta Nova 4041 
MemCodeTM Reversible Protein Stain Kit Thermo Scientific 24580 
Methanol J.T. Baker 8402 
N,N,N',N'-Tetramethyl-ethylenediamine (TEMED) Serva 35925 
N-2-Hydroxyethylpiperazine- N'-2-ethane sulfonic acid 
(HEPES) 
Biomol 5288 
PageRulerTM Prestained Protein ladder Fermentas SM0671 
Phenylmethylsulfonylfluorid Sigma-Aldrich P7626 
Ponceau-S Sigma-Aldrich 81460 
Protran BA83 Nitrocellulose Blotting Membrane, 0.2 µm, 
82 mm 
GE Healthcare 10401396 
Sodium dodecylsulfate (SDS) GEBRU 1012 
Sucrose Merck  1.076.511.000 
Tris-Base Sigma-Aldrich T1503 
Tween 20 Sigma-Aldrich P7949 
 
 





Bio-Rad mini gel electrophoresis system (protean II) Bio Rad 
BioScience Ultrospec3100pro Amersham 
Blotting system, TE22 Mighty Snall tank transfer Hoefer 
POTTER'S Homogenizer B.Braun 
 
2.4.1.3. Media and buffer 
 
Homogenization Buffer: (320mM sucrose, 5mM HEPES (pH7.4), 1mM EDTA, 0.1µM Aprotinin, 
50µM Leupeptin, 0.2mM PMSF) 
Lysis Buffer: (320mM Sucrose, 10mM Tris-HCl (pH 7.5), 5mM HEPES (pH7.4), 150mM NaCl, 1mM 
EDTA, 1mM EGTA, 0.1% IGEPAL, 0.2µM Aprotinin, 20µM Leupeptin, 1mM PMSF) 
3x SDS-sample buffer: (10% SDS, 140mM Tris-HCL (pH 6.8), 3mM EDTA, 30% Sucrose, 100mM 
DTT, 0.1 % bromophenolblue,150 mM DTT) 
Upper stacking gel (5 % AMBA, 125 mM Tris-HCL (pH 6.8), 0.1% SDS, 0.05% APS, 0.005% 
TEMED) 
Lower resolving gel (7-15% AMBA, 325 mM Tris-HCL (pH 8.8), 0.1% SDS, 0.05% APS, 0.005% 
TEMED) 
Running buffer(25mM Tris-HCl, 250 mM Glycine, 0.1% SDS, pH 8.8) 
Transfer Buffer:(25mM Tris-Base, 190 mM Glycine, 20 % Methanol) 
TBS:(10mM Tris-HCl, 150 mM NaCl, pH 7.5) 
Blocking buffer:(5% milk powder, 5% Goat Serum, 9.1/ Tween 20 in TBS) 
Washing Buffer(0.1% Tween 20 in TBS) 




Product / concentration Company / Reference Cat. No. 
anti-Munc13-1 (affinity purified rabbit polyclonal, N-
terminal #40); 1:1000 
(Varoqueaux et al. 2005; 
Cooper et al. 2012) 
  
anti-Munc13-1 (affinity purified rabbit polyclonal, C-
terminal #N395); 1:250 
(Betz et al., 1997)  
anti-ß-Tubulin (mouse monoclonal) 1:5000 Sigma TUB 2.1 
anti-Synaptophysin (purified mouse monoclonal) 
1:10000 
Synaptic Systems 101 011 
 
Secondary goat anti-mouse and anti-rabbit affinity purified antibodies conjugated to horse 
radish peroxidase (HRP) (Bio Rad) were used in this study at a concentration of 1:10000.  
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2.4.2.  Methods 
 
2.4.2.1. Mouse Brain Homogenate 
 
P0 mice were killed by decapitation and the brains were removed and each transferred 
into 1 ml ice-cold Homogenization buffer. The brain tissue was homogenized at 900 rpm 
with a glas/Teflon homogenizer at 4°C and collected for Western Blot analysis. 
 
2.4.2.2. Cell Culture Homogenization 
 
To check for changes in protein levels of lentiviral infected continental mouse 
hippocampal neuron cultures, neurons were washed twice with PBS and then incubated 
for 10min on ice in Lysis buffer. Samples were transferred to Eppendorf cups, centrifuged 
at 900x gmax for 10 minutes and the supernatant was collected and used for Western Blot 
analysis. 
 
2.4.2.3. Preparation of Proteins Samples for SDS Electrophoresis 
 
The protein concentration was determined using the Bradford Assay, measuring the 
absorbance of the sample at 595 nm wavelength with a BioScience Ultrospec3100pro 
spectrophotometer (Bradford, 1976). For a detailed protocol refer to the “Bio-Rad Protein 
Assay” manual. For all the biochemical experiments, samples were standardized to the 
same concentration in Homogenization- or Lysis buffer. The protein samples were then 
dissolved in SDS sample buffer to a 1x final concentration and boiled at 95°C for 5 
minutes.  
 
2.4.2.4. SDS-PAGE (Laemmli 1970) and Western Blotting (Towbin 1979;  
  Burnette 1981) 
 
In order to separate proteins based on their molecular seize, sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) was performed under denaturing 
conditions. SDS as an anionic detergent linearizes proteins and adds a negative charge to 
them (Schägger, 2006). Negatively charged proteins will migrate in an electric field 
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through a porous gel towards the anode. Briefly, samples in SDS sample buffer were 
loaded onto a two-layer Tris-glycine gel (stacking- and resolving gel) in a Bio-Rad mini gel 
electrophoresis system filled with running buffer and ran with 20 mA in the stacking- and 
with 30mA in the resolving gel until the dye ran out of the gel.  
The Western Blot technique was used to transfer the separated protein samples after 
SDS-PAGE onto a nitrocellulose membrane. Proteins were elecrophoretically transferred 
from the acrylamide gel onto a nitrocellulose membrane for 600 milliampere-hours (mAh) 
in transfer buffer in a tank blotting system.  
The blotting efficiency was monitored by subsequent reversible Ponceau-staining or by 
using the MemCodeTM Reversible Protein Stain Kit if low protein concentrations had 
been loaded. The nitrocellulose membrane was then washed once with TBS and then 
incubated in the blocking buffer for 30 min at room temperature with gentle agitation. The 
blot was then incubated with a primary antibody that was designed to specifically detect 
an epitope in the protein of interest for either 1 hour at room temperature or overnight at 
4°C. The membrane was then washed multiple times with the washing buffer before the 
blot was incubated with a secondary antibody conjugated to HRP. The membrane was 
washed again multiple times and immune-reactive protein bands were then visualized with 
an enhanced chemi-luminescence (ECL) detection system. In this reaction, the HRP 
catalyzes the oxidation of luminol in the presence of the oxidizing agent hydrogen 
peroxide, which results in the emission of light with a 428 nm wavelength. The signal can 
then be detected and visualized on Amersham Hyperfilm films.  
 
2.5.  Immunostaining procedures 
 
2.5.1.  Materials 
 
2.5.1.1. Chemicals and reagents 
 
Product Company Cat. No. 
Albumin from bovine serum (BSA) Sigma A4503 
Aqua Poly Mount Polysciences 18606 
Disodium phosphate (Na2HPO4) Sigma S9763 
Fish Skin Gelatin  Sigma G7041 
Goat Serum Gibcro, Invitrogen 16210-072 
Monopotassium phosphate (KH2PO4) Merck 1.048.731.000 
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Product Company Cat. No. 
Paraformaldehyde (PFA) Serva 3.1628.02 
Potassium chloride (KCl) Merck 1.049.361.000 
Sodium Chloride (NaCl) Merck 1.076.511.000 





LAS AF Software Leica 
TCS SP5 Confocal Microscope Leica 
 
2.5.1.3. Media and Solutions 
 
Incubation Solution 1: 10% goat serum, 0.3% Triton-X 100, 0.1% fish skin gelatin in PBS 
Incubation Solution 2: 1% goat serum, 0.1% Triton-X-100 in PBS 
Blocking Solution: 20% BSA; 0.1% Triton-X-100 in PBS 
Permeabilization Solution: 1% Triton-X-100 in PBS 
1x PBS: 137 mM NaCl, 2.7 mM KCl; 10 mM Na2HPO4; 1.8 mM KH2PO4  
 
2.5.1.4.  Antibodies 
 
Product / concentration Company / Reference Cat. No. 
SNAP23 (rabbit polyclonal antiserum) 1:2000 Synaptic Systems 111 202 
SNAP25 (purified mouse monoclonal, 71.1) 1:600 Synaptic Systems 111 011 
VGLUT1 (guinea pig polyclonal antiserum)  
1:1000 – 1:2000 
Synaptic Systems 135 304 
Synaptobrevin-1 (rabbit polyclonal antiserum) 1:400 Synaptic Systems 104 002 
Synaptobrevin-2 (purified mouse monoclonal, 69.1) 
1:200 
Synaptic Systems 104 211 
MAP2 (chicken polyclonal antiserum) 1:1000 Novus Biologicals NB300-213 
Munc13-1 (affinity purified rabbit polyclonal) 1:1000 Synaptic Systems 126 103 
 
Secondary antibodies were coupled to Alexa 488, 555, 633 fluophores (Invitrogen) and 
were used in a concentration of 1:1300. 
 
 
                                                                                             2. Material and Methods 
 52 
2.5.2.  Methods 
 
2.5.2.1. Immunocytochemistry on autaptic hippocampal neurons 
 
Hippocampal autaptic neuron cultures were fixed for 20 min in 4% PFA in PBS. After three 
5 minutes washing steps, coverslips were incubated for one hour in incubation solution 
without antibodies to block non-specific binding sites. Then, coverslips were incubated for 
two hours at room temperature with the primary antibodies diluted in incubation solution 1, 
washed three times with PBS and afterwards incubated in secondary antibodies diluted in 
incubation solution for one hour at room temperature. After additional three washes in 
PBS, coverslips were mounted on object slides and stored at 4°C prior imaging. 
 
2.5.2.2. Immunohistochemistry on hippocampal organotypic slices 
 
Immunohistochemistry, imaging and image processing of hippocampal organotypic 
organotypic slices was performed by Dr. Benjamin Cooper. Hippocampal organotypic 
slices were fixed in 4% paraformaldehyde in PBS overnight at 4°C. Slices were then 
washed three times in PBS and then carefully separated from the small membrane 
confetti with a thin brush. Subsequently, slices were incubated in permeabilization solution 
to allow better antibody penetration overnight at 4°C. Slices were then transferred into 
blocking solution and incubated for one hour at room temperature. Subsequently, slices 
were incubated in diluted primary antibodies in incubation solution 2 for 48 hours at 4°C 
under gentle agitation. Then, the slices were washed several times in PBS prior 
secondary antibody incubation diluted in incubation solution 2 for two hours at room 
temperature. Coverslips were mounted on slides using Aqua Poly/Mount (Polysciences, 




Confocal laser scanning micrographs of organotypic hippocampal slices and autaptic 
hippocampal cultures were acquired with a Leica TCS-SP5 confocal microscope equipped 
with a tuneable White Light Laser (WLL) excitation source and hybrid GaAsP Detectors 
(HyD). High-magnification single-plane micrographs (1024x1024; pixel spacing x,y = 50.6 
nm) of randomly selected sites of synaptic neuropil were imaged in sequential scanning 
                                                                                             2. Material and Methods 
 53 
mode with an HCX PL APO 100x/1.44NA oil objective and a pinhole setting of 0.38 AU. 
Acquired images were exported from LAS AF (Leica) acquisition software as TIF files for 
quantitative analysis. 
 
2.5.2.4. Image processing and analysis 
 
Confocal images were subjected to spatial deconvolution by use of two ImageJ (National 
Institutes of Health; Bethesda, MD) plugins: point spread functions (PSF) were generated 
using Diffraction PSF 3D plugin and iterative deconvolution was performed with the 
Richardson-Lucy algorithm (DeconvolutionLab plugin; Biomedical Imaging Group, EPFL; 
Lausanne, Switzerland). 
The Colocalization plugin of ImageJ was used to detect and graphically represent sites of 
colocalization between Synaptobrevin-1 or SNAP23 and vesicular glutamate transporter 1 
(VGLUT1). The plugin overlays 8-bit images from green (Synaptobrevin-1) and red 
(VGLUT1) channels and displays colocalized points in white (display value = 255). Two 
signals were considered colocalized if their respective channel intensities exceeded an 
arbitrary threshold (set to 40 for both channels) and the ratio of pixel intensities for both 
channels exceeded 50%. Identical parameters were used for the analysis of control and 
mutant slices. The Analyse Particles feature of ImageJ was used to count and to measure 
the area of punctate labelling and sites of colocalization. To quantify and compare the 
degree to which Synaptobrevin-1 is spatially associated with glutamatergic presynapses in 
control and mutant slices the relative proportion of VGLUT1-positive presynapses 
exhibiting colocalization with Synaptorevin-1 was calculated by dividing the number of 
individual colocalized sites by the total number of VGLUT1 puncta. These approaches are 
potentially vulnerable to the following sources of inaccuracy: (i) the ImageJ analyse 
particles feature occasionally failed to recognize VGLUT1 puncta or sites of colocalization 
in close proximity to one another as independent signals and (ii) this type of analysis is 
insensitive to multiple sites of colocalization within a single VGLUT1 puncta. However, 
both genotypes were subject to the same experimental bias and analysed under identical 
conditions. 
Statistical analyses were performed with GraphPad Prism (Version 6.00; GraphPad, 
LaJolla,CA). Normally distributed data sets were compared by unpaired Student t-tests. 
Images (27 images each from control and Synaptobrevin-2 KOs; 18 images each from 
control and SNAP25 KOs) from two animals per genotype were included in the analysis. 
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2.6.1.1. Chemicals and Reagents  
Product Company Cat. No. 
2-Dodecenylsuccinic acid anhydride (DDSA) Serva 20755 
Acetone, glass distilled Electron Microscopy Sciences 10015 
Bovine Serum Albumin Sigma - Aldrich A-3350 
Chloroform EMSURE 1.024.451.000 
copper 100 mesh grids Plano G2410C 
DMP-30 Plano R1065 
Gelatin capsules Electron Microscopy Sciences 70100, Size 00 
Glycid ether 100 Serva 21045 
Gridboxes Plano B801003080 
Hexadecane Fluka 52276 
KOH MERCK UN1813 
Lead(II)nitrate MERCK 1.073.980.100 
Methylnadic anhydride (MNA) Serva 29452 
Osmium tetroxide (OsO4) EMS 19119 
Protein A 10 nm gold Utrecht   
Sample holder half cylinder Leica 16770135 
Sample holder middle plate Leica 16770136 
Sodium Citrate Dihydrate Calbiochem 567446 
Specimen carriers Type A, 3 mm Ø Leica 16770141 
Specimen carriers Type B, 3 mm Ø Leica 16770142 
Tannic Acid Sigma-Aldrich 403040 
Uranyl acetate SPI-CHEM 2624 
Vinylec E (Formvar®) Resin Plano / TED Pella, inc.  21201 / 19223 
 
 
2.6.1.2. Equipment  
Product Company 
JEM-2100 200kV JEOL 
Leica EM AFS2 Leica 
Leica EM HPM100 Leica 
Leica Ultracut UCT ultramicrotome Leica 
Leica-EM TRIM m. Stereo 2 Leica 
Orius SC1000 CCD camera  GATAN 
Sharp:eye CCD camera Tröndle, TRS 
Ultra 45° diamond knife Diatome 
Zeiss LEO 912-Omega 80kV Zeiss 
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2.6.1.3. Media and buffer  
 
1% Formvar: (Vinylec E Resin) in chloroform 
0.3% lead citrate (aqueous)  
1% uranyl acetate (aqueous)  
0.1% Tannic acid in acetone 
2% OsO4 in acetone 




2.6.2.1. High-Pressure-Freezing   
 
Hippocampal slices were transferred with forceps by handling the small membrane 
confetti into a small petri dish of Culture Medium. Excess membrane was trimmed at the 
sides with a scalpel. The slice was dipped into external cryoprotectant (20% bovine serum 
albumin in Culture Medium) and carefully loaded into the central cavity of the high-
pressure freezing sample carriers (2 mm Ø, 0.1 mm height) with the membrane side 
facing upwards. Carriers were placed in the sample cartridge of the EM HPM100 (Leica, 
Vienna, Austria) High-Pressure Freezing device. The lid was dipped in 1-hexadecene and 
placed on top the sample carrier, in order to facilitate the removal of the lid after freezing. 
The sample carrier was then inserted into the high-pressure chamber for rapid 
cryofixation. Finally, the frozen sample in the specimen carriers was automatically 
released into the liquid nitrogen dewar and the specimen carriers were then transferred 
with pre-cooled forceps into cryotubes and stored in liquid nitrogen until further 
processing.  
 
2.6.2.2. Freeze Substitution and EPON embedding 
 
The high pressure frozen samples were freeze-substituted in the Leica EM AFS-2 unit 
(AFS: automated freeze substitution, Vienna, Austria) at low temperatures (-90°C) 
according to the following protocol ('Paris protocol') modified from S. Marty (Rostaing et 
al., 2006; Siksou et al., 2007): 100 h in 0.1% tannic acid in dehydrated acetone at -90°C; 
four washing steps within 2 h in acetone at -90°C; 7 h fixing and contrasting in 2% osmium 
tetroxide (OsO4) during a temperature ramp from -90°C to 4°C within 40 h (14 h with 
5°C/h increments from -90 to -20°C, 16 h at -20°C, 2.4 h with 10°C/h increments to 4°C); 
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three washing steps in acetone at 4°C for 4 h; Infiltration with EPON resin was performed 
at room temperature in several steps: acetone/EPON 1:1 for 3 h, overnight incubation in 
90% EPON in acetone at RT, 36 h incubation in pure EPON at RT. Finally, specimen 
carriers containing infiltrated samples were placed sample-side-up on Parafilm®-covered 
glass slides. EPON-filled gelatin capsules were inverted on the specimen carriers and 
polymerized for 24 h at 60°C. 
 
2.6.2.3. Sectioning and contrasting 
 
Ultrathin sections (60 nm) were cut with a diamond knife (Ultra 45°, Diatome) on a Leica 
Ultracut UCT ultramicrotome (Leica, Vienna, Austria). Sections were collected onto a 
Formvar-filmed, carbon-coated, copper mesh grid. Ultrathin sections were treated 30 min 
with 1% UA in ddH2O, washed three times by dipping the grids seven times in ddH2O, 
treated 2 min with 0.3% lead citrate, washed again and dried with filter paper. For electron 
tomography, 200 nm thick sections were collected onto Formvar-filmed, carbon-coated 
copper mesh grids. To introduce fiducial markers for tomographic reconstruction, a 1:3 
dilution of Protein A (ProtA) conjugated to 10 nm gold particles (Utrecht, The Netherlands) 
in ddH20 was applied to both sides of the grid for 1 min each. The grids were washed 




For two-dimensional ultrastructural analyses of synaptic morphology, electron 
micrographs from ultrathin sections were acquired with a transmission electron 
microscope (Zeiss LEO 912-Omega) operating at 80 kV. Micrographs (2048 x 2048 
pixels) of synaptic profiles were acquired with a sharp:eye CCD camera (Tröndle, TRS) at 
12,500 fold magnification and  a pixel spacing of 0.95 nm. 
For the three-dimensional electron tomographic analysis of synaptic vesicle 
docking/priming, fiducially-coated 200 nm-thick sections were imaged in a JEM-2100 
transmission electron microscope (JEOL) operating at 200 kV. The SerialEM software 
enabled automated tilt series acquisition by using predictions for specimen positions 
during the tilt series based on the positions at previous tilts (Mastronarde, 2005). Single-
axis tilt series were recorded from −60 to +60° with 1° increment binned by the factor two 
at 30,000 fold magnifications with an Orius SC1000 camera (Gatan). The target defocus 
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during image acquisition was set to -0.2-0.4 µm. The individual images in the tilt series 
before tomogram reconstruction had 1336 x 1336 pixels with an individual pixel spacing of 
0.52 nm. 
 
2.6.2.5. IMOD Software package 
 
All tomographic volumes were reconstructed from their respective tilt series with the IMOD 
package (Kremer et al., 1996; Mastronarde, 1997). Windows version required installation 
of a Unix-like environment called Cygwin. All IMOD programs use the MRC image file 
format (*.mrc) and for an in-depth introduction and a tutorial to the IMOD software, the 
webpage of the Boulder laboratory for 3-D electron microscopy 
(http://bio3d.colorado.edu/) can be consulted. Tomogram generation was performed with 
the graphical user interface eTomo of the IMOD software package in a multi-step process. 
Afterwards, the *.mrc file extension was renamed in *.st to be recognized as single stack 
by eTomo. Second, in the pre-processing step, camera artefacts, like random x-rays 
causing extremely dark or bright pixels were removed by replacing them with 
neighbouring average values (program Ccderaser). In the following steps, the image stack 
was coarse aligned by using the programs Tiltxcorr, Xftoxg and Newstack. Then, a fiducial 
model was created computationally, based on the position of gold particles that were 
applied to both sides of the grid before image acquisition. These were then tracked 
through all projections by running the program Beadtrack. In the fine alignment step, the 
program Tiltalign was used to solve for displacements between the different tilted views to 
reduce the residual error mean. In a next step, three small sample tomograms (top, 
middle and bottom of the volume) were created to calculate the minimal volume of the 
final tomogram by defining the angle around the x- and y-axes and the z-position of the 
section after drawing boundary lines at the end of biological material in the sample 
tomograms. Then, in a final alignment step by running the program Tomopitch, a full-
aligned stack was produced using linear interpolation. During reconstruction, the 
projections were binned three times, resulting in a final isotropic voxel size of 1.55 nm. 
Finally, the actual tomogram was computed (program Tilt) using a back projection 
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2.6.2.6. Two-dimensional (2D) ultrastructural analysis of synaptic morphology 
 
Two-dimensional electron micrographs taken at 12,500 fold magnification were analyzed 
manually with the iTEM software version 5.1 (Olympus Soft Imaging Solutions GmbH). 
The different parameters measured are depicted in Fig. 2.1 and comprised of the synaptic 
vesicle number, the presynaptic terminal area, the number of synaptic vesicles normalized 
to the terminal area (terminal density, Fig. 2.1 A), the synaptic vesicle cluster area, and 
the number of synaptic vesicles normalized to the cluster area (cluster density, Fig. 2.1. 
B). Moreover, the length of the PSD (Fig. 2.1 C), the number of recycling endosomes per 
presynaptic terminal (Fig. 2.1 D, open arrows) and the number of LDCVs (Fig. 2.1 D, 
white arrows) were quantified. Synaptic vesicle terminal density and cluster density are 
specified as number of synaptic vesicles per 0.01 µm2 area. The PSD length is displayed 
in nanometers (nm).  
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Figure 2.1. Two-dimensional ultrastructural analysis of synaptic morphology 
Ultrastructural analysis of presynaptic parameters in electron micrographs from ultrathin sections. 
The number of synaptic vesicles (white crosses, A, B) within a presynaptic profile was normalized 
to the terminal area (blue, A) for the terminal density and to the cluster area (red, B) for the cluster 
density. The length of the postsynaptic density (white dotted line, C) was measured and the 
number of large dense core vesicles (LDCVs, white arrows, D) and endosomes (open arrows, D) 
was quantified. Scale Bar in D: 200 nm. 
 
2.6.2.7. Three-dimensional (3D) electron tomographic (ET) analysis of 
synaptic vesicle docking 
 
Synaptic vesicle docking analyses were performed on tomographic volumes reconstructed 
with an isotropic voxel size of 1.55 nm. Tomographic volumes were exported as TIFF 
image stacks (program tif2mrc) into ImageJ for quantitative analysis. The smallest vesicle 
distances from the outer leaflet of the synaptic vesicle membrane to the inner leaflet of the 
active zone membrane were measured using the straight line tool of the ImageJ software. 
Only synaptic vesicles observed to be in physical contact with the presynaptic membrane 
at their midline were considered docked (0-2 nm distance). Synaptic vesicles that were 
close to the active zone membrane, but not in physical contact were categorized together 
with the membrane-attached synaptic vesicles in a second 0-4 nm bin. Moreover, 
membrane proximal synaptic vesicles (0-40 nm distance) and all vesicles within 100 nm of 
the active zone were quantified. The active zone area was calculated by measuring the 
active zone length on each consecutive slice using the freehand line tool in ImageJ. The 
obtained values were added and then multiplied by the factor of 1.55 nm (isotropic voxel 
size; z-dimension) to obtain the final active zone area per tomogram. The final results for 
the quantifications are displayed as the number of vesicles in the respective bin (0-2 nm; 
0-4 nm; 0-40 nm and 0-100 nm) normalized to 0.01 µm2 active zone area. The mean 
synaptic vesicle diameter (d, nm) was calculated from the area (A) of the vesicle 
measured at its midline to the outer leaflet of the synaptic vesicle membrane using the 
elliptical selection tool in ImageJ (d=2√ (A/π)). As the sample sections were exposed to 
high electron doses during the image series acquisition, sample shrinkage in the z-
dimension was commonly observed, resulting in deformed, compressed synaptic vesicles 
shapes. The mean synaptic vesicle volume (V) was therefore extrapolated from the mean 
area measured at the midline of the synaptic vesicle and the presented values therefore 
include the vesicular phospholipid bilayer (V= π d3/6).  
For the images in this study, seven consecutive virtual tomographic slices were 
projected onto each other to be able to display a 10.88 nm thick sub-volume, using the 
Slicer tool of the 3dmod software of the IMOD software package. To illustrate the spatial 
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arrangements of synaptic vesicles with respect to the active zone, ultrastructural features 
of presynaptic profiles observed in tomographic reconstructions were manually 
segmented using the 3dmod software of the IMOD software package. The active zone 
membrane was reconstructed by drawing a contour on each consecutive section of the 
tomogram. Synaptic vesicle, endosomal and LDCV membranes were not segmented by 
tracing the vesicle outlines, but rather represented schematically as individual closed 
contours that were placed around the center of the vesicles.  
                                                                                             2. Material and Methods 
 61 
2.7.  Statistical Analysis 
 
Statistical analysis was performed using Prism (version 5.0) software. To test sample 
distributions for their normality, the Kolmogorov-Smirnov test was used.  
For the two-dimensional ultrastructural analysis of synaptic morphology the 
following parameters were obtained (for details refer to 2.6.2.6. Two-dimensional 
ultrastructural analysis of synaptic morphology): number of vesicles per synaptic profile, 
the synaptic vesicle terminal density, the synaptic vesicle cluster density, the average 
PSD length (nm), the number of endosomes and the number of LDCVs per synaptic 
profile. Most of the data sets from the two-dimensional analysis deviated from being 
normally distributed and therefore for all these parameters the nonparametric Mann–
Whitney U test was used. Data presented in the text as mean and standard error of the 
mean (SEM): (mean ± SEM), N=number of animals, n=number of synaptic profiles. 
For the three-dimensional electron tomographic analyses the following parameters 
were measured (for details refer to 2.6.2.7. Three-dimensional electron tomographic 
analysis of synaptic vesicle docking): number of synaptic vesicles within 100 nm of the 
active zone normalized to 0.01 µm2 active zone area, number of synaptic vesicles within 
100 nm of the active zone normalized to 0.01 µm2 active zone area, number of synaptic 
vesicles within 100 nm of the active zone normalized to 0.01 µm2 active zone area, 
number of synaptic vesicles within 100 nm of the active zone normalized to 0.01 µm2 
active zone area, mean outer synaptic vesicle diameter and mean synaptic vesicle 
volume. Most of these data sets were normally distributed and were therefore compared 
by using a parametric unpaired student’s t-test. For genotypes exhibiting dramatic 
reductions in the number of docked vesicles, which resulted in non-Gaussian distributions, 
the non-parametric Mann-Whitney U test was used. Data presented in the text: (mean ± 
SEM), N=number of animals, n=number of tomograms. 
The data obtained from electrophysiological experiments in order to access the 
physiological consequences of Cre-mediated Munc13-1 deletion in neurons, the following 
parameters were compared between the two groups: EPSC amplitude (nA), RRP size 
(nC) measured during hypertonic sucrose solution application and Pvr (%). For all three 
parameters, the non-parametric Mann-Whitney U test was used. In the control group 
(pFUG-GFP infected), one cell was excluded from the analysis since the measured RRP 
size was 8fold higher than the calculated mean of the data set. Data presented in the text: 
(mean ± SEM), N=number of cultures, n=cells. 






3.1. Analysis of the morphological correlate of synaptic vesicle priming 
3.1.1. Ultrastructural organization of mouse hippocampal organotypic slice 
cultures 
 
The experimental approach used in the present study yielded excellent ultrastructural 
preservation of high-pressure frozen and freeze-substituted hippocampal organotypic 
slices. To effectively freeze slices without subjecting them to hyperosmotic shock, different 
external cryoprotectants were tested for their ability to inhibit ice-crystal formation (data 
not shown). Freezing of the samples in cell culture medium resulted in sub-optimal 
freezing quality. The best freezing quality throughout the whole sample was obtained with 
a previously published combination of 20% dextran and 5% sucrose in culture medium, 
however the osmolarity of this solution measured ~600 mOsm, which was in our opinion 
too high to guarantee physiological conditions during freezing (Fernández-Busnadiego et 
al., 2010b; Zuber et al., 2005). A solution of 20% BSA in culture medium was ultimately 
selected for the study, since it yielded excellent preservation of synaptic ultrastructure in 
large areas while exposing the sample to only a minor increase in osmolarity (to ~340 
mOsm).  
After cryo-immobilization, well conserved samples were characterized by a densely 
packed neuropil of neuronal processes with smooth plasma membranes exhibiting parallel 
bilayers and small, round and symmetrically shaped synaptic vesicles (Fig. 3.1). 
Excitatory (asymmetric, Gray's Type I), glutamatergic spine synapses were identified by 
their prominent postsynaptic density (PSD) in the postsynaptic spine head and by an 
accumulation of synaptic vesicles in close proximity to the active zone of the presynaptic 
terminal (Fig. 3.1 A, B). Spine synapses lacked mitochondria and microtubules in their 
postsynaptic compartments. Some spine heads contained tubular organelles bearing 
morphological characteristics consistent with those described for the spine apparatus. The 
spine apparatus is thought to function in postsynaptic Ca2+-buffering by serving as an 
intracellular Ca2+-storage, and to participate in postsynaptic plasticity processes (Fig. 3.1 
B) (reviewed in Segal et al. 2010). Occasionally, we observed astrocytic processes in the 
vicinity of a synaptic cleft, which could be identified by the presence of small electron-
dense glycogen particles (Fig. 3.1 A). Astrocytes are known to provide trophic support to 
neurons and have been implicated in glutamate recycling at synapses, both being 
important functions in synaptic maintenance.  







Figure 3.1. Ultrastructural organization of mouse hippocampal organotypic slice cultures. 
Electron microscopy (EM) samples prepared by high-pressure freezing fixation and freeze 
substitution exhibit excellent ultrastructural preservation of neuropil in organotypic hippocampal 
slices (A-F). Glutamatergic, excitatory synapses (Gray's Type I; asterisks in A) exhibit a prominent 
postsynaptic density (PSD) and an accumulation of synaptic vesicles at the presynaptic active 
zone. Glutamatergic spine synapses are characterized by a small postsynaptic compartment 
lacking mitochondria (B, C; enlarged from panel A). Dendritic spines occasionally contain a spine 
apparatus ("SA" in C). Astrocyte processes contacting synapses can be identified by their glycogen 
particle content (“A” in A and B). Inhibitory synapses (Gray's Type II) preferentially contact the cell 
somata and dendritic shafts and can be identified by an absence of a prominent postsynaptic 
density (asterisks in D). In comparison to small synaptic vesicles, large dense core vesicles 
(LDCVs) are characterized by a larger size and an electron-dense appearance (white arrows in D). 
Well-preserved samples exhibit unswollen mitochondria with regular cristae (M in D and F). Rapid 
cryo-fixation for EM can capture pre- and postsynaptic clathrin-mediated endocytic events (white 
arrowheads; E, F). Scale Bar in A: 1 µm; B, C, E, F: 500 nm; D: 2 µm. 





Synapses contacting dendritic shafts or neuronal cell bodies often displayed a weaker 
postsynaptic density (symmetric, Gray's Type II) and were most likely of an inhibitory type 
(Fig. 3.1 D). A consequence of maintaining a near-native state of ultrastructural 
preservation in high-pressure frozen samples is that classical criteria for discriminating 
synaptic subtypes in conventionally prepared EM samples are less evident. Indeed, 
differences in vesicular shape and size, induced by the differential tonicity of excitatory 
and inhibitory vesicular populations upon chemical fixation, are no longer apparent in 
rapidly frozen material (Gaugler et al., 2012; Gray, 1959; Kaeser et al., 2009; Megías et 
al., 2001; Siksou et al., 2013). Rapid high-pressure freezing fixation of unstimulated 
organotypic slices could capture dynamic cellular events like pre-synaptic clathrin-
dependent endocytosis as well as postsynaptic receptor endo- or exocytosis at the PSD 
(Fig. 3.1 E, F). The preservation of cytoskeletal components by the applied freeze 
substitution protocol in slices frozen under physiological conditions was indicated by the 
presence of clathrin molecules coating endocytic intermediates. Slices exhibiting artifacts 
from suboptimal freezing conditions (e.g. nuclear chromatin reticulation resulting from ice 
crystal formation, pressure induced membrane disruption) were excluded from my 
analysis.  
 
3.1.2. Synaptic vesicle interactions with the active zone membrane 
 
In this study, I use the terms “active zone” or “release sites” to describe the presynaptic 
plasma membrane in direct apposition to the PSD. Due to the fact that I did not image full 
synaptic terminals, but rather synaptic sub-volumes with a focus on the active zone 
region, I use the term “synaptic profiles”, which refers to the sub-volume of the presynaptic 
terminal sampled in a respective tomogram. The definitions for “tethers”, describing 
filaments from synaptic vesicles to the active zone, and “connectors”, referring to filaments 
between synaptic vesicles, were taken from cryo-electron tomographic studies by R. 
Fernández-Busnadiego and colleagues (Fernández-Busnadiego et al., 2010, 2013). The 
number of tethers and connectors in tomographic reconstructions was not quantified in the 
course of the present study. Morphologically docked (or simply “docked”) synaptic 
vesicles describe vesicles in direct membrane to membrane contact at the active zone 
(Fig.3.2 A1, A2). Such vesicles would fall into the 0-2 nm distance from the active zone, 
since the maximum resolution achievable in the analysed tomographic reconstructions 
was limited by an isotropic voxel size of ~1.6 nm. The term “membrane-attachment” is 
used as a synonym for the term “docking” in this study. The term “closely tethered 





synaptic vesicles” describes all vesicles within 0-4 nm of the active zone, including those 
that were membrane-attached and those that were potentially linked by multiple short 
filaments to the release site (Fig. 3.2 B1, B2, tethers indicated by white arrow heads). 
Multiple short tethers (<5 nm length) seen in cryo-electron tomograms were previously 
described as likely corresponding to assembled SNARE complexes (Fernández-
Busnadiego et al., 2010). Occasionally, potential synaptic vesicle hemifusion events were 
detected at active and periactive zone sites (Fig. 3.2 A2). These vesicles were included in 
the category of membrane-attached synaptic vesicles (0-2 nm) in my analysis. Very rarely, 
I was able to see an open fusion pore during synaptic vesicle fusion (Fig. 3.2. C1) or 
observe full collapse fusion events (Fig. 3.2. C2). These vesicles were excluded from the 
analysis. Occasionally, I observed inward membrane curvatures at periactive zonal sites 
that were considered to be early endocytotic events (Fig. 3.2 D1, D2).  
The term “membrane-proximal synaptic vesicles” was used to describe synaptic vesicles 
within 40 nm of the active zone membrane. These vesicles would have been included in 
the pool of membrane-attached synaptic vesicles in studies that considered all vesicles 
within a diameter distance (e.g. 40 nm) as “docked” (discussed in: Verhage & Sørensen 
2008). Moreover, recent studies showed that synaptic vesicles within 45 nm of the active 
zone can still connect to the plasma membrane via single long tethers (Fernández-
Busnadiego et al., 2010, 2013; Siksou et al., 2009, 2011).  
 
Figure 3.2. Direct interactions of synaptic vesicles with the active zone membrane 
A Direct membrane-attachment of synaptic vesicles (SVs) with the active zone membrane (0-2 
nm). A1 No visible gap between the inner phospholipid layer of the active zone plasma membrane 
and the outer vesicular phospholipid layer. A2 Occasional inward curvature of the active zone 
membranes towards the membrane-attached SV displaying potential early hemifusion events 
(asterisk). B (B1+B2) Synaptic vesicles are not in direct contact, but closely tethered to the 





membrane (0-4 nm) by multiple, short filaments (white arrowheads). C Synaptic vesicle fusion 
events. C1 A synaptic vesicle is in a fused state displaying a prominent open fusion pore (asterisk). 
C2 Full collapse fusion event at the active zone membrane. D (D1+D2) Presynaptic endocytotic 
events at the periactive zone. Scale bar in D2: 50 nm. 
 
3.1.3. Docking Analysis of presynaptic mutants 
 
3.1.3.1. The role of the synaptic vesicle priming factors Munc13-1 and 
Munc13-2 in synaptic vesicle docking 
 
Munc13 proteins are key regulators of synaptic vesicle release, as evidenced by the 
complete loss of evoked and spontaneous neurotransmitter release in the absence of 
Munc13 priming factors. Munc13s reside in the dense protein network at the presynaptic 
active zone. Their mode of action is believed to involve the opening of the t-SNARE 
Syntaxin-1 by displacing Munc18-1, allowing t-SNARE acceptor complex formation (Ma et 
al., 2011). A previous study has shown that KO of Munc13 proteins results in a massive 
decrease in the number of “docked” or “membrane-attached” synaptic vesicles in neurons 
(Siksou et al., 2009). Therefore I decided to start with the reanalysis of synaptic vesicle 
docking in Munc13-1/2 DKO neurons in order to validate my experimental system 
(Augustin et al., 1999a; Varoqueaux et al., 2002). Homozygous Munc13-2 KO neurons 
are phenotypically indistinguishable from wild-type neurons (Varoqueaux et al., 2002). In 
this study, I therefore compared four Munc13-1/2 DKO animals (N=4) with four littermate 
control animals (N=4) from two cultures. The control animals were either wild-type or 
heterozygous for the Munc13-1 KO allele in a homozygous Munc13-2 KO background, or 
heterozygous for Munc13-1 and Munc13-2 KO alleles.  
 
3.1.3.1.1. 2D-EM analysis of synaptic morphology in Munc13-1/2 DKO neurons 
 
In a first experiment, ultrastructural parameters of Munc13-1/2 DKO synapses were 
analyzed in electron micrographs from 60 nm ultrathin EPON sections after high-pressure 
freezing fixation, freeze-substitution and EPON embedding in order to rule out any major 
changes of presynaptic morphology that could influence the results obtained from a high-
resolution electron tomographic analysis (Fig. 3.3). I did not observe any major 
morphological changes between control and Munc13-1/2 DKO synaptic profiles, although 
a potential increase in the size of synaptic vesicles was apparent in Munc13-1/2 DKO 





terminals (Fig. 3.3 A, B). I found that the total number of synaptic vesicles per synaptic 
profiles in Munc13-1/2 DKO synapses was unchanged in comparison to control synaptic 
profiles (control: 61.44 ± 3.195, n=106; Munc13-1/2 DKO: 70.53 ± 4.203, n=103 / 
P=0.2565, n.s.; Fig. 3.3 C). Moreover, I did not detect any significant changes in the 
number of synaptic vesicles normalized to the presynaptic terminal size (synaptic vesicles 
per 0.01 µm² terminal area or synaptic vesicle terminal density) (control: 1.633 ± 0.059, 
n=106; Munc13-1/2 DKO: 1.489 ± 0.057, n=103 / P=0.0558, n.s.) nor in the measured 
length of the PSD (control: 371.1 ± 11.95, n=106; Munc13-1/2 DKO: 393.7 ± 12.97, n=103 
/ P =0.1895, n.s.; Fig.3.3 D, F). However, I did observe a small decrease in the number of 
synaptic vesicles normalized to the size of the synaptic vesicle cluster (synaptic vesicles 
per 0.01 µm² cluster area or synaptic vesicle cluster density) (control: 3.149 ± 0.056, 
n=106; Munc13-1/2 DKO: 2.883 ± 0.055, n=103 / P=0.0018, **; Fig. 3.3 E). I also noticed 
an increase in the number of vesicular structures with a larger diameter than synaptic 
vesicles, possibly representing components of the endocytotic recycling pathway in the 
presynaptic terminal (control: 1.000 ± 0.127, n=106; Munc13-1/2 DKO: 1.650 ± 0.198, 
n=103 / P =0.0462, *; Fig. 3.3 G). A recent study indicated a role of proteins from the 
Munc13 family in LDCV release in neurons, without detecting any changes in the number 
of LDCVs in presynaptic terminals from Munc13-1/2 DKO and control neurons (van de 
Bospoort et al., 2012). I could confirm these results in our experimental setting as I failed 
to observe a difference in the number of LDCVs per synaptic profile (control: 0.236 ± 
0.056, n=106; Munc13-1/2 DKO: 0.233 ± 0.054, n=103 / P=0.8375, n.s.; Fig. 3.3 H).  
 
3.1.3.1.2.  3D-ET analysis of synaptic vesicle docking in Munc13-1/2 DKO 
neurons 
 
I then moved on to analyze synaptic vesicle docking in presynaptic terminals from electron 
tomographic reconstructions of 200 nm-thick semithin sections through glutamatergic, 
spine synapses of control and Munc13-1/2 DKO samples (Fig. 3.4 A-F). For the three-
dimensional analysis of electron tomograms, I compared samples from three Munc13-1/2 
DKO animals (N=3) with samples from two littermate controls (N=2). Control animals were 
either wild-type for the Munc13-1 KO allele in a homozygous Munc13-2 KO background, 
or heterozygous for both Munc13-1 and Munc13-2 KO alleles. In agreement with previous 
publications, I detected an almost complete loss of membrane-attached vesicles (0-2 nm) 






Figure 3.3. Two-dimensional ultrastructural analysis of synaptic morphology in Munc13-1/2 
DKO neurons 
Electron micrographs of control (A) and Munc13-1/2 DKO (B) synaptic profiles acquired from 60 
nm-thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). Mean 
number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number of SVs 
normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) length (F) 
Mean number of endosomes per synaptic profile (G). Mean number of large dense-core vesicles 
(LDCVs) per synaptic profile (H). C-H: Control: N=4, n=106; Munc13-1/2 DKO: N=4, n=103 (Mean 
+ SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 
 
normalized to 0.01 µm² active zone area in Munc13-1/2 DKO in comparison to control 
synaptic profiles (control: 0.979 ± 0.134, n=16; Munc13-1/2 DKO: 0.042 ± 0.004, n=15 / 
P<0.001, ***; Fig. 3.4 I), which was still statistically significant after including vesicles that 
are closely tethered (0-4 nm) normalized to 0.01 µm² active zone area (control: 1.651 ± 
0.201, n=16; Munc13-1/2 DKO: 0.145 ± 0.089, n=15 / P<0.001, ***; Fig. 3.4 J). 14 out of 
15 synaptic profiles (93%) harbored no membrane-attached (0-2 nm) vesicles, and 12 
synaptic profiles (80%) lacked docked and closely tethered vesicles (0-4 nm). The number 
of membrane-attached (0-2 nm) and closely tethered (0-4 nm) synaptic vesicles was 
reduced to 4% and 11% of control profiles, respectively. However, the number of vesicles 
that were close to the active zone (within 40 nm) normalized to 0.01 µm² active zone area 
was unchanged (control: 2.487 ± 0.188, n=16; Munc13-1/2 DKO: 2.113 ± 0.179, n=15 / 
P=0.1626, n.s.; Fig. 3.4 H). Consistent with this finding, the synaptic vesicles in Munc13-
1/2 DKO synapses seem to accumulate at a close distance to the active zone membrane, 
with a peak in the vesicle distribution around 8-10 nm (Fig. 3.4 M). Those membrane-





proximal, but not docked vesicles, were often linked to the presynaptic plasma membrane 
by thin, long filaments similar to previous findings (Siksou et al., 2009). I also detected a 
decrease in the number of vesicles within 100 nm distance from the active zone 
membrane, normalized to 0.01 µm² active zone area (control: 6.547 ± 0.395, n=16; 
Munc13-1/2 DKO: 5.023 ± 0.384, n=15 / P=0.0099, **; Fig. 3.4 G). A likely explanation for 
this is a dramatic increase in the mean outer synaptic vesicle diameter, first observed in 
two-dimensional electron micrographs from Munc13-1/2 DKO synapses, and 
subsequently confirmed by three-dimensional electron tomographic analysis (control: 
46.25 ± 0.485, n=16; Munc13-1/2 DKO: 50.15 ± 0.715, n=15; P<0.001, ***; Fig. 3.4 K, N). 
This increase in the outer vesicle diameter in Munc13-1/2 DKO presynaptic terminals 
leads to a corresponding 28% increase in the synaptic vesicle volume (control: 52473 ± 
1656, n=16; Munc13-1/2 DKO: 67158 ± 2853, n=15; P<0.001, ***; Fig. 3.4 L). The 
increased number of larger vesicular structures, possibly components of the endocytotic 
recycling pathway or precursors of vesicular biosynthesis, in the presynaptic terminals in 
Munc13-1/2 DKO synaptic profiles raises the possibility that synaptic trafficking or vesicle 
recycling is disrupted in the absence of Munc13 proteins.  
In summary, the ultrastructural findings presented here are in agreement with previously 
published data, showing an almost complete loss of membrane-associated synaptic 
vesicles in synapses lacking synaptic vesicle priming molecules of the Munc13 family 
(Siksou et al., 2009). Moreover, the inability of synaptic vesicles to dock to the presynaptic 
active zone membrane strongly supports the hypothesis that the terms morphological 
synaptic vesicle “docking” and physiological synaptic vesicle “priming” may describe the 
same molecular process.  
 
3.1.3.2. The role of the synaptic vesicle priming factors CAPS-1 and CAPS-2 
in synaptic vesicle docking 
 
Next, I decided to focus on CAPS-1/2 proteins, which are thought to regulate synaptic 
vesicle priming in concert with Munc13s. Autaptic hippocampal cultures from CAPS1/2 
DKO neurons revealed a complex physiological phenotype: similar to Munc13-1/2 DKO 
neurons, 39% of all CAPS-1/2 DKO neurons lack any presynaptic activity and are 
deficient of fusion-competent vesicles (Jockusch et al., 2007). However, in the remaining 
61% cells, synaptic responses are not completely abolished, but EPSC sizes and the RRP 
probed by sucrose application are reduced by 68% and 85%, respectively (Jockusch et 
al., 2007). 






Figure 3.4. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
Munc13-1/2 DKO neurons 
Tomographically reconstructed subvolumes of control (A) and Munc13-1/2 DKO (B) synapses from 
200 nm-thick sections. Three-dimensional models of tomographically reconstructed control (C) and 
Munc13-1/2 DKO (D) synaptic profiles. Ultrastructural features reconstructed in the models include 
the active zone plasma membrane (white), synaptic vesicles (membrane-attached, green; non-





attached, grey), and large dense core vesicles (LDCVs; beige). Orthogonal views of control (E) and 
Munc13-1/2 DKO (F) tomographic models displaying the spatial arrangement of membrane-
attached synaptic vesicles within the reconstructed active zone area. Mean number of SVs within 
100 nm of the AZ normalized to AZ area (G). Mean number of SVs within 40 nm of the AZ 
normalized to AZ area (H). Mean number of membrane-attached SVs (within 0-2 nm of the AZ) 
normalized to AZ area (I). Mean number of membrane-attached and closely-tethered SVs (within 0-
4 nm of the AZ) normalized to AZ area (J). Mean outer SV diameter (K). Mean SV volume 
including the membrane bilayer (L). Spatial distribution of SVs within a 100 nm distance of the AZ 
membrane (M). Distribution of synaptic vesicle diameters of vesicles within 100 nm of the AZ (N). 
G-L: Control: N=2, n=16; Munc13-1/2 DKO: N=3, n=15 (Mean + SEM), P<0.001: ***; P<0.01: **; 
P<0.05: *. M, N: (511 SVs in control and 402 SVs in Munc13-1/2 DKO synaptic profiles). Scale 
bar: B, 100 nm. 
 
As previously shown, homozygous CAPS-2 KO neurons are phenotypically 
indistinguishable from wild-type neurons (Jockusch et al., 2007). For the two-dimensional 
analysis of electron micrographs from ultrathin sections, four CAPS-1/2 DKO animals 
(N=4) were compared with three littermate control animals (N=3) from three cultures. The 
control animals were either wild-type or heterozygous for the CAPS-1 KO allele in a 
homozygous CAPS-2 KO background.  
 
3.1.3.2.1.  2D-EM analysis of synaptic morphology in CAPS-1/2 DKO neurons 
 
Morphologically, no major differences in the gross synaptic ultrastructure of neurons 
lacking both CAPS isoforms were observed in electron micrographs from ultrathin (60 nm) 
sections (Fig. 3.5 A, B). The total number of synaptic vesicles per synaptic profile did not 
differ in CAPS-1/2 deficient neurons in comparison to control samples (control: 63.15 ± 
3.641, n=109; CAPS-1/2 DKO: 60.74 ± 2.907, n=115 / P=0.9228, n.s.; Fig. 3.5 C). 
Moreover, the synaptic vesicle terminal density was not significantly altered (control: 1.454 
± 0.059, n=109; CAPS-1/2 DKO: 1.535 ± 0.057, n=115 / P=0.2858, n.s.; Fig. 3.5 D), with 
only a slight decrease in the synaptic vesicle cluster density (control: 3.436 ± 0.061, 
n=109; CAPS-1/2 DKO: 3.285 ± 0.056, n=115 / P=0.0308, *; Fig 3.5 E) and no changes in 
the mean PSD length (control: 330.5 ± 11.06, n=109; CAPS-1/2 DKO: 315.2 ± 8.849, 
n=115 / P=0.5539, n.s.; Fig. 3.5 F). In contrast to synapses lacking Munc13s, I did not 
observe an increase in the number of recycling endosomes per synaptic profile in neurons 
deficient for CAPS-1 and -2 in comparison to control neurons (control: 1.248 ± 0.170, 
n=109; CAPS-1/2 DKO: 1.270 ± 0.142, n=115 / P=0.5173, n.s.; Fig.3.5 G). Also, no 
change in the number of LDCVs in synapses lacking all CAPS isoforms was detected in 
my experimental setting (control: 0.147 ± 0.043, n=109; CAPS-1/2 DKO: 0.191 ± 0.046, 
n=115 / P=0.4204, n.s.; Fig. 3.5 H), confirming previous findings (Jockusch et al., 2007).  





3.1.3.2.2.  3D-ET analysis of synaptic vesicle docking in CAPS-1/2 DKO neurons 
 
In the electron tomographic three-dimensional analysis, I analyzed samples from three 
CAPS-1/2 DKO (N=3) and three control animals (N=3) (Fig. 3.6 A-F). I noticed that CAPS-
1/2 DKO synaptic profiles analyzed by electron tomography exhibited a drastic reduction 
in the number of membrane-associated vesicles (0-2 nm) in comparison to control 
synaptic profiles (control: 1.202 ± 0.143, n=22; CAPS-1/2 DKO: 0.083 ± 0.026, n=19 / 
P<0.001, ***; Fig. 3.6 I), and also a strong decrease in the number of closely tethered (0-4 
nm) synaptic vesicles (control: 1.598 ± 0.158, n=22; CAPS-1/2 DKO: 0.180 ± 0.063, n=19 
/ P<0.001, ***; Fig. 3.6 J). However, the number of vesicles within 40 nm of the 
presynaptic plasma membrane (control: 2.660 ± 0.196, n=22; CAPS-1/2 DKO: 2.393 ± 
0.191, n=19 / P=0.3400, n.s.; Fig. 3.6 H) and the number of vesicles within 100 nm of the 
presynaptic release sites were unaltered (control: 7.121 ± 0.413, n=22; CAPS-1/2 DKO: 
6.015 ± 0.391, n=19 / P=0.0614, n.s.; Fig. 3.6 G). In contrast to synapses lacking 
Munc13s, synaptic vesicles in synapses lacking both CAPS isoforms appeared to be 
randomly distributed within the first 100 nm from the active zone membrane, rather than 
accumulating at an 8-10 nm distance (Fig. 3.6 M). Moreover, neither the mean outer 
synaptic vesicle diameter (control: 45.19 ± 0.560, n=22; CAPS-1/2 DKO: 45.54 ± 0.649, 
n=19 / P=0.6434, n.s.; Fig. 3.6 K, N) nor the mean outer synaptic vesicle volume were 
significantly different from controls (control: 49181 ± 1896, n=22; CAPS-1/2 DKO: 50355 ± 
2022, n=19 / P=0.6743, n.s.; Fig. 3.6 L) for CAPS-1/2 DKO neurons. 
In my analysis, 63% of all sampled CAPS-1/2 DKO synaptic profiles (12 out of 19 
tomograms) were completely devoid of membrane-attached vesicles (0-2 nm) and 58% of 
all CAPS-1/2 DKO synaptic profiles (11 out of 19 tomograms) also lacked vesicles closely 
tethered to the active zone membrane (0-4 nm). In comparison to control synaptic profiles, 
the number of membrane-attached (0-2 nm) and closely tethered (0-4 nm) synaptic 
vesicles in CAPS-1/2 DKO neurons was reduced to 7% and 12%, respectively. 
Tomograms from CAPS-1/2 DKO synapses that still harbored membrane-attached 
synaptic vesicles, docking (0-2 nm) and close tethering (0-4 nm) was reduced to 19% and 
28% compared to controls, respectively.  
 






Figure 3.5. Two-dimensional ultrastructural analysis of synaptic morphology in CAPS-1/2 
DKO neurons 
Electron micrographs of control (A) and CAPS-1/2 DKO (B) synaptic profiles acquired from 60 nm-
thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). Mean 
number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number of SVs 
normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) length (F) 
Mean number of endosomes per synaptic profile (G). Mean number of large dense-core vesicles 
(LDCVs) per synaptic profile (H). C-H: Control: N=3, n=109; CAPS-1/2 DKO: N=4, n=115 (Mean + 
SEM), P<0. 001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 
 
These ultrastructural findings indicate that CAPS proteins perform not only to produce 
functionally prime synaptic vesicles, but, similar to Munc13s, have an important role in 
docking synaptic vesicles to the presynaptic active zone membrane. I interpret these 
findings as further support for the hypothesis that the RRP of functionally primed vesicles 
is comprised of membrane-attached synaptic vesicles capable of securing fast synaptic 
release (Murthy et al., 2001; Schikorski and Stevens, 2001). This pool of readily-
releasable and docked vesicles has been shown here to be either completely depleted or 
strongly diminished in neurons lacking proteins from the Munc13 or CAPS family.  






Figure 3.6. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
CAPS-1/2 DKO neurons 
Tomographically reconstructed subvolumes of control (A) and CAPS-1/2 DKO (B) synapses from 
200 nm-thick sections. Three-dimensional models of tomographically reconstructed control (C) and 
CAPS-1/2 DKO (D) synaptic profiles. Ultrastructural features reconstructed in the models include 
the active zone plasma membrane (white) and synaptic vesicles (membrane-attached, green; non-





attached, grey). Orthogonal views of control (E) and CAPS-1/2 DKO (F) tomographic models 
displaying the spatial arrangement of membrane-attached synaptic vesicles within the 
reconstructed active zone area. Mean number of SVs within 100 nm of the AZ normalized to AZ 
area (G). Mean number of SVs within 40 nm of the AZ normalized to AZ area (H). Mean number of 
membrane-attached SVs (within 0-2 nm of the AZ) normalized to AZ area (I). Mean number of 
membrane-attached and closely-tethered SVs (within 0-4 nm of the AZ) normalized to AZ area (J). 
Mean outer SV diameter (K). Mean SV volume including the membrane bilayer (L). Spatial 
distribution of SVs within a 100 nm distance of the AZ membrane (M). Distribution of synaptic 
vesicle diameters of vesicles within 100 nm of the AZ (N). G-L: Control: N=3, n=22; CAPS-1/2 
DKO: N=3, n=19 (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. M, N: (716 SVs in control and 
560 SVs in CAPS-1/2 DKO synaptic profiles). Scale bar: B,100 nm. 
 
3.1.3.3. The role of the t-SNARE SNAP25 in synaptic vesicle docking 
 
Since Munc13s are believed to open Syntaxin-1 to enable t-SNARE acceptor complex 
formation with SNAP25, and CAPS proteins have been shown to facilitate SNARE 
complex formation in vitro, I decided to reinvestigate the role of SNARE proteins SNAP25, 
Syntaxin-1 and Synaptobrevin-2 in synaptic vesicle docking in my experimental setting 
(Daily et al., 2010; James et al., 2009, 2010; Ma et al., 2011). In order to understand the 
function of SNARE proteins in the synaptic vesicle membrane-attachment process, I first 
decided to analyze mouse mutants that show no or decreased expression of the neuronal 
t-SNAREs SNAP25 and Syntaxin-1. Both t-SNARE molecules have been implicated in 
secretory vesicle docking in non-neuronal systems (de Wit et al., 2006, 2009; Wu et al., 
2012).  
SNAP25 mice (Washbourne et al., 2002) were received from Maarten Loos (Amsterdam) 
and Ina Herfort (Göttingen). Neurons from SNAP25 mutant mice were described to slowly 
degenerate in dissociated neurons cultures beyond DIV 7. However, previous studies 
showed that high-density cultures can prolong neuronal survival of SNAP25 KO neurons 
(Bronk et al., 2007; Washbourne et al., 2002). In my hippocampal organotypic slice culture 
system, slices from SNAP25 KO animals were considerably thinner than control slices, 
however, immunhistochemistry revealed an increased density and a larger mean area of 
VGLUT1-immunoreactive puncta (See section 3.1.3.3.3). Previous physiological analysis 
of autaptic neurons lacking SNAP25 revealed an 88% reduction in the RRP size in KO 
neurons in comparison to control neurons (Bronk et al., 2007).  
 
  





3.1.3.3.1.  2D-EM analysis of synaptic morphology in SNAP25 KO neurons 
 
As wild-type and mice heterozygous for SNAP25 were phenotypically indistinguishable at 
birth, SNAP25 heterozygous mice were used as controls for this study (Delgado-Martínez 
et al., 2007). For the analysis of two-dimensional electron micrographs from synaptic 
profiles of ultrathin sections, organotypic slices from six SNAP25 KO mice (N=6) were 
compared with slices from six littermate mice (N=6) heterozygous for the SNAP25 allele in 
three cultures. The gross synaptic morphology was unaltered between control and 
SNAP25 KO samples, but similar to Munc13-1/2 DKO synapses, the presence of larger 
vesicle sizes in SNAP25 KO synapses was apparent (Fig. 3.7 A, B). The total number of 
synaptic vesicles per synaptic profile did not significantly differ between KO and control 
cultures (control: 68.73 ± 3.790, n=82; SNAP25 KO: 63.74 ± 3.276, n=101 / P=0.4061, 
n.s.; Fig. 3.7 C), and no change in the PSD length was observed (control: 374.1 ± 15.62, 
n=82; SNAP25 KO: 351.6 ± 11.31, n=101 / P=0.3844, n.s.; Fig. 3.7 F). However, both the 
synaptic vesicle terminal density (control: 1.688 ± 0.074, n=82; SNAP25 KO: 1.446 ± 
0.051, n=101 / P=0.0245, *; Fig. 3.7 D) and the synaptic vesicle cluster density (control: 
4.712 ± 0.084, n=82; SNAP25 KO: 3.785 ± 0.053, n=101 / P<0.001, ***; Fig 3.7 E) were 
significantly reduced. Moreover, a dramatic increase in the number of large, vesicular, 
possibly endosomal structures, in SNAP-25 KO synaptic profiles was detected (control: 
1.415 ± 0.247, n=82; SNAP25 KO: 4.168 ± 0.456, n=101 / P<0.001, ***; Fig. 3.7 G). This 
finding supports the hypothesis that SNAP25 may play additional roles in vesicle recycling 
or trafficking pathway (Aikawa et al., 2006; Peng et al., 2013). In addition, I observed a 
slight, though statistically insignificant increase in the number of LDCVs per synaptic 
profile in synapses lacking SNAP25 (control: 0.183 ± 0.046, n=82; SNAP25 KO: 0.317 ± 
0.064, n=101 / P=0.2601, n.s.; Fig. 3.7 H). 
 
3.1.3.3.2.  3D-ET analysis of synaptic vesicle docking in SNAP25 KO neurons 
 
For the electron tomographic analysis, organotypic slices from five SNAP25 KO mice 
(N=5) were compared with slices from five littermate mice (N=5) heterozygous for the 
SNAP25 allele in three cultures (Fig. 3.8 A-F). Tomographic analysis revealed a strong 
reduction in membrane-attached synaptic vesicles (0-2 nm) in SNAP25 KO synaptic 
profiles compared to controls (control: 1.125 ± 0.130, n=24; SNAP25 KO: 0.241 ± 0.062, 
n=25 / P<0.001, ***; Fig. 3.8 I) as well as synaptic vesicles closely tethered (0-4 nm) to the 
presynaptic release site (control: 1.462 ± 0.179, n=24; SNAP25 KO: 0.508 ± 0.101, n=25 / 





P<0.001, ***; Fig. 3.8 J). In contrast to this strong reduction in the number of membrane-
associated synaptic vesicles, the number of membrane proximal synaptic vesicles (0-40 
nm) was unaltered (control: 2.779 ± 0.219, n=24; SNAP25 KO: 2.749 ± 0.132, n=25 / 
P=0.9047, n.s.; Fig. 3.8 H).  
 
Figure 3.7. Two-dimensional ultrastructural analysis of synaptic morphology in SNAP25 KO 
neurons 
Electron micrographs of control (A) and SNAP25 KO (B) synaptic profiles acquired from 60 nm-
thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). Mean 
number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number of SVs 
normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) length (F) 
Mean number of endosomes per synaptic profile (G). Mean number of large dense-core vesicles 
(LDCVs) per synaptic profile (H). C-H: Control: N=6, n=82; SNAP25 KO: N=6, n=101 (Mean + 
SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 
 
The number of vesicles within 100 nm distance from the active zone was only slightly 
reduced (control: 6.766 ± 0.396, n=24; SNAP25 KO: 5.682 ± 0.236, n=25 / P=0.0216, *; 
Fig. 3.8 G). In this analysis, 13 out of 25 tomograms from SNAP25 KO synapses (52%) 
were completely devoid of membrane-attached vesicles (0-2 nm), with 7 out of 25 
tomograms (28%) lacking both physically docked and closely tethered synaptic vesicles 
(0-4 nm). In the absence of SNAP25, the numbers of membrane-attached and closely 
tethered vesicles were reduced to 21% and 35% of controls, respectively. Moreover, in 
tomograms from SNAP25 KO synapses that still harbored membrane-attached synaptic 
vesicles, docking (0-2 nm) and close tethering (0-4 nm) was reduced to 41% and 64% of 
controls, respectively.  






Figure 3.8. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
SNAP25 KO neurons 
Tomographically reconstructed subvolumes of control (A) and SNAP25 KO (B) synapses from 200 
nm-thick sections. Three-dimensional models of tomographically reconstructed control (C) and 
SNAP25 KO (D) synaptic profiles. Ultrastructural features reconstructed in the models include the 
active zone plasma membrane (white), synaptic vesicles (membrane-attached, green; non-
attached, grey) and endosomes (light blue). Orthogonal views of control (E) and SNAP25 KO (F) 





tomographic models displaying the spatial arrangement of membrane-attached synaptic vesicles 
within the reconstructed active zone area. Mean number of SVs within 100 nm of the AZ 
normalized to AZ area (G). Mean number of SVs within 40 nm of the AZ normalized to AZ area (H). 
Mean number of membrane-attached SVs (within 0-2 nm of the AZ) normalized to AZ area (I). 
Mean number of membrane-attached and closely-tethered SVs (within 0-4 nm of the AZ) 
normalized to AZ area (J). Mean outer SV diameter (K). Mean SV volume including the membrane 
bilayer (L). Spatial distribution of SVs within a 100 nm distance of the AZ membrane (M). 
Distribution of synaptic vesicle diameters of vesicles within 100 nm of the AZ (N).  G-L: Control: 
N=5, n=24; SNAP25 KO: N=5, n=25 (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. M, N: (850 
SVs in control and 732 SVs in SNAP25 KO synaptic profiles).Scale bar: B,100 nm. 
 
 
Similar to synapses lacking Munc13s, terminals that were devoid of the neuronal t-SNARE 
SNAP25 showed a prominent accumulation of synaptic vesicles at a distance of 4-8 nm 
from the active zone membrane (Fig. 3.8 M). These membrane-proximal, but not 
physically docked, vesicles were often linked to the presynaptic plasma membrane by 
thin, long filaments, but were not connected to the membrane by multiple short tethers at 
this distance. Moreover, I observed an enormous increase in the mean outer vesicle 
diameter in SNAP25 KO synapses (control: 46.12 ± 0.482, n=24; SNAP25 KO: 52.53 ± 
0.486, n=25 / P<0.001, ***; Fig. 3.8 K, N), resulting in 48 % increase in the mean vesicular 
volume (control: 52132 ± 1682, n=24; SNAP25 KO: 76926 ± 2191, n=25 / P<0.001, ***; 
Fig. 3.8 L), supporting the idea that SNAP25 might have an additional role in presynaptic 
membrane recycling (Peng et al. 2013; Xu et al. 2013). 
 
In our heterozygous control animals from two different cultures we observed two synapses 
that do not harbor many docked vesicles, but show small, omega-shaped membrane 
invaginations, active zone regions with concave curvature described as full-collapse 
fusion events (Fernández-Busnadiego et al., 2010), and large endocytotic structures 
connected to the plasma membrane in the perimeter of the active zone (data not shown). 
These structures are most likely features of synapses that had been captured in or shortly 
after the process of neurotransmitter release. I occasionally observe these structures in 
other genotypes, albeit with a significantly lower frequency. Since control synapses 
lacking these ultrastructural correlates of high synaptic activity displayed normal numbers 
of docked vesicles, we decided to continue our analysis with the heterozygous control 
group. A previous analysis of the neurological Coloboma mouse (Cm/+), which lacks one 
copy of the SNAP25 gene, revealed an epileptic phenotype caused by synaptic 
hyperexcitability due to altered voltage-gated calcium channel modulation (Corradini et al., 
2012; Zhang et al., 2004). Mice heterozygous for SNAP25 may therefore exhibit increased 
slice activity leading to the detection or more dynamic fusion and endocytotic events.  
  





3.1.3.3.3.  SNAP23 does not compensate for the loss of SNAP25  
 
In the present study, organotypic hippocampal slices from SNAP25 KO mice underwent 
considerable thinning during the first weeks in culture, consistent with the reported 
degeneration of SNAP25 KO neurons in low density culture (Bronk et al., 2007; 
Washbourne et al., 2002). To assess the impact of this on local excitatory networks, we 
decided to evaluate the spatial density of glutamatergic synapses in our preparation. 
Moreover, we were interested to see whether SNAP23, another well-characterized SNAP 
isoform could potentially compensate for the loss of SNAP25 in the surviving neurons. 
Overexpression of SNAP23 in SNAP25 KO neurons has been shown to rescue the 
reduction in RRP sizes, but not the almost complete loss of evoked responses (Delgado-
Martínez et al., 2007) 
Immunohistochemistry studies and the imaging analysis were performed by Dr. Benjamin 
Cooper, Department of Molecular Neurobiology of the Max-Planck Institute of 
Experimental Medicine, Göttingen, Germany. Organotypic slices from two wild-type and 
two SNAP25 KO animals were fixed after 4-5 weeks in culture and processed for 
immunohistochemistry by using antibodies against SNAP23, SNAP25 and VGLUT1. 
VGLUT1, the vesicular glutamate transporter, resides in the synaptic vesicle membrane in 
glutamatergic synapses and therefore serves as an appropriate marker for excitatory 
spine synapses, the synaptic subtype used for ultrastructural analyses in this study. 
SNAP25 immunoreactivity in wild-type slices was localized along the neuronal processes 
and at synapses, but was absent in SNAP25 KO slices (data not shown). Punctate 
SNAP23 labeling was distributed throughout the slices in both, wild-type and KO 
conditions (Fig. S1 A, D). Although absent from excitatory presynapses, SNAP23 was 
often observed in close apposition to VGLUT1 signals, indicating a potential postsynaptic 
localization of the protein in wild-type and SNAP25 KO synapses (Fig. S1 B, C, E ,F). The 
density of SNAP23 signals in SNAP25 KO slices normalized to control samples (control: 
1.000 ± 0.060, n=18; SNAP25 KO: 1.363 ± 0.105, n=18 / P=0.005, **; Fig. S1 G) and the 
density of VGLUT1 positive puncta in SNAP25 KO samples normalized to control cultures 
is increased (control: 1 ± 0.055, n=18; SNAP25 KO: 1.718 ± 0.045, n=18 / P<0.001, ***; 
Fig. S1 H). Moreover, a significant increase in the sizes of VGLUT1 puncta was detected 
in SNAP25 KO slices (control: 1 ± 0.036, n=18; SNAP25 KO: 1.792 ± 0.056, n=18 / 
P<0.001, ***; Fig. S1 I).  
In summary, mature SNAP25 KO organotypic hippocampal slices exhibit a high density of 
excitatory synapses despite the cell loss in the first week of culturing. Moreover, the 





number of VGLUT1 positive puncta increases in SNAP25 KO slices likely indicating a 
compensatory effect. The increase of the size of VGLUT1-positive puncta could reflect 
either the increased synaptic vesicle sizes observed in electron tomograms or retention of 
VGLUT1 in the presynaptic membrane as a consequence of disrupted endocytosis. Since 
the methods used to quantify the number and area of puncta are sensitive to signal 
intensities, it is possible that a compensatory increase in VGLUT1 expression in SNAP25 
deficient neurons brings a greater number of VGLUT1 synapses above the intensity 
threshold for inclusion in the analysis, thereby explaining the observed increase in 
VGLUT1 density. Considering the lack of colocalization with VGLUT, it is however unlikely 
that SNAP23 can compensate for the loss of SNAP25 in surviving neurons. 
 
3.1.3.4. The role of the t-SNARE Syntaxin-1 in synaptic vesicle docking 
 
Since Munc13s are thought to regulate SNARE complex formation by open Syntaxin-1 to 
trigger SNARE nucleation, we were interested in the role of the second t-SNARE 
Syntaxin-1 in synaptic vesicle docking. First, we wanted to analyze a double mutant 
mouse line deficient for Syntaxin-1A and -B, which recently became available in the 
laboratory of Prof. Christian Rosenmund, Berlin. Unfortunately, these mice displayed a 
strong neurodegenerative phenotype, comparably severe to that described for Munc18-1 
KO neurons in culture (Verhage et al., 2000). As I failed to rescue or significantly prolong 
survival of the slices by employing the organotypic slice culture system, we selected a 
Syntaxin-1B Knock-in mouse line, which expresses Syntaxin-1B fused to YFP in the 
Syntaxin-1A KO background (Syntaxin-1A KO/ -BYFP) for further analyses (Arancillo et al., 
2013; Gerber et al., 2008). This mouse line permits the study of neurons with reduced 
Syntaxin-1 levels under hypomorphic conditions, but prevents the cultured cell death 
characteristic of the full KO. No significant alterations in basic physiological characteristics 
were detected in Syntaxin-1A-/-, Syntaxin-1B+/+ and Syntaxin-1A-/-, Syntaxin-1Byfp/+ autapic 
neuron cultures, indicating that one functional allele of Syntaxin-1B is enough for normal 
synaptic function (Arancillo et al., 2013). For this study, I therefore pooled control data 
from two Syntaxin-1A-/-, Syntaxin-1B+/+ and four Syntaxin-1A-/-, Syntaxin-1Byfp/+ mice and 
compared them with data from six Syntaxin-1A KO/ -BYFP mice from two independent 
cultures.  
 










Electron micrographs of control (A) and Syntaxin-1A KO/ -B
YFP
 (B) synaptic profiles acquired from 
60 nm-thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). 
Mean number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number 
of SVs normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) 
length (F) Mean number of endosomes per synaptic profile (G). Mean number of large dense-core 
vesicles (LDCVs) per synaptic profile (H). C-H: Control: N=6, n=129; Syntaxin-1A KO/ -B
YFP
: N=6, 
n=106 (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 
 
3.1.3.4.1.  2D-EM analysis of synaptic morphology in Syntaxin-1A KO/ -BYFP 
neurons 
 
Reduction of Syntaxin-1 levels in the Syntaxin-1A KO/ -BYFP mouse line did not affect 
gross synaptic morphology, which was comparable to that of controls in electron 
micrographs from ultrathin sections (Fig. 3.9 A, B). The number of synaptic vesicles per 
synaptic profile was unchanged between Syntaxin-1A KO/ -BYFP and control samples 
(control: 76.25 ± 3.179, n=129; Syntaxin-1A KO/ -BYFP: 71.79 ± 3.575, n=106 / P=0.2609, 
n.s.; Fig. 3.9 C). No significant changes were observed in either the PSD length (control: 
349.8 ± 8.515, n=129; Syntaxin-1A KO/ -BYFP: 342.0 ± 11.65, n=106 / P=0.2569, n.s.; Fig. 
3.9 F) or the synaptic vesicle terminal density (control: 2.006 ± 0.058, n=129; Syntaxin-1A 
KO/ -BYFP: 1.852 ± 0.065, n=106 / P=0.1072, n.s.; Fig. 3.9 D) between the two groups. 
However, I detected a significant decrease in the synaptic vesicle cluster density (control: 





5.378 ± 0.056, n=129; Syntaxin-1A KO/ -BYFP: 5.168 ± 0.055, n=106 / P=0.0070, **; Fig. 
3.9 E). Similar to Munc13-1/2 DKO and SNAP25 KO synapses, synapses with reduced 
levels of Syntaxin-1 showed a tendency towards an increased number of endosomal 
structures per presynaptic profile (control: 1.264 ± 0.160, n=129; Syntaxin-1A KO/ -BYFP: 
2.009 ± 0.253, n=106 / P=0.0315, *; Fig. 3.9 G). In addition, I detected a slight, though not 
statistically significant, increase in the number of LDCVs per synaptic profile in synapses 
expressing reduced levels of Syntaxin-1 (control: 0.233 ± 0.042, n=129; Syntaxin-1A KO/ -
BYFP: 0.453 ± 0.106, n=106 / P=0.1893, n.s.; Fig. 3.9 H). 
 
3.1.3.4.2.  3D-ET analysis of synaptic vesicle docking in Syntaxin-1A KO/ -BYFP 
neurons 
 
By electron tomographic analysis, it was first tested whether differences in the number of 
docked vesicles were detectable between Syntaxin-1A-/-, Syntaxin-1B+/+ and Syntaxin-1A-/-
, Syntaxin-1Byfp/+ mice (graphs not shown). Confirming the physiological findings, I was not 
able to detect significant changes in the number of active zone membrane-attached 
vesicles (0-2 nm) in Syntaxin-1A-/-, Syntaxin-1B+/+ synaptic profiles in comparison to 
Syntaxin-1A-/-, Syntaxin-1Byfp/+ synaptic profiles (Syntaxin-1A-/-, Syntaxin-1B+/+: 1.028 ± 
0.224, N=2, n=6; Syntaxin-1A-/-, Syntaxin-1Byfp/+: 1.003 ± 0.182, N=3, n=15 / P=0.9381, 
n.s.). I obtained a similar result, when including those synaptic vesicles that were closely 
tethered to the presynaptic release site (0-4 nm; Syntaxin-1A-/-, Syntaxin-1B+/+: 1.703 ± 
0.319, n=6; Syntaxin-1A-/-, Syntaxin-1Byfp/+: 1.338 ± 0.215, n=15 / P=0.3667, n.s.). I 
therefore decided to pool the data obtained from both genotypes into one control group. 
Electron tomographic analysis was performed on organoypic slices from four Syntaxin-1A 
KO/ -BYFP mice (N=4) and compared with slices from five control mice (N=5) (Fig. 3.10 A-
F). Syntaxin-1A KO/ -BYFP presynaptic terminals exhibited a reduction in the number of 
membrane-attached (0-2 nm; control: 1.010 ± 0.142, n=21; Syntaxin-1A KO/ -BYFP: 0.623 
± 0.110, n=23 / P=0.0356, *; Fig. 3.10 I) and closely tethered vesicles (0-4 nm; control: 
1.442 ± 0.178, n=21; Syntaxin-1A KO/ -BYFP: 0.937 ± 0.129, n=21 / P=0.0249, *; Fig. 3.10 
J).  










Tomographically reconstructed subvolumes of control (A) and Syntaxin-1A KO/ -B
YFP
 (B) synapses 
from 200 nm-thick sections. Three-dimensional models of tomographically reconstructed control 
(C) and Syntaxin-1A KO/ -B
YFP
 (D) synaptic profiles. Ultrastructural features reconstructed in the 
models include the active zone plasma membrane (white), synaptic vesicles (membrane-attached, 





green; non-attached, grey) and endosomes (light blue). Orthogonal views of control (E) and 
Syntaxin-1A KO/ -B
YFP
 (F) tomographic models displaying the spatial arrangement of membrane-
attached synaptic vesicles within the reconstructed active zone area. Mean number of SVs within 
100 nm of the AZ normalized to AZ area (G). Mean number of SVs within 40 nm of the AZ 
normalized to AZ area (H). Mean number of membrane-attached SVs (within 0-2 nm of the AZ) 
normalized to AZ area (I). Mean number of membrane-attached and closely-tethered SVs (within 0-
4 nm of the AZ) normalized to AZ area (J). Mean outer SV diameter (K). Mean SV volume 
including the membrane bilayer (L). Spatial distribution of SVs within a 100 nm distance of the AZ 
membrane (M). Distribution of synaptic vesicle diameters of vesicles within 100 nm of the AZ (N). 
G-L: Control: N=5, n=21; Syntaxin-1A KO/ -B
YFP
: N=4, n=23 (Mean + SEM), P<0.001: ***; P<0.01: 
**; P<0.05: *. M, N: (748 SVs in control and 818 SVs in Syntaxin-1A KO/ -B
YFP
 synaptic profiles). 
Scale bar: B, 100 nm. 
 
The number of membrane proximal synaptic vesicles (0-40 nm; control: 2.978 ± 0.1712, 
n=21; Syntaxin-1A KO/ -BYFP: 2.693 ± 0.197, n=23 / P=0.284, n.s.; Fig. 3.10 H) and the 
number of vesicles within 100 nm distance from the active zone (control: 7.107 ± 0.312, 
n=21; Syntaxin-1A KO/ -BYFP: 6.996 ± 0.273, n=23 / P=0.7896, n.s.; Fig. 3.10 G) were 
unaltered. In comparison to control samples, Syntaxin-1A KO/ -BYFP neurons showed a 
reduction in the number of membrane-attached and closely tethered vesicles to 62% and 
65%, respectively. Looking at the distribution of synaptic vesicles within 100 nm of the 
active zone, one can recognize the reduction in the number of membrane-attached 
vesicles in the first 0-2 nm bin, however the general distribution of vesicles appears to be 
unaltered (Fig.3.10 M). Moreover, no differences in the mean outer vesicle diameter 
(control: 44.60 ± 0.385, n=21; Syntaxin-1A KO/ -BYFP: 45.31 ± 0.539, n=23 / P=0.2975, 
n.s.; Fig. 3.10 K, N) or in the mean vesicle volume were detected between the two groups 
(control: 46932 ± 1193, n=21; Syntaxin-1A KO/ -BYFP: 49567 ± 1802, n=23 / P=0.2388, 
n.s.; Fig. 3.10 L). 
 
3.1.3.5.  The role of the v-SNARE Synaptobevin-2 in synaptic vesicle docking 
 
Next, we decided to analyze the role of the v-SNARE Synaptobrevin-2 in synaptic vesicle 
docking in my experimental setting. Previous studies showed a 90% reduction of the 
sucrose-evoked RRP size in Synaptobrevin-2 KO neurons, but no change in the number 
of docked vesicles in electron micrographs (Deák et al., 2004; Schoch et al., 2001). 
However, a recent morphological study in PC12 cells expressing BoNT/D cleaving 
Synaptobrevin-1/2 indicated a role for the neuronal v-SNARE in large-dense core vesicle 
docking to the plasma membrane (Wu et al., 2012). These results are in contrast to 
previous findings that propose Synaptotagmin-1 as the molecular partner on vesicle 
membranes for LDCV docking, placing full SNARE-complex assembly downstream of 
docking (de Wit et al., 2009).  





3.1.3.5.1.  2D-EM analysis of synaptic morphology in Synaptobrevin-2 KO 
neurons 
 
For the two-dimensional analysis, seven Synaptobrevin-2 KO animals (N=7) were 
compared with six littermate control animals (N=6), that were either wild-type or 
heterozygous for the Synaptobrevin-2 allele, from three cultures. Synaptobrevin-2 KO 
mice (Schoch et al., 2001) were purchased from ‘The Jackson Laboratory’. The gross 
presynaptic morphology seemed to be unperturbed in Synaptobrevin-2 KO synaptic 
profiles analyzed in electron micrographs of ultrathin sections (Fig. 3.11 A, B). Neither the 
total number of synaptic vesicles per synaptic profile (control: 67.54 ± 2.951, n=155; 
Synaptobrevin-2 KO: 70.15 ± 2.654, n=162 / P=0.4100, n.s.; Fig. 3.11 C), nor the synaptic 
vesicle terminal density were different between the two groups (control: 1.733 ± 0.050, 
n=155; Synaptobrevin-2 KO: 1.652 ± 0.043, n=162 / P=0.2223, n.s.; Fig. 3.11 D). 
Surprisingly, I observed an increase in PSD length in Synaptobrevin-2 KO synapses 
(control: 386.2 ± 10.08, n=155; Synaptobrevin-2 KO: 426.9 ± 8.674, n=162 / P<0.001, ***; 
Fig. 3.11 F), which could only partially be explained by the observation that presynaptic 
terminals were slightly larger in Synaptobrevin-2 KO synapses (control: 398140 ± 13958, 
n=155; Synaptobrevin-2 KO: 431227 ± 13022, n=162 / P=0.0570, n.s.; graph not shown). 
Moreover, a strong reduction in the synaptic vesicle cluster density for Synaptobrevin-2 
KO synapses was observed (control: 4.525 ± 0.055, n=155; Synaptobrevin-2 KO: 4.065 ± 
0.050, n=162; P<0.001, ***; Fig. 3.11 E), correlating with an increase in the number of 
larger, vesicular endosomal structures in presynaptic terminals of Synaptobrevin-2 KO 
synapses (control: 1.297 ± 0.172, n=155; Synaptobrevin-2 KO: 4.648 ± 0.380, n=162; 
P<0.001, ***; Fig. 3.11 G). Additionally, I observed a dramatic increase in the number of 
LDCVs per synaptic profile in synapses lacking Synaptobrevin-2 (control: 0.290 ± 0.057, 
n=155; Synaptobrevin-2 KO: 0.661 ± 0.080, n=162; P<0.001, ***; Fig. 3.11 H). 
 
3.1.3.5.2.  3D-ET analysis of synaptic vesicle docking in Synaptobrevin-2 KO 
neurons 
 
Samples from four Synaptobrevin-2 KO mice (N=4) and four control mice (N=4), from two 
independent cultures, were compared by electron tomographic analyisis (Fig. 3.12). This 
analysis revealed a strong reduction in the number of membrane-attached vesicles (0-2 
nm; control: 1.080 ± 0.136, n=25; Synaptobrevin-2 KO: 0.355 ± 0.099, n=24; P<0.001, ***; 
Fig. 3.13 C) and closely tethered vesicles (0-4 nm; control: 1.46 ± 0.161, n=25; 
Synaptobrevin-2 KO: 0.629 ± 0.123, n=24 / P<0.001, ***; Fig. 3.13 D) in Synaptobrevin-2 





KO synapses compared to controls. The number of membrane-proximal vesicles (0-40 
nm; control: 2.600 ± 0.173, n=25; Synaptobrevin-2 KO: 2.672 ± 0.105, n=24 / P=0.7286, 
n.s.) (Fig. 3.13 B) as well as the number of vesicles within 100 nm distance of the active 
zone was unaltered (control: 6.451 ± 0.338, n=25; Synaptobrevin-2 KO: 5.909 ± 0.197, 
n=24 / P=0.1772, n.s.; Fig. 3.13 A). Synapses lacking Synaptobrevin-2 thus showed 
reductions in the number of membrane-attached and closely tethered vesicles to 33% and 
43% of controls, respectively. Similar to synapses that were completely devoid of 
Munc13s and SNAP25, terminals lacking the neuronal v-SNARE Synaptobrevin-2 
exhibited a prominent accumulation of synaptic vesicles at a close distance to the 
presynaptic active zone membrane, with a peak frequency occurring at around 4-6 nm 
from the active zone (Fig. 3.13 G). Moreover, synaptic vesicles in Synaptobrevin-2 KO 
presynaptic terminals exhibited increased mean outer synaptic vesicle diameters (control: 
45.81 ± 0.450, n=25; Synaptobrevin-2 KO: 49.07 ± 0.411, n=24 / P<0.001, ***; Fig. 3.13 E, 
H) with a corresponding increase in the mean synaptic vesicle volume (control: 51115 ± 
1549, n=25; Synaptobrevin-2 KO: 62908 ± 1599, n=24 / P<0.0001, ***; Fig 3.13 F). These 
data indicate an increase in the mean vesicle diameter by 7% with a corresponding 25% 
increase in vesicle volume.  
 
  





Figure 3.11. Two-dimensional ultrastructural analysis of synaptic morphology in 
Synaptobrevin-2 KO neurons 
Electron micrographs of control (A) and Synaptobrevin-2 KO synaptic profiles (B) acquired from 60 
nm-thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). Mean 
number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number of SVs 
normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) length (F) 
Mean number of endosomes per synaptic profile (G). Mean number of large dense-core vesicles 
(LDCVs) per synaptic profile (H). C-H: Control: N=6, n=155; Synaptobrevin-2 KO: N=7, n=162 
(Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 
 
However, when comparing the individual docking profiles from Synaptobrevin-2 KO 
tomograms, I noticed that 8 out of 24 KO synapses (33%) had similar number of 
membrane-attached vesicles (0-2 nm) as control synapses, whereas the remaining 16 
synapses (67%) had few or no docked vesicles (Fig. 3.13 I). I termed the synaptic profiles 
with normal synaptic vesicle docking KOPlus (Fig. 3.13 C, F, I), and the synapses that are 
almost completely devoid of docked synaptic vesicles KOMinus (Fig. 3.13 B, E, H). 
 
Figure 3.12. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
Synaptobrevin-2 KO neurons 
Tomographically reconstructed subvolumes of control (A), Synaptobrevin KO
Minus
 (B) and 
Synaptobrevin KO
Plus
 (C) synapses from 200 nm-thick sections. Three-dimensional models of 
tomographically reconstructed control (D) Synaptobrevin KO
Minus
 (E) and Synaptobrevin KO
Plus
 (F) 
synaptic profiles. Ultrastructural features reconstructed in the models include the active zone 
plasma membrane (white), synaptic vesicles (membrane-attached, green; non-attached, grey) and 
endosomes (light blue). Orthogonal views of control (G) Synaptobrevin KO
Minus
 (H) and 
Synaptobrevin KO
Plus
 (I) tomographic models displaying the spatial arrangement of membrane-
attached synaptic vesicles within the reconstructed active zone area. Scale bar: B, 100 nm. 
 





The number of membrane-attached synaptic vesicles (0-2 nm) was unchanged between 
control and KOPlus synaptic profiles (control: 1.080 ± 0.136, n=25; Synaptobrevin-2 KOPlus: 
0.968 ± 0.123, n=8 / P=0.6576, n.s.; Fig. 3.13 J). However, the number of docked synaptic 
vesicles (0-2 nm) was dramatically reduced when comparing control with KOMinus synaptic 
profiles (control: 1.080 ± 0.136, n=25; Synaptobrevin-2 KOMinus: 0.049 ± 0.022, n=16 / 
P<0.001, ***) and KOPlus with KOMinus synaptic profiles (KOPlus: 0.968 ± 0.123, n=8; 
Synaptobrevin-2 KOMinus: 0.049 ± 0.022, n=16 / P<0.001, ***; Fig. 3.13 J). In comparison 
to control and KOPlus samples, KOMinus synaptic profiles exhibited a reduction in the 
number of membrane-attached vesicles to 5%.  
To rule out the possibility that an increase in vesicle diameter could cause the reduced 
ability of synaptic vesicles to become attached to the presynaptic active zone membrane, I 
compared the mean outer synaptic vesicle diameter between control and  KOPlus (control: 
45.81 ± 0.45, n=25; Synaptobrevin-2 KOPlus: 48.65 ± 0.54, n=8 / P=0.0023, **) as well as 
between control and KOMinus synaptic profiles (control: 45.81 ± 0.4503, n=25; 
Synaptobrevin-2 KOMinus: 49.28 ± 0.558, n=16 / P=<0.001, ***). I detected a significant 
increase in the vesicle diameter for Synaptobrevin-KO synapses in both cases, though 
with a slightly stronger phenotype for KOMinus synaptic profiles (Fig. 3.13 K). The mean 
outer synaptic vesicle diameters of KOPlus and KOMinus synaptic profiles were not 
statistically different (Synaptobrevin-2 KOPlus: 48.65 ± 0.540, n=8; Synaptobrevin-2 
KOMinus: 49.28 ± 0.558, n=16; P=0.4822, n.s.; Fig. 3.13 K, N). I observed the same 
tendencies for the mean synaptic vesicle volume, which was significantly increased in 
KOPlus synaptic profiles compared to controls (control: 51115 ± 1549, n=25; 
Synaptobrevin-2 KOPlus: 61097 ± 2125, n=8 / P=0.0023, **) and in KOMinus synaptic profiles 
compared to controls (control: 51115 ± 1549, n=25; Synaptobrevin-2 KOMinus: 63814 ± 
2160, n=16 / P<0.001, ***; Fig. 3.13 L). The vesicle volume measured in KOPlus and 
KOMinus synaptic profiles was not statistically different (Synaptobrevin-2 KOPlus: 61097 ± 
2125, n=8; Synaptobrevin-2 KOMinus: 63814 ± 2160, n=16 / P=0.4554, n.s.; Fig. 3.13 L). 
When comparing the synaptic vesicle distribution within 100 nm distance of the active 
zone, KOMinus synaptic profiles have almost no membrane-attached vesicles (0-2 nm), 
whereas both, the KOPlus and KOMinus groups, have a strong accumulation of membrane-
proximal vesicles. These synaptic vesicles accumulate in a close distance to the 
presynaptic active zone membrane, with a peak frequency at around 4-6 nm distance 
from the active zone (Fig. 3.13 M). I therefore exclude the possibility that an increase in 
synaptic vesicle size is responsible for the observed reduction in membrane-attached 
vesicles in Synaptobrevin-2 KO synapses. 







Figure 3.13. Quantitative analysis of synaptic vesicle docking in Synaptobrevin-2 KO 
neurons 
Mean number of SVs within 100 nm of the AZ normalized to AZ area (A). Mean number of SVs 
within 40 nm of the AZ normalized to AZ area (B). Mean number of membrane-attached SVs 
(within 0-2 nm of the AZ) normalized to AZ area (C). Mean number of membrane-attached and 
closely-tethered SVs (within 0-4 nm of the AZ) normalized to AZ area (D). Mean outer SV diameter 
(F). Mean SV volume including the membrane bilayer (E). Spatial distribution of SVs within a 100 
nm distance of the AZ membrane (G). Distribution of synaptic vesicle diameters of vesicles within 
100 nm of the AZ (H). Scatterplot showing number of membrane-attached SVs (0-2 nm) 
normalized to AZ area in individual tomograms from control and Synaptobrevin-2 KO synaptic 
profiles (I). Mean number of membrane-attached SVs (within 0-2 nm of the AZ) normalized to AZ 









synaptic profiles (J). 









synaptic profiles (L). Spatial distribution of 





synaptic profiles (M). Distribution of synaptic vesicle diameters of vesicles 





profiles (N).  
A-F: Control: N=4, n=25; Synaptobrevin-2 KO: N=4, n=24 (Mean + SEM), P<0.001: ***; P<0.01: **; 
P<0.05: *. G, H: (890 SVs in control and 753 SVs in Synaptobrevin-2 KO synaptic profiles). J-L: 
Control: N=4, n=25; Synaptobrevin-2 KO
Plus
: N=4, n=8; Synaptobrevin-2 KO
Minus
: N=4, n=16 (Mean 
+ SEM), P<0.001: ***; P<0.01: **; P<0.05: *. M, N: (251 SVs in Synaptobrevin-2 KO
Plus
 and 502 
SVs in Synaptobrevin-2 KO
Minus
 synaptic profiles). Scale bar: B, 100 nm. 
J-L: Control: N=4, n=25; Synaptobrevin-2 KO
Plus
: N=4, n=8; Synaptobrevin-2 KO
Minus
: N=4, n=16 
(Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. G, H: (251 SVs in Synaptobrevin-2 KO
Plus
 and 
502 SVs in Synaptobrevin-2 KO
Minus
 synaptic profiles). 
 
3.1.3.5.3.  Synaptobrevin-1 can compensate for the loss of Synaptobrevin-2 in 
synapses 
 
In order to explain the presence of membrane-attached synaptic vesicles in a subset of 
Synaptobrevin-2 KO synapses (KOPlus), we scrutinized the localization pattern of 
immunolabeled Synaptobrevin-1 to reveal any potential compensatory changes in 
organotypic slices lacking Synaptobrevin-2. In an earlier study, Synaptobrevin-1 was not 
detected by Western blot analysis of P0 Synaptobrevin-2 KO mouse brain (Schoch et al., 
2001). However, in situ hybridization data indicate that expression of Synaptobrevin-1 in 
the hippocampus starts in vivo at around P14 (Allen Developing Mouse Brain Atlas). 
Immunohistochemistry experiments and the imaging analysis were performed by Dr. 
Benjamin Cooper, Department of Molecular Neurobiology of the Max-Planck Institute of 
Experimental Medicine, Göttingen, Germany. Organotypic slices from two wild-type and 
two Synaptobrevin-2 KO animals were fixed after 4-5 weeks in culture, processed for 
immunohistochemistry and labeled by using isoform-specific antibodies against 
Synaptobrevin-2, Synaptobrevin-1 and VGLUT1. Wild-type organotypic slices exhibited a 
specific punctate labeling of Synaptobrevin-2, which highly co-localized with VGLUT1, but 
was not detectable in Synaptobrevin-2 KO cultures (data not shown). In wild-type slices, 
Synaptobrevin-1 labeling revealed the presence of large immunoreactive puncta in 
organotypic slices (Fig. S2 A). However, only a subset (~8%) of VGLUT1 positive puncta 
colocalized with the Synaptobrevin-1 signal (Fig. S2 B, C). These findings indicate that in 
control slices, Synaptobrevin-1 is predominantly localized to nonglutamatergic synapses. 
Synaptobrevin-2 KO organotypic slices exhibited an increase in the number of 
Synaptobrevin-1 positive puncta, contributed by an increase in the frequency of low 





intensity Synaptobrevin-1 immunoreactive structures (control: 1 ± 0.03910, n=27; 
Synaptobrevin-2 KO: 2.738 ± 0.229, n=27 / P<0.001,***; Fig. S2 D, G). In comparison to 
control slices, the relative number of VGLUT1 positive puncta was slightly increased in 
Synaptobrevin-2 KO cultures (control: 1 ± 0.0286, n=27; Synaptobrevin-2 KO: 1.195 ± 
0.030, n=27 / P<0.001,***; Fig. S2 H). Similar to SNAP25 KO organotypic slices, cultures 
devoid of Synaptobrevin-2 exhibited a significant increase in the size of VGLUT1 
immunoreactive puncta (control: 1 ± 0.030, n=27; Synaptobrevin-2 KO: 1.577 ± 0.068, 
n=27 / P<0.001,***; Fig. I). Interestingly, we found an increase in the degree of co-
localization for VGLUT1 and Synaptobrevin-1 in Synaptobrevin-2 KO slices (Fig. S2 E, F). 
In Synaptobrevin-2 KO slices, 36% of VGLUT1 positive puncta were immunoreactive for 
Synaptobrevin-1, indicating that Synaptobrevin-1 expression is upregulated in 
glutamatergic synapses in the absence of Synaptobrevin-2 (control: 7.739 ± 1.459, n=27; 
Synaptobrevin-2 KO: 36.39 ± 2.046, n=27 / P<0.001,***; Fig. S2 J).  
In summary, mature organotypic hippocampal slices deficient of Synaptobrevin-2 exhibit a 
compensatory increase in the number of Synaptobrevin-1 positive glutamatergic, 
excitatory synapses, potentially explaining the observation that 33% of all sampled 
synaptic profiles in the electron tomographic analysis of synaptic vesicle docking still had 
membrane-attached synaptic vesicles. However, whether or not Synaptobrevin-1 can 
rescue the physiological deficits seen in Synaptobrevin-2 deficient neurons has not yet 
been assessed to my knowledge.  
 
3.1.3.6. The role of the vesicular Ca2+-sensor Synaptotagmin-1 in synaptic 
vesicle docking 
 
Next, I studied the function of Synaptotagmin-1 in synaptic vesicle docking. 
Synaptotagmin-1, the exocytotic Ca2+-sensor, has also been implicated in secretory and 
synaptic vesicle docking, and in the regulation of total synaptic vesicle numbers, which are 
reduced in Synaptotagmin-1 KO animals (Jorgensen et al., 1995; Liu et al., 2009; de Wit 
et al., 2009). In-vitro data from liposome fusion assays indicated a role for Synaptotagmin-
1 as a distance-regulator for synaptic vesicle fusion, keeping plasma membrane and 
vesicle membrane apart to prevent SNARE-complex formation and fusion prior to Ca2+-
influx. Ca2+-binding to the C2 domains of Synaptotagmin-1 would then trigger SNARE-
nucleation and membrane fusion in a post-docking step (van den Bogaart et al., 2011). In 
vivo, the role of Synaptotagmin-1 in synaptic vesicle docking in neurons remains a point of 
heavy discussion, a confounding factor being the variety of model systems, fixation 





protocols (chemical vs. cryo-fixation), data acquisition methods (two-dimensional versus 
three-dimensional EM analyses), and above all, differences in “docking” definitions used 
to study membrane-attachment by EM (discussed in: Verhage and Sørensen 2008).  
 
3.1.3.6.1.  2D-EM analysis of synaptic morphology in Synaptotagmin-1 KO 
neurons 
 
For the two-dimensional analysis of basic ultrastructural features in the absence of 
Synaptotagmin-1, samples from four Synaptotagmin-1 KO animals (N=4) were compared 
with samples from five control animals (N=5), that were either wildtype or heterozygous for 
the Synaptotagmin-1 KO allele. No major morphological changes between control and 
Synaptotagmin-1 KO synaptic profiles were observed in electron micrographs (Fig. 3.14 
A, B). First, no changes in the overall number of synaptic vesicles per synaptic profile 
were detected between genotypes (control: 52.8 ± 2.573, n = 114; Synaptotagmin-1 KO: 
50.3 ± 2.608, n = 97 / P = 0.4952, n.s.; Fig. 3.14 C). However, when I normalized the 
number of synaptic vesicles to the area of the synaptic terminal I could unmask a small 
but significant reduction in the terminal vesicle density in Synaptotagmin-1 KO synapses 
(control: 1.595 ± 0.05415, n = 114; Synaptotagmin-1 KO: 1.363 ± 0.055, n = 97 / P = 
0.0045, **; Fig. 3.14 D), which was also detected as a reduction of the synaptic vesicle 
cluster density (control: 3.946 ± 0.063, n = 114; Synaptotagmin-1 KO: 3.658 ± 0.062, n = 
97 / P = 0.0034, **; Fig. 3.14 E). No differences in the PSD length (control: 333.4 ± 10.03, 
n = 114; Synaptotagmin-1 KO: 345.0 ± 11.67, n = 97 / P = 0.3661, n.s.; Fig. 3.14 F) in the 
number of endosomes per synaptic profile (control: 0.211 ± 0.046, n = 114; 
Synaptotagmin-1 KO: 0.175 ± 0.046, n = 97 / P = 0.046; Fig. 3.14 G), or in the number of 
LDCVs per synaptic profile were detected (control: 0.211 ± 0.046, n = 114; 
Synaptotagmin-1 KO: 0.175 ± 0.046, n = 97 / P = 0.5481, n.s.; Fig. 3.14 H). 
 
3.1.3.6.2.  3D-ET analysis of synaptic vesicle docking in Synaptotagmin-1 KO 
neurons 
 
For the three-dimensional electron tomographic analysis of synaptic vesicle docking in the 
absence of Synaptotagmin-1, samples from three Synaptotagmin-1 KO animals (N=3) 
were compared with samples from four control animals (N= 4), that were either wildtype or 
heterozygous for the Synaptotagmin-1 KO allele (Fig. 3.15 A-F). Synaptotagmin-1 KO 
profiles exhibited reductions in the number of membrane-attached synaptic vesicles (0-2 





nm; control: 1.494 ± 0.203, n = 23; Synaptotagmin-1 KO: 0.906 ± 0.156, n = 20 / P = 
0.0302, *; Fig. 3.15 I) and in the number of closely tethered synaptic vesicles (0-4 nm; 
control: 2.062 ± 0.185, n = 23; Synaptotagmin-1 KO: 1.433 ± 0.217, n = 20 / P = 0.0319, *; 
Fig. 3.15 J). In contrast to all previously analyzed mouse mutants, I detected a significant 
decrease in the number of membrane-proximal synaptic vesicles (0-40 nm) in synapses 
lacking Synaptotagmin-1 in comparison to control synaptic profiles (control: 3.630 ± 0.243, 
n = 23; Synaptotagmin-1 KO: 2.802 ± 0.289, n = 20 / P = 0.0329, *; Fig. 3.15 H), whereas 
the number of vesicles within 100 nm distance of the active zone was only slightly, but not 
significantly, reduced (control: 8.997 ± 0.644, n = 23; Synaptotagmin-1 KO: 7.628 ± 0.500, 
n = 20 / P = 0.1080, n.s.; Fig. 3.15 G). Moreover, the synaptic vesicle distribution within 
100 nm distance of the active zone revealed a reduction in the number of membrane-
attached synaptic vesicles, but did not show an accumulation of vesicles close to the 
active zone membrane as was observed for the KOs of the t-SNARE SNAP25 and of 
Munc13s (Fig. 3.15 M).  
 
 
Figure 3.14. Two-dimensional ultrastructural analysis of synaptic morphology in 
Synaptotagmin-1 KO neurons 
Electron micrographs of control (A) and Synaptotagmin-1 KO (B) synaptic profiles acquired from 60 
nm-thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). Mean 
number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number of SVs 
normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) length (F). 
Mean number of endosomes per synaptic profile (G). Mean number of large dense-core vesicles 
(LDCVs) per synaptic profile (H). C-H: Control: N=5, n=114; Synaptotagmin-1 KO: N=4, n=97 
(Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. 






Figure 3.15. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
Synaptotagmin-1 KO neurons 
Tomographically reconstructed subvolumes of control (A) and Synaptotagmin-1 KO (B) synapses 
from 200 nm-thick sections. Three-dimensional models of tomographically reconstructed control 
(C) and Synaptotagmin-1 KO (D) synaptic profiles. Ultrastructural features reconstructed in the 
models include the active zone plasma membrane (white), synaptic vesicles (membrane-attached, 
green; non-attached, grey), large dense core vesicles (LDCVs, beige) and endosomes (light blue). 





Orthogonal views of control (E) and Synaptotagmin-1 KO (F) tomographic models displaying the 
spatial arrangement of membrane-attached synaptic vesicles within the reconstructed active zone 
area. Mean number of SVs within 100 nm of the AZ normalized to AZ area (G). Mean number of 
SVs within 40 nm of the AZ normalized to AZ area (H). Mean number of membrane-attached SVs 
(within 0-2 nm of the AZ) normalized to AZ area (I). Mean number of membrane-attached and 
closely-tethered SVs (within 0-4 nm of the AZ) normalized to AZ area (J). Mean outer SV diameter 
(K). Mean SV volume including the membrane bilayer (L). Spatial distribution of SVs within a 100 
nm distance of the AZ membrane (M). Distribution of synaptic vesicle diameters of vesicles within 
100 nm of the AZ (N). G-L: Control: N=4, n=23; Synaptotagmin-1 KO: N=3, n=20 (Mean + SEM), 
P<0.001: ***; P<0.01: **; P<0.05: *. M, N: (807 SVs in control and 650 SVs in Synaptotagmin-1 KO 
synaptic profiles). Scale bar: B, 100 nm. 
 
 
In comparison to control synaptic profiles, synapses devoid of Synaptotagmin-1 exhibited 
reductions in the number of membrane-attached and closely tethered vesicles to 61% and 
70% of controls, respectively. The number of membrane-proximal vesicles within 40 nm of 
the active zone is reduced to 77% compared to control synaptic profiles. However, taking 
the reduced density of membrane proximal synaptic vesicles into consideration, the 
number of membrane-attached (0-2 nm) and closely tethered (0-4 nm) vesicles 
normalized to the total number of vesicles within 40 nm of the active zone show 
reductions to only 74% and 83% of controls, respectively. In addition to these findings, I 
did not observe any changes in the mean outer vesicle diameter (control: 46.81 ± 0.548, n 
= 23; Synaptotagmin-1 KO: 45.41 ± 0.582, n = 20 / P = 0.0873, n.s.; Fig. 3.15 K, N) or in 
the mean vesicle volume between the two groups (control: 54578 ± 2011, n = 23; 
Synaptotagmin-1 KO: 49958 ± 1941, n = 20 / P = 0.1086, n.s.; Fig. 3.15 L). 
 
In summary, Synaptotagmin-1 KO neurons exhibit a decrease in the number of 
membrane-attached synaptic vesicles, which points towards a regulatory function of 
Synaptotagmin-1 in synaptic vesicle docking. 
 
3.1.3.7. The role of Complexins in synaptic vesicle docking 
 
Finally, I included a Complexin-1/2/3 triple KO (TKO) mouse line into my analysis (Xue et 
al., 2008). Complexins are a family of proteins, which can bind with a central α-helix to the 
assembled SNARE-complex. By this action, murine Complexin isoforms were previously 
shown to facilitate fast neurotransmitter release in a post-priming step ('super-priming'), 
since the EPSC amplitude and the vesicular release probability is drastically reduced in 
hippocampal neurons from Complexin-1/2/3 triple KO mice with no changes in the RRP 
size or in the number of docked vesicles (Reim et al., 2001; Xue et al., 2007, 2008). 
However, a recent study describes a drastic decrease in the RRP size after lentiviral 





knock-down of Complexin, proposing a priming role for Complexin upstream of 
Synaptotagmin-1 function and an additional role as a fusion clamp for asynchronous and 
spontaneous release in concert with Synaptotagmin-1 (Yang et al., 2010). Moreover, C. 
elegans Complexin mutants show a severe reduction in the number of docked vesicles, 
most likely due to an increase in spontaneous fusion events caused by the absence of 
Complexin-mediated inhibitory clamping-functions (Hobson et al., 2011).  
 
3.1.3.7.1.  2D-EM analysis of synaptic morphology in Complexin-1/2/3 TKO 
neurons 
 
Samples from three Complexin TKO animals (Complexin-1-/-, Complexin-2-/-,  
Complexin-3-/-) were compared with three control animals with the following genotypes 
(Complexin-1+/+, Complexin-2-/-, Complexin-3-/-), (Complexin-1+/-, Complexin-2-/-, 
Complexin-3-/-), (Complexin-1+/-, Complexin-2-/-, Complexin-3+/-). In the two-dimensional 
analysis of electron micrographs, no statistically significant differences were detected in 
any of the parameters measured (Fig. 3.16 A, B). The total number of synaptic vesicles 
per synaptic profile (control: 68.75 ± 2.635, n = 222; Complexin-1/2/3 TKO: 67.66 ± 3.241, 
n = 155 / P = 0.4543, n.s.; Fig. 3.16 C), the synaptic vesicle terminal density (control: 
1.539 ± 0.037, n = 222; Complexin-1/2/3 TKO: 1.581 ± 0.043, n = 155 / P=0.4448, n.s.; 
Fig. 3.16 D) and the synaptic vesicle cluster density were unchanged between the two 
groups (control: 3.883 ± 0.038, n = 222; Complexin-1/2/3 TKO: 3.991 ± 0.050, n = 155 / P 
= 0.2399, n.s.; Fig. 3.16 E). Moreover, the PSD length (control: 361.3 ± 8.92, n = 222; 
Complexin-1/2/3 TKO: 378.2 ± 12.22, n = 155 / P = 0.3383, n.s.; Fig. 3.16 F), the number 
of endosomes per synaptic profile (control: 1.063 ± 0.108, n = 222; Complexin-1/2/3 TKO: 
1.103 ± 0.121, n = 155 / P = 0.7002, n.s.; Fig. 3.16 G) and the number of LDCVs per 
presynaptic profile did not differ between Complexin-1/2/3 TKO and control neurons 
(control: 0.176 ± 0.031, n = 222; Complexin-1/2/3 TKO: 0.219 ± 0.047, n = 155 / P = 
0.6946, n.s.; Fig. 3.16 H).  
 






Figure 3.16. Two-dimensional ultrastructural analysis of synaptic morphology in Complexin-
1/2/3 TKO neurons 
Electron micrographs of control (A) and Complexin-1/2/3 TKO (B) synaptic profiles acquired from 
60 nm-thick ultrathin sections. Mean number of synaptic vesicles (SVs) per synaptic profile (C). 
Mean number of SVs normalized to synaptic terminal area (SV terminal density; D). Mean number 
of SVs normalized to SV cluster area (SV cluster density; E). Mean postsynaptic density (PSD) 
length (F) Mean number of endosomes per synaptic profile (G). Mean number of large dense-core 
vesicles (LDCVs) per synaptic profile (H). C-H: Control: N=3, n=222; Complexin-1/2/3 TKO: N=3, 
n=155 (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: B, 500 nm. *. Imaging and 
analysis were performed by S. Krinner. 
 
3.1.3.7.2.  3D-ET analysis of synaptic vesicle docking in Complexin-1/2/3 TKO 
neurons 
 
Next, I analyzed synaptic vesicle docking in presynaptic terminals from electron 
tomographic reconstructions of 200 nm semithin sections in glutamatergic, excitatory 
spine synapses of control (N=3) and Complexin-1/2/3 TKO samples (N=3) (Fig. 3.17 A-F). 
In three-dimensional electron tomograms, no significant changes were detected in the 
number of active zone membrane-attached synaptic vesicles (0-2 nm; control: 0.871 ± 
0.147, n = 19; Complexin-1/2/3 TKO: 1.116 ± 0.145, n = 25 / P = 0.248, n.s.; Fig. 3.17 I) or 
in the number of closely-tethered synaptic vesicles (0-4 nm; control: 1.219 ± 0.168, n = 19; 
Complexin-1/2/3 TKO: 1.602 ± 0.159, n = 25 / P = 0.1586, n.s.; Fig. 3.17 J). However, 
there was a tendency towards a slightly higher number of membrane-attached vesicles in 
Complexin-1/2/3 TKO synapses. The number of membrane proximal vesicles within 40 





nm distance of the active zone did not differ between the two groups (control: 2.386 ± 
0.180, n = 19; Complexin-1/2/3 TKO: 2.728 ± 0.140, n = 25 / P = 0.135, n.s.; Fig. 3.17 H), 
although a slight increase in the number of vesicles within 100 nm of the active zone in 
Complexin-1/2/3 synaptic profiles was observed (control: 6.005 ± 0.319, n = 19; 
Complexin-1/2/3 TKO: 6.861 ± 0.247, n = 25 / P = 0.0371, *; Fig. 3.17 G). The synaptic 
vesicle distribution within 100 nm distance from the presynaptic active zone membrane 
revealed no major differences between control and Complexin-1/2/3 KO synaptic profiles, 
with the largest percentage of vesicles being membrane-attached in both groups (Fig. 
3.17 M). Neither the mean outer synaptic vesicle diameter (control: 44.71 ± 0.621, n = 19; 
Complexin-1/2/3 TKO: 44.11 ± 0.407, n = 25 / P = 0.409, n.s.; Fig. 3.17 K, N) nor the 
mean synaptic vesicle volume were altered in synapses lacking all Complexin isoforms 
(control: 47600 ± 2017, n = 19; Complexin-1/2/3 TKO: 45536 ± 1198, n = 25 / P = 0.3596, 
n.s.; Fig. 3.17 L).  
In summary, I could not detect any statistically significant differences in either the number 
of synaptic vesicles in presynaptic terminals or in the number of membrane-attached 
synaptic vesicles in Complexin-1/2/3 TKO synapses. These findings correlate well with 
electrophysiological data for neurons lacking all three Complexin isoforms, which showed 
no changes in the size of RRP measured after the application of hyperosmolaric sucrose 
solution (Reim et al., 2001; Xue et al., 2007, 2008). It was possible to reveal a slight 
increase in the membrane-proximal vesicles in Complexin-1/2/3 TKO neurons. One 
possible explanation could be that neurons devoid of all Complexin isoforms have an 
impaired ability to release synaptic vesicles in response to action potential stimuli, leading 
to an accumulation of synaptic vesicles close to the active zone membrane. However, my 
data does not support the hypothesis of a clamping function for Complexins in mouse 
neurons, since in such a scenario I would have expected to see rather a slight decrease in 
the number of docked vesicles at the membrane, as had been shown in C. elegans 
Complexin mutants (Hobson et al., 2011). Taken together, the results of the present study 
support the hypothesis that Complexins are facilitators of synaptic vesicle release, which 
act on the assembled SNARE-complex after synaptic vesicle docking/priming. 
 






Figure 3.17. Three-dimensional electron tomographic analysis of synaptic vesicle docking in 
Complexin-1/2/3 TKO neurons 
Tomographically reconstructed subvolumes of control (A) and Complexin-1/2/3 TKO (B) synapses 
from 200 nm-thick sections.Three-dimensional models of tomographically reconstructed control (C) 
and Complexin-1/2/3 TKO (D) synaptic profiles. Ultrastructural features reconstructed in the models 
include the active zone plasma membrane (white), synaptic vesicles (membrane-attached, green; 





non-attached, grey) and endosomes (light blue). E, F Orthogonal views of control (E) and 
Complexin-1/2/3 TKO (F) tomographic models displaying the spatial arrangement of membrane-
attached synaptic vesicles within the reconstructed active zone area. Mean number of SVs within 
100 nm of the AZ normalized to AZ area (G). Mean number of SVs within 40 nm of the AZ 
normalized to AZ area (H). Mean number of membrane-attached SVs (within 0-2 nm of the AZ) 
normalized to AZ area (I). Mean number of membrane-attached and closely-tethered SVs (within 0-
4 nm of the AZ) normalized to AZ area (J). Mean outer SV diameter (K). Mean SV volume 
including the membrane bilayer (L). Spatial distribution of SVs within a 100 nm distance of the AZ 
membrane (M). Distribution of synaptic vesicle diameters of vesicles within 100 nm of the AZ (N).  
G-L: Control: N=3, n=19; Complexin-1/2/3 TKO: N=3, n=25 (Mean + SEM), P<0.001: ***; P<0.01: 
**; P<0.05: *. M, N: (617 SVs in control and 953 SVs in Complexin-1/2/3 TKO synaptic profiles). 
Scale bar: B, 100 nm. 
 
 
3.1.3.8.  The impact of the synaptic vesicle size on membrane-attachment 
 
To exclude the possibility that the severe docking deficits and the accumulation of 
membrane proximal synaptic vesicles observed in Munc13-1/2 DKO, SNAP25 KO and 
Synaptobrevin-2 KO synapses were an indirect consequence of the measured increases 
in synaptic vesicle size, I decided to reanalyze the size of exclusively membrane-attached 
(0-2 nm) and closely-tethered (0-4 nm) synaptic vesicles in these genotypes (Fig. 3.18).  
When all synaptic vesicles within 100 nm of the active zone were included in the analysis, 
Munc13-1/2 DKO synapses exhibited an 8% increase in the synaptic vesicle diameter 
(control: 46.25 ± 0.485, n=16; Munc13-1/2 DKO: 50.15 ± 0.715, n=15; P<0.001, ***; Fig. 
3.4 K) causing a 28% increase in the synaptic vesicle volume. In Munc13-1/2 DKO 
synapses, membrane-attached (0-2 nm; control: 46.14 ± 0.453, n=76; Munc13-1/2 DKO: 
54.97 ± 3.15, n=3; P=0.0106, *; Fig. 3.18 A) and closely-tethered (0-4 nm; control: 46.10 ± 
0.366, n=129; Munc13-1/2 DKO: 50.59 ± 1.510, n=10; P=0.0014, **; Fig. 3.18 B) synaptic 
vesicles exhibited similarly increased synaptic vesicle sizes. Analysis of synaptic vesicles 
within 100 nm of the active zone revealed a 14% increase in the mean outer vesicle 
diameter for SNAP25 KO synapses (control: 46.12 ± 0.482, n=24; SNAP25 KO: 52.53 ± 
0.586, n=25 / P<0.001, ***; Fig. 3.8 K). With a focus on membrane-attached (0-2 nm; 
control: 44.86 ± 0.336, n=149; SNAP25 KO: 51.83 ± 0.586, n=32 / P<0.001, ***) (Fig. 3.18 
C) and closely-tethered (0-4 nm; control: 45.03 ± 0.279, n=24; SNAP25 KO: 52.08 ± 
0.665, n=25 / P<0.001, ***) (Fig. 3.18 D) synaptic vesicles in SNAP25 KO synaptic 
profiles, a similar increase in the mean outer synaptic vesicle diameter was observed. 
Moreover, Synaptobrevin-2 synapses exhibited a 7% increase in the synaptic vesicle 
diameter measured for all vesicles within 100 nm of the active zone (control: 45.81 ± 
0.450, n=25; Synaptobrevin-2 KO: 49.07 ± 0.411, n=24 / P<0.001, ***; Fig. 3.13 E). 
Membrane-attached (0-2 nm; control: 45.17 ± 0.353, n=149; Synaptobrevin-2 KO: 48.03 ± 





0.659, n=45 / P<0.001, ***; Fig. 3.18 E) and closely-tethered (0-4 nm; control: 45.23 ± 
0.301, n=209; Synaptobrevin-2 KO: 47.91 ± 0.522, n=79 / P<0.001, ***; Fig. 3.18 F) 
showed comparable increases in synaptic vesicle diameter. 
In summary, in all analyzed groups, synaptic vesicle membrane-attachment was still 
possible when vesicles exhibited an enlarged volume. These findings indicate that the 
increased synaptic vesicle size is unlikely to be responsible for the severe docking-deficits 
observed in Munc13-1/2 DKO, SNAP25 KO and Synaptobrevin-2 KO neurons. 
 
Figure 3.18. Enlarged vesicle diameters do not impair synaptic vesicle docking 
A, B Mean outer SV diameter for membrane attached synaptic vesicles (0-2 nm; A) and vesicles 
within 0-4 nm (B) in Control and Munc13-1/2 DKO electron tomograms. Mean outer SV diameter 
for membrane attached synaptic vesicles (0-2 nm; C) and vesicles within 0-4 nm (D) in Control and 
SNAP25 KO electron tomograms. Mean outer SV diameter for membrane attached synaptic 
vesicles (0-2 nm; E) and vesicles within 0-4 nm (F) in Control and Synaptobrevin-2 KO electron 
tomograms. n=number of membrane-attached vesicles (Mean + SEM), P< 0.001: ***, P<0.01: **; 
P<0.05: *. 
 
3.1.3.9. SNARE mutants accumulate LDCVs in presynaptic terminals 
 
All mouse mutants analyzed in the course of this study have also been shown to function 
in the release of LDCVs from mouse chromaffin cells of the adrenal medulla (Ashery et 
al., 2000; Borisovska et al., 2005; Cai et al., 2008; Liu et al., 2008; Speidel et al., 2005; de 
Wit et al., 2006, 2009). Especially SNAP25, Syntaxin-1 and Synaptotagmin-1 have been 
implicated in LDCV docking in chromaffin cells, whereas the loss of CAPS in Drosophila 
has been shown to cause an accumulation of LDCVs at the neuromuscular junction 
(Renden et al., 2001; de Wit et al., 2006, 2009). We therefore decided to quantify the 
number of LDCVs in presynaptic terminals, which is inherently very low.  






Figure 3.19. SNARE mutants accumulate LDCVs in presynaptic terminals  
Mean number of large dense core vesicles (LDCVs) within 200 nm of the AZ per synaptic profile in 
Synaptobrevin-2 KO (A), SNAP25 KO (D), Syntaxin-1A KO / 1B
YFP 
(G), Munc13-1/2 DKO (J), 
CAPS-1/2 DKO (K), Synaptotagmin-1 KO (L) and Complexin-1/2/3 TKO (M) tomograms in 
comparison to their respective control groups. In Synaptobrevin-2 KO (B, C), SNAP25 KO (E, F) 
and Synatxin-1A 1B
YFP
 (H, I) synaptic profiles, LDCVs (asterisk) have the tendency to accumulate 
within 40 nm, but not to dock to the active zone. n= number of tomograms (Mean + SEM), 
P<0.001: ***, P<0.01: **; P<0.05: *. Scale Bar in I: 100 nm. 
 
As previously mentioned, in two-dimensional electron microscopic analyses, I observed a 
slight, though not statistically significant, increase in the number of LDCVs per synaptic 





terminal in SNAP25 KO synaptic profiles (See 3.1.3.3.1; Fig. 3.7 H). The number of 
LDCVs doubled in Syntaxin-1A/ -BYFP synaptic profiles (See 3.1.3.4.1; Fig. 3.9 H) and the 
most dramatic increase in the number of LDCVs was observed in synaptic profiles from 
Synaptobrevin-2 KO slices (See 3.1.3.5.1; Fig. 3.11 H). 
These increases in LDCV density in the presynaptic terminals of SNARE mouse mutants 
were confirmed by three-dimensional analysis of synaptic profiles by electron tomography 
(Fig.3.19). Since I did not image full synaptic terminals but rather focused on the active 
zone area, I limited the analysis to a 200 nm distance from the active zone. In synaptic 
profiles of Synaptobrevin-2 KO organotypic slices, the number of LDCVs within 200 nm 
was increased ~ 19-fold in comparison to control tomograms (control: 0.040 ± 0.040, 
n=25; Synaptobrevin-2 KO: 0.792 ± 0.233, n=24 / P<0.001, ***; Fig. 3.19 A). Two 
Synaptobrevin-2 KO tomograms exhibited LDCVs within 40 nm of the active zone (Fig. 
3.19 B, C). These vesicles were in close proximity to the plasma-membrane, but not 
docked. In SNAP25 KO synaptic profiles, the number of LDCVs within 200 nm of the 
active zone membrane increased 3.5-fold (control: 0.125 ± 0.069, n=24; SNAP25 KO: 
0.440 ± 0.142, n=25 / P=0.0858, n.s.; Fig. 3.19 D). In four SNAP25 KO synaptic profiles, 
LDCVs were detected within 40 nm of the active zone, but were not in contact with the 
plasma membrane (Fig. 3.19 E, F). Synaptic profiles from Syntaxin-1A/ -BYFP neurons 
revealed a ~ 3.6-fold increase in the number of LDCVs within 200 nm of the active zone 
(control: 0.143 ± 0.078, n=21; Syntaxin-1A/ -BYFP: 0.522 ± 0.139, n=23 / P=0.0314, *; Fig. 
3.19 G). Three Syntaxin-1A/ -BYFP synaptic profiles contained LDCVs within 40 nm of the 
active zone that were not membrane-attached (Fig. 3.19 H, I). No LDCVs were detected 
within 40 nm of the active zone membrane in control groups for the SNARE mutants. 
In Munc13-1/2 DKO (control: 0.188 ± 0.136, n=16; Munc13-1/2 DKO: 0.267 ± 0.153, n=15 
/ P=0.7012, n.s.; Fig. 3.19 D), CAPS-1/2 DKO (control: 0.273 ± 0.117, n=22; CAPS-1/2 
DKO: 0.053 ± 0.053, n=19 / P=0.1126, n.s.; Fig 3.19 E), Synaptotagmin-1 KO (control: 
0.174 ± 0.081, n=23; Synaptotagmin-1 KO: 0.250 ± 0.123, n=20 / P=0.5993, n.s.) and 
Complexin-1/2/3 TKO (control: 0.211 ± 0.096, n=19; Complexin-1/2/3 TKO: 0.040 ± 0.040, 
n=25 / P=0.0808, n.s.) the number of LDCVs within 200 nm of the active zone remained 
unchanged between controls and mutant synaptic profiles. However, despite the absence 
of LDCV accumulation within profiles of Synaptotagmin-1 KO synapses, three of the 
acquired tomograms contained LDCVs within 40 nm of the active zone that were close to, 
but not in physical contact with the plasma membrane (examples not shown). In Munc13-
1/2 DKO, CAPS-1/2 DKO and Complexin-1/2/3 TKO synaptic profiles, no LDCVs were 
found within 40 nm of the active zone. However, in the Complexin-1/2/3, CAPS-1/2 and 
Synaptotagmin-1 control groups, one synaptic profile each contained a single LDCV within 





40 nm of the active zone, but LDCV docking at the active zone membrane was never 
observed.  
 
3.2.  Generation and characterization of a Munc13-1 conditional knock-out 
(CKO) mouse line 
 
The Munc13 family of priming proteins is essential for synaptic transmission. Munc13-1 is 
the most abundant isoform in the central nervous system and the loss of Munc13-1 
courses perinatal lethality and severe deficits in glutamatergic transmission (Augustin et 
al., 1999a). Munc13-2- and Munc13-3-deficient mice are viable and fertile and neurons 
function normally under basal conditions, indicating a dominant role for Munc13-1 in 
mammalian synapses. Over the last years an important role of Munc13s in regulating 
synaptic plasticity became evident (Breustedt et al., 2010; Chen et al., 2013; Lipstein et 
al., 2013; Yang and Calakos, 2011; Zhao et al., 2012a, 2012b). However, due to the lethal 
phenotype, a detailed study of the function of Munc13-1 in the mature, developed brain 
and therefore in a physiological network, has not yet been possible. I therefore set out to 
generate a conditional Munc13-1 mouse line, where Munc13-1 expression can be shut 
down at different developmental time-points or in specific subsets of neurons. 
 
3.2.1.   Generation of a CKO targeting vector  
 
The aim was to generate a mouse in which exon 21 in the Munc13-1 gene is flanked by 
two loxP sites, so that upon site-specific Cre-recombinase activity in the neurons exon 21 
will be deleted. This, in turn, is predicted to result in a frame shift in the gene transcription 
product, and therefore to a loss of the Munc13-1 protein.  
For the generation of a conditional knockout (CKO) targeting vector, I chose 
recombination-mediated genetic engineering (recombineering), a method based on 
homologous recombination via gap repair in E.coli bacterial cells. This method utilizes the 
specialized E.coli strains E350 and SW106 (Lee et al., 2001; Liu et al., 2003; Warming et 
al., 2005), derived from DH10B BAC DNA host cells and modified to express enzymes 
required for gap repair (Exo, Beta, and Gam) in a temperature-dependent manner from a 
defective prophage λ (Lee et al., 2001). In addition to the heat-controlled expression of 
Exo, Beta, and Gam, E350 and SW106 cells encode the adenoviral P1 bacteriophage 





cyclization recombination (Cre)-recombinase under an L-arabinose-inducible promoter. 
E350 and SW106 strains only differed by an additional galK-based selection system 
integrated into SW106, which I did not employ in this study (Warming et al., 2005). The 
expression of these enzymes enables recombination of DNA fragments between vectors 
carrying homologous sequences.  
 
  





Figure 3.20. Generation of a Munc13-1 conditional knock-out targeting vector 
Schematic representation of the cloning strategy for a Munc13-1 conditional knock-out (cko) 
targeting vector. Exons are labeled as grey boxes, introns as white boxes and exon 21 as a red 
box. White triangles indicate loxP sites, black triangles indicate FRT sites. 1. BAC DNA retrieval 
via gap repair: Two homology arms (A+B) were amplified by PCR and subcloned into the PL253 
retrieval vector. The vector was linearized by HindIII digest. A 9.7 kb fragment of the Munc13-1 
gene containing exon 21 was retrieved from the SV129 embryonic stem (ES) cell derived bacterial 
artificial chromosome (BAC) plasmid bMQ411l13 via homologous recombination into the PL253 
retrieval vector. 2. Targeting of the first loxP site: The two homology arms (C+D) were amplified 
by PCR and subcloned into the PL452 vector plasmid to flank a floxed neomycin resistance gene 
(Neo) cassette. The floxed Neo cassette with the two homology arms was excised by KpnI and 
NotI digestion, together with ScaI to cut the plasmid backbone in the Amp gene. The floxed Neo 
cassette was inserted upstream of exon 21 via homologous recombination and excised after L-
arabinose-induced Cre-recombinase expression, resulting in a single loxP site with a diagnostic 
HindIII restriction site. 3. Targeting of the second loxP site: The two homology arms (E+F) were 
amplified by PCR and subcloned into the PL451 vector plasmid to flank a Neo cassette flanked by 
FRT sites and a downstream loxP site. The FRT site flanked Neo cassette with the two homology 
arms was excised by XhoI and SacII digest, together with ScaI to cut the plasmid backbone in the 
Amp gene, and inserted downstream of exon 21 via homologous recombination. The Neo cassette, 
HSV-TK cassette, and FRT and loxP sites are not drawn to scale. Neo, neomycin resistance gene; 
HSV-TK, herpes simplex virus thymidine kinase; Amp, Ampicilin. Based on (Liu et al., 2003) 
 
Using recombineering, I retrieved a 9.7 kb Munc13-1 gene fragment containing exons 13-
26. This fragment was retrieved from a BAC, namely the 129SV ES cell derived BAC 
clone bMQ 441l13 containing the full Munc13-1 genomic sequence. bMQ 441l13 is part of 
a 129SV ES cell DNA BAC library and contains a pBACe3.6 vector backbone with a 
chloramphenicol resistance gene for selection (Adams et al., 2005; Frengen et al., 1999). 
The fragment was retrieved into a plasmid containing a MC1 promotor controlled herpes 
simplex virus thymidine kinase cassette (MC1TK). I subsequently introduced loxP sites 
and a neomycin resistance (Neo) cassette for positive selection in embryonic stem (ES) 
cells (Liu et al. 2003). The individual recombineering steps for the generation of the 
targeting vector are presented schematically in Fig. 3.20, and the strategy for the 
generation of the Munc13-1 CKO mouse line is illustrated in Fig.3.21 A.  
 
3.2.1.1.  Retrieving of BAC DNA fragment into the PL253 vector 
 
In the first step, a 9.7 kb fragment containing the targeted exon 21 and the flanking long- 
and short arm for homologous recombination in ES cells was retrieved via recombineering 
from the BAC into the pBluescript-based targeting vector backbone PL253, containing a 
modified MC1TK cassette (Liu et al. 2003) (Fig. 3.20). First, the BAC clone bMQ 441l13 
DNA was amplified and a restriction analysis was performed to confirm the identity of the 
clone. 4 μg freshly prepared BAC was electroporated into electrocompetent EL350 cells 





and the bacteria were plated on LB agar plates containing chloramphenicol to select for 
the presence of the BAC plasmid. Colonies were chosen and BAC DNA was purified. 10 
μl of purified BAC DNA before and after transformation was digested overnight at 37°C 
with 20 units of the restriction enzymes SalI, NruI and ClaI in 50 μl volumes each. The 
respective restriction patterns were compared after pulsed field gel electrophoresis on an 
agarose gel. The expected band pattern for all restriction enzymes was found in all clones 
tested, with the exception of NruI, which did not cut at one predicted restriction site (data 
not shown). This finding indicated small differences between the C57BL/6J reference 
sequence and the SV129 ES cell DNA. Indeed, during the generation of the Munc13-1 
CKO targeting vector, some minor differences to the C57BL/6J reference sequence were 
observed after sequencing. However, these differences in the nucleotide sequence did not 
alter the identity of the encoded amino acids and were therefore considered to reflect 
genomic polymorphisms between strains.  
In the next step, short homology arms (labeled A and B; Fig 3.20.1) were amplified from 
the BAC clone using PCR and subcloned into PL253, resulting in the plasmid PL253-AB 
(see 2.2.2.16.1.). These short homology arms define the borders of the desired sequence 
to be retrieved from the BAC clone. For the retrieval of the 9.7 kb BAC fragment into the 
PL253 retrieval vector, 600 ng of the PL253-AB DNA was linearized by 20 units HindIII for 
2 h. Next, 170 ng DNA was electroporated into electrocompetent EL350 cells that contain 
the bMQ 441l13 BAC and in which the expression of the gap repair enzymes was 
induced. Ampr colonies (i.e. colonies transformed with PL253-AB) were screened by PCR 
for the integration of the 9.7 kb Munc13-1 genomic sequence into the PL253-AB retrieval 
vector. In three independent experiments, 120 colonies were screened but gave rise to 
only one positive clone. To select against plasmid multimers, which can occur in 
pBluescript-based vectors by rolling circle replication during the gap repair process, 1 ng 
of the gap-repaired plasmid was retransformed into Electro10 Blue cells and Ampr 
colonies were selected and tested for the presence of the targeted plasmid.  
 
3.2.1.2.  Targeting of the first loxP site upstream of Munc13-1 exon 21 
 
In order to introduce one loxP site upstream exon 21 of the Munc13-1 gene, a Neo 
cassette flanked by two loxP sites was first introduced into the Munc13-1 genomic 
sequence via site-specific recombineering (Fig. 3.20.2). In a subsequent step, the Neo 
cassette was excised by Cre-mediated recombination after L-arabinose induced Cre-
recombinase expression in SW106 E.coli cells. The Neo resistance gene that was used 





(from the PL452 vector) is flanked by two loxP sites and is regulated by two promotors: 
the phosphoglycerate kinase I (PGK) promotor, which permits the expression of the Neo 
resistance gene in eukaryotic cells, and the EM7 promotor, which enables prokaryotic cell 
expression. Moreover, the Neo cassette is followed by a bovine growth hormone 
polyadenylation site (bpA), a termination signal for protein expression in eukaryotic cells.  
Short homology arms (Labeled C and D; Fig. 3.20.2) were PCR amplified from the BAC 
DNA and subcloned into PL452 (See 2.2.2.16.2.). The Neo cassette flanked by the two 
short homology arms was cut out of the resulting PL452 vector by digestion with 20 units 
of KpnI and NotI as well as ScaI (to cut the plasmid backbone in the ampicilin resistance 
gene). 100 ng of the C-loxP-PGK-EM7-NeobpA-loxP-D fragment were electroporated 
together with 10 ng of the PL253 vector containing the 9.7 kb Munc13-1 genomic insert 
into electrocompetent and induced SW106 cells and Ampr (PL253 vector) and Kanr (Neo 
cassette) colonies were selected. Five independent experiments were performed, in total 
~450 clones were screened, however only the last attempt gave rise to 11 positive 
colonies. Positive colonies contained a mix of gap-repaired and non-gap-repaired 
plasmids. Therefore, 1 ng of the gap-repaired plasmid was retransformed into XL1-Blue 
cells and colonies resistant to Ampr and Kanr were selected. 1 ng of the retrieval vector 
containing the loxP-PGK-EM7-NeobpA-loxP cassette was then electroporated into 
electrocompetent SW106 cells after arabinose-induced Cre-expression. Cre activity 
resulted in the removal of the Neo cassette by Cre-mediated recombination between the 
two loxP sites in all selected Ampr colonies, leaving only one loxP site upstream of 
Munc13-1 exon 21.  
 
3.2.1.3.  Targeting of the second loxP downstream of Munc13-1 exon 21 
 
In order to introduce the second loxP site and a Neo cassette for positive selection in ES 
cells, a Neo cassette, flanked by two flippase (FLP) recombinase target (FRT) sequences 
and followed by a single loxP site was integrated downstream of Munc13-1 exon 21 by 
site-specific recombination in E.coli cells. Generation and subcloning of short homology 
arms amplified from the BAC DNA (termed E and F: Fig. 3.20.3) into PL451 is described 
in 2.2.2.16.3. The expression of the Neo resistance gene is controlled by a PGK and an 
EM7 promotor together with a bpA site. The Neo cassette, flanked by the two short 
homology arms, was cut out of the E-FRT-PGK-EM7-NeobpA-FRT-loxP-F containing 
vector PL451 by subsequent digestion with 20 units of XhoI and SacII as well as ScaI to 
cut the plasmid backbone in the ampicilin resistance gene. 40 ng of the E-FRT-PGK-EM7-





NeobpA-FRT-loxP-F fragment were electroporated together with 10 ng of the PL253 
retrieval vector from the previous step into electrocompetent and induced cells. Ampr 
(PL253 vector) and Kanr (Neo cassette) colonies were selected. 32 colonies were 
screened and four positive clones were obtained, which contained a mixture of gap-
repaired and non-gap-repaired plasmids. 1 ng of the plasmid DNA was retransformed into 
XL1-Blue cells and Ampr and Kanr colonies were selected. Positive clones contained a 
single FRT-PGK-EM7-NeobpA-FRT-loxP cassette downstream of the Munc13-1 exon 21 
in addition to the one loxP site upstream of exon 21 (Fig. 3.23.3 and 3.24 A). 
 
3.2.2.   Generation of recombinant ES cells and mice 
 
In order to prepare the Munc13-1 CKO targeting vector for ES cell electroporation, the 
plasmid was purified with the EndoFree Plasmid Maxi Kit (Qiagen). A total of 450 μg DNA 
was liniarized in nine tubes, each one containing 50 μg DNA and 100 units NotI in a 
volume of 300 μl and in the presence of 1x BSA for 5 hours at 37°C. To check the 
digestion efficiency, 1 μl of each tube was loaded onto a gel. The NotI linearized CKO-
targeting vector was then electroporated into SV129/Ola ES cells and the transformed 
clones were selected for their G418 and ganciclovir resistance. G418, also called 
geneticin, is an antibiotic used for positive selection in eukaryotic cells expressing the Neo 
cassette. Ganiclovir is an anti-viral drug that becomes toxic upon phosphorylation by HSV-
TK and is therefore used for negative selection to prevent ES cell clones that had random 
insertion of the targeting vector backbone from growing. Out of 192 clones analyzed by 
Southern blot after HindIII digest and probed with a P32-labelled probe that is located 
upstream of the sequence used in the targeting vector (5’ probe; Fig. 3.24A), 29 positive 
clones were identified. Because of an introduced HindIII site along with the 1st loxP site, 
which was located upstream of exon 21, homologous recombinants carrying the CKO 
allele generated a 9.8 kb (wt) band and a 8.4 kb (mutant) band after probing with the 5’ 
probe (Fig. 3.21 B). From these colonies, 12 clones were subsequently tested after MfeI 
digestion by hybridization with a P32-labelled probe located downstream of the sequence 
used in the targeting vector (3’ probe), and with a P32-labelled probe targeting the Neo 
cassette sequence (Neo probe). In ES cells that carry the cko allele in the desired 
location, a 7.9 kb (WT) band and a 9.7 kb (mutant) band can be detected after probing 
with the 3’ probe as the length of the FRT-PGK-EM7-NeobpA-FRT-loxP cassette had 
been added (Fig. 3.21 B), and a single 9.6 kb band can be detected after probing with the 
Neo probe. No additional signal was detected in the Southern blot probed for Neo, which 





indicated that these clones exhibited no random integration of the targeting vector into the 
genome. All 12 clones were tested positive for 5’, 3’ and a Neo probe (data not shown). 
The Munc13-1 allele containing the Neo cassette was termed Munc13-1 Neo. 
The ES cell clones A4, B7 and H6 were chosen for blastocyst injection. Blastocyst 
injection was conducted by Monica Schindler in the Transgenic Animal Facility of the Max-
Planck-Institute of Experimental Medicine, Göttingen, Germany. The blastocysts for the 
procedure were derived from C57BL/6N and C57BL/6 albino mice and planted into 
hormone-treated pseudo-pregnant C57BL/6 females. ES cells originating from the 
SV129/Ola line carry the agouti allele, which adds a yellow shimmer to mouse fur and 
leads to a brownish hair color in C57BL/6 and to a cream-colored appearance of C57BL/6 
albino chimeras. A high percentage of brown or cream colored fur corresponded to a high 
degree of chimerism. From ES cell clone H6, seven male chimeras were identified by 
brown coat patches (2x10%, 1x15%, 2x30%, 1x60%, 1x70%; presented as estimated 
percentage of the coat surface), Of which two males were germline competent (60% and 
70%). From ES clone B7 two male chimeras (1x30% and 1x40%) were obtained with one 
being germline competent (40%). The chimeric offsprings were crossed with FLPeR 
(“flipper”) mice, that express the FLP-recombinase, which enables, via site-specific FLP-
recombination, the excision of the Neo cassette at the FRT sites flanking the Neo 
cassette, leaving a single FRT site and one loxP site (Farley et al., 2000). As the FLPeR 
allele was crossed into the C57BL/6N genetic background, which encodes for black fur 
color, germ-line transmission of the Munc13-1 Flp allele in the SV129/Ola background 
would only produce brown-colored offspring, independent of the origin of the blastocysts 
(C57BL/6N or C57BL/6 albino). The two chimeric animals from ES cell clone H6 produced 
altogether eight brown-colored pups, the one chimeric animal from ES cell clone B7 
produced five brown-colored pups. As the excision of the Neo cassette was detected only 
in a subset of cells after one crossing with the flipper mice, the animals were crossed with 
C57BL/6J mice and offspring exhibiting germ-line transmission of the Cre-recombined 
allele were selected. The Munc13-1 allele after Flp-mediated excision of Neo cassette 
was termed Munc13-1 Flp and was characterized by a single loxP site upstream and a 
FRT and loxP site downstream of exon 21 in the Munc13-1 gene locus. Offspring 
homozygous for the Munc13-1 Flp allele was viable and fertile. For all following 
experiments, I only worked with offspring generated from the ES cell clone H6.  







Figure 3.21. Generation and characterization of Munc13-1 conditional knock-out mice 
A Schematic representation of the Munc13-1 wild-type gene (Munc13-1 WT), the targeting vector, 
the mutated gene after homologous recombination (Munc13-1 Neo), the mutated gene after 
flippase (FLP)-mediated excision of the neomycin (Neo) resistance cassette (Munc13-1 Flp), and 
the mutated gene after adenoviral cyclization recombination (Cre)-mediated recombination 
(Munc13-1 Cre). The targeted exon 21 is indicated in red, remaining exons are labeled grey. White 
triangles indicate loxP sites, black triangles indicate FRT sites. The 5’ and 3’ probes, represented 
by black horizontal bars, were used for Southern blot analysis. HindIII and MfeI restriction sites 
employed for diagnostic digestion for Southern blot analysis are indicated. TK: herpes simplex virus 





thymidine kinase gene B 5’ probe Southern blot hybridization after HindIII-digestion of embryonic 
stem (ES) cell clone DNA produced a 9.8 kb (wt) band and an 8.4 kb (Neo) band. 3’ probe 
Southern blot hybridization after MfeI-digestion of ES cell clone DNA produced a 7.9 kb (wt) band 
and a 9.7 kb (Neo) band. C Schematic representation of the genotyping strategy for the Munc13-1 
WT, Munc13-1 Neo, Munc13-1 Flp and Munc13-1 Cre allele. The positions of the diagnostic 
polymerase chain reaction (PCR) fragments are indicated in green together with their expected 
sizes in base pairs (bp). The primers (#1-#4) used for the respective PCR reactions are not drawn 
to scale. D Western blot analysis of Munc13-1 levels (~ 200 kDa, black arrowheads) as well as ß-
Tubulin and Synaptophysin loading control levels in cell homogenates from a Munc13-1 Flp 
hippocampal neuron mass culture that was either not infected (lane 1) or infected on DIV 2 with 
pFUGW-GFP- (lane 2) or pFUGW-iCre- (lane 3) containing lentiviral particles. Absence of Munc13-
1 in pFUGW-iCre infected neurons was confirmed with an antibody directed against the N-terminal 
part of Munc13-1 (#40) (upper left panel) (Varoqueaux et al. 2005; Cooper et al. 2012) and with an 
antibody against the C-terminal part of Munc13-1 (#N395AP) (right panel) (Betz et al., 1997). E 
Genotyping results for the indicated genotypes obtained from PCR amplification of either mouse 
tail DNA (Munc13-1 wt/wt, Munc13-1 wt/flflp, Munc13-1 flflp/flflp), ES cell clone DNA (Munc13-1 
wt/flNeo) or DNA lysates from pFUGW-iCre infected neuron cultures (Munc13-1 flflp/flflp – pFUGW-
iCre). 
 
3.2.3.   Genotyping Strategy 
 
The primers used in the genotyping PCR reaction and the predicted PCR DNA products 
for the individual stages of the generation of the mouse line are depicted in Fig.3.21 C. 
Genotyping of mouse DNA prepared from tail tissue was used at all breeding stages and 
prior to all experiments to confirm the genotype. The respective DNA fragment patterns 
were visualized on an agarose gel, as presented in Fig. 3.21 E. Before the FLP-mediated 
recombination of the Neo cassette, the genotyping reaction contained three primers (#1, 
#2, #3). Under the given PCR conditions (see materials and methods), the wild-type 
Munc13-1 allele was identified by a 149 bp long PCR fragment (amplified from the primer 
pair #2 and #3). The Munc13-1 Neo allele was detected by the presence of a 196 bp long 
PCR product between primers #1 and #2, as primer #1 anneals within the Neo cassette. 
Excision of the Neo cassette by Flp-mediated recombination (Munc13-1 Flp allele) 
produced a 253 bp long PCR product using the primers #2 and #3. At this stage, we 
occasionally observed an additional PCR product of approximately 230 bp (data not 
shown). The band only appeared when a PCR mix containing all primers was used, and 
not when a single primer pair was used, and was therefore considered to be non-specific. 
Primers #2 and #3 were used from that point on for routine genotyping of the mouse line. 
In order to produce a full Munc13-1 KO allele, the Cre/loxP system was employed 
(Kaartinen and Nagy, 2001). Site-specific Cre-recombinase mediated recombination 
would lead to the deletion of exon 21 of Munc13-1 and therefore induce a predicted 
frame-shift mutation, which would result in a complete Munc13-1 KO allele, termed 
Munc13-1 Cre. The Munc13-1 Cre allele was predicted to produce a 209 bp long PCR 





product with the primers #2 and #4. To examine whether a full deletion can occur in 
neurons carrying the Munc13-1 Flp allele, I infected hippocampal neurons in vitro from 
Munc13-1 Flp mice with a lentivirus that carries the cre cassette (pFUGW-iCre; see 
section 3.2.4 for more details). DNA extracts from these cells were collected and analyzed 
with the genotyping PCR (Fig. 3.21 E lane 5). Indeed, a single band of roughly 209 bp 
was observed, indicating efficient Cre-recombination. To show that Cre-mediated 
recombination is possible also in vivo, we started to cross the Munc13-1 Flp allele into the 
EIIa-Cre mouse line that expresses the Cre-recombinase protein controlled by the 
adenoviral EIIa promotor in cells from all body tissues (Lakso et al., 1996). The expression 
from the EIIa promotor starts at early embryonic stages that thereby results in early 
excision of the Neo cassette, which is expected to produce the Munc13-1 Cre allele in all 
neurons. At this point we were able to obtain mice that were heterozygous for the 
Munc13-1 Cre allele and I can therefore confirm Cre-mediated deletion of Munc13-1 exon 
21 in vivo (data not shown). In a PCR amplification using the primers #2 and #4, the wild-
type Munc13-1 allele and the not Cre-recombined Munc13-1 Flp allele were expected to 
additionally produce 746 bp and 953 bp long fragments, respectively (bands not shown in 
Fig. 3.21 E.). These PCR products were of no diagnostic use to us. 
 
3.2.4.   Characterization of the Munc13-1 CKO mouse line 
 
In order to analyze Munc13-1 protein expression after Cre-mediated deletion of exon 21, I 
employed lentiviral expression of the Cre-recombinase protein from the pFUGW-iCre 
vector plasmid in cultured hippocampal neurons from Munc13-1 Flp mice. Dissociated 
neuron cultures were infected at DIV 2 with lentiviral particles containing either the empty 
pFUGW plasmid that expresses GFP only (pFUGW-GFP) or the pFUGW-iCre plasmid 
that expresses Cre-recombinase protein and GFP. Western blot analysis was performed 
on homogenates produced at DIV 21 to detect the Munc13-1 protein levels. I tested for 
the presence of the full length Munc13-1 protein by using an antibody directed against a 
C-terminal epitope of Munc13-1 (#N395AP) (Fig. 3.21 D right panel) (Betz et al., 1997). In 
addition, I used an antibody directed against an N-terminal epitope of Munc13-1 (#40), 
which specifically detects Munc13-1 without detectable cross-reactivity with other Munc13 
isoforms (Cooper et al., 2012; Varoqueaux et al., 2005). The results revealed a complete 
loss of the Munc13-1 protein in the homogenates infected with pFUGW-iCre compared 
with the non-infected or pFUGW-GFP infected cell homogenates (Fig. 3.21 D). I was not 
able to detect Munc13-1 full length protein as well as any residual N-terminal fragment in 





cell homogenates from pFUGW-iCre infected neurons (Fig. 3.21 D left panel). Therefore, 
Cre-mediated deletion of Munc13-1 results in non-detectable Munc13-1 protein levels by 
Western blot analysis in vitro.   
In order to assess physiological consequences of Cre-mediated Munc13-1 deletion in 
neurons, autaptic hippocampal neuron cultures from Munc13-1 Flp mice were infected 
with pFUGW-GFP or pFUGW-iCre lentivirus on DIV 2 and tested for their basic 
electrophysiological properties at different time points (Fig. 3.22 A-E). Electrophysiological 
experiments and analysis was performed by Dr. Riikka Liisa Uronen, Department of 
Molecular Neurobiology, Max-Planck Institute of Experimental Medicine, Göttingen, 
Germany. Already on DIV 10, a strong reduction in the measured excitatory postsynaptic 
current amplitude (EPSC, nA) and in the size of the readily-releasable pool (RRP, nC) 
were measured for cells infected with pFUGW-iCre (data not shown). Therefore data from 
recordings conducted on following days (DIV 12-16) from one culture were pooled for the 
analysis. The EPSC amplitude was dramatically reduced in cells infected with pFUGW-
iCre in comparison to pFUGW-GFP infected neurons (pFUGW-GFP: 3.141 ± 0.5676, 
n=32; pFUGW-iCre: 0.7037 ± 0.1136, n=41 / P<0.0001, ***) (Fig. 3.22 A, D). Moreover the 
measured RRP size (nC) was greatly diminished in pFUGW-iCre infected cells (pFUGW-
GFP: 376.0 ± 75.91, n=17; pFUGW-iCre: 75.41 ± 11.31, n=18 / P=0.0003, ***; Fig. 3.22 B, 
E), with no significant differences in the calculated vesicular release probability (Pvr, %) 
(pFUGW-GFP: 7.361 ± 0.9006, n=17; pFUGW-iCre: 8.672 ± 1.387, n=18 / P=0.7791, n.s.; 
Fig. 3.22 C).  
Immuncocytochemical experiments of cultured neurons confirmed the biochemical and 
electrophysiological findings mentioned above. Immunofluorescent labelings of autaptic 
cells with primary antibodies directed against Munc13-1 protein infected with pFUGW-
GFP or pFUGW-iCre lentivirus and fixed on DIV 21 were performed. Neurons infected 
with pFUGW-GFP revealed close association of immunoreactivity for the active zone 
protein Munc13-1 (red) with immunoreactivity for the vesicular glutamate transporter 
VGLUT1 (green) along MAP-2 positive neuronal processes (grey) (Fig.3.22 F). Autaptic 
neurons infected with pFUGW-iCre were still able to form synapses, represented by the 
strong synaptic vesicle immunolabeling of VGLUT1. However Munc13-1 immunoreactivity 
was almost completely absent (Fig.3.22 G). Some background labeling was observed 
using the Munc13-1 primary antibody in both experimental conditions, most likely 
originating from the surrounding wild-type astrocyte cell layer since astrocyte cultures 
have been proposed to express Munc13-1 (Mungenast, 2011). 
 






Figure 3.22. Electrophysiological and morphological characterization of pFUGW-iCre 
infected Munc13-1 Flp hippocampal autaptic neurons 
Physiological characteristics of autaptic excitatory hippocampal neurons infected at DIV 2 with 
either pFUGW-GFP or pFUGW-iCre lentivirus and whole-cell voltage clamped at DIV 12-16. A The 
Mean amplitude of the excitatory postsynaptic current (EPSC) resulting from an evoked action 
potential. B Mean size of the readily-releasable pool (RRP) after application of 0.5 M hypertonic 
sucrose solution for 5 seconds. C Mean vesicular release probability (Pvr), as calculated by the 
ratio of charge evoked during a single action potential and that evoked during the sucrose 
application. D Example traces of evoked EPSC responses for neurons infected with pFUGW-GFP 
(black) or pFUGW-iCre (red). E Example traces for RRP release after stimulation with 0.5 M 
sucrose in neurons infected with pFUGW-GFP (black) or pFUGW-iCre (red). F,G Immunolablling of 
Munc13-1 (red), MAP-2 (grey) and VGLUT1 (green) in pFUGW-GFP infected autaptic neurons (F, 
left panel) and in pFUGW-iCre infected autaptic neurons (G, left panel). Upper right panel: MAP-2 
and VGLUT1 overlay, lower right panel: Munc13-1 immunolabelling. A-C: n=number of cells from 
one culture (Mean + SEM), P<0.001: ***. Scale bar: G, 10 µm. Electrophysiological recordings 
were performed by Dr. R. L. Uronen. 






4.1.  Methodological aspects in studying synaptic vesicle docking 
4.1.1. The organotypic slice culture system for studying lethal mouse 
mutants 
 
All mouse mutants that were investigated in the course of this study die either pre- or 
perinatally. Despite this, multiple options were available to prepare brain samples for 
ultrastructural analysis by high-pressure freezing fixation and freeze substitution. The 
advantages gained by high-pressure freezing and freeze substitution, in terms of superior 
sample preservation compared to chemical fixation, are however offset by the need to 
work with small sample volumes, since freezing quality deteriorates with increasing 
sample size, introducing artifacts and perturbing cellular ultrastructure. The first option 
was to prepare acute slices of brain tissue as used for electrophysiological experiments, 
however this method is experimentally challenging for E18 – P0 mouse brains and the 
mechanical disruption of the slice surface introduced during sectioning bears the risk of 
inducing local excitotoxicity and stimulation of neuronal release in an unphysiological 
manner. However, surface areas of high-pressure frozen tissue are usually preferentially 
selected for ultrastructural studies, since they undergo extremely rapid cooling in proximity 
to external cryo-protectant during the freezing process and as a consequence, they 
typically exhibit improved ultrastructual preservation compared to the slice center. The 
second reason arguing against the acute slice preparation method was the fact that 
synaptic density in cortical regions, including the hippocampus, is very low at birth, which 
would have restricted the analysis to synapses in immature developmental stages and 
made a large-scale ultrastructural analysis of synaptic morphology more challenging.  
I therefore decided to employ the hippocampal organotypic slice culture system for my 
purpose. Organotypic slice cultures from brain tissues, cultivated on small membrane 
inserts with the so-called interface method, provide established culture settings with a 
comparable rate of neuronal development and synaptogenesis to that of the intact tissue 
(reviewed in Gähwiler, 1997; De Simoni et al., 2003; Stoppini et al., 1991). Analysis of 
presynaptic protein KO mouse mutants has been successfully conducted by combining 
hippocampal organotypic slice culture preparations with electrophysiological experiments 
as well as ultrastructural analyses after cryo-fixation methods for electron microscopy 
(Kerr et al., 2008; Siksou et al., 2009; Zhao et al., 2012a). The main advantages of this 
culture system for our purpose were the fact that slice cultures could recover from cutting 





damage, permitting neurons and synapses to grow and develop in an in-situ-like 
environment. Moreover, slices thinned-out during four weeks in culture and became a 
perfect size to fit in a sample carrier for high-pressure freezing fixation. In comparison to 
dissociated neuron cultures, tissue slices are kept in a more physiological environment, 
which has been shown to extend the survival period of cultured neurons from mice 
carrying neurodegenerative mutations (Broeke et al., 2010; Heeroma et al., 2004). 
Hippocampal organotypic slices from mouse control and presynaptic protein mutants were 
therefore cultured for 4-5 weeks to guarantee a high synaptic density and to enable 
synapse maturation, also for mutant tissues that might suffer potential delays in neuronal 
development caused by the reduction or blockage of synaptic transmission, as has been 
reported for Munc13-1/2 DKO neurons (Broeke et al., 2010).  
Using the combination of hippocampal organotypic slice cultures, high pressure freezing 
and freeze substitution, it became possible to obtain well-frozen samples with minimally 
perturbed ultrastructure. In control synapses from all genotypes, the vast majority of the 
vesicles within 40 nm of the active zone were indeed membrane-attached, indicating 
physiological, unstimulated conditions during the freezing process. Potential fusion 
intermediates, such as synaptic vesicles in hemifused or fully-collapsed states, were 
however only occasionally observed. Initially, freezing the samples in the presence of 
tetrodotoxin was considered to obtain an even more accurate approximation of the 
number of docked vesicles in non-stimulated neurons. Tetrodotoxin prevents action 
potential propagation along the neurons by blocking voltage-gated sodium channels. 
However, the homeostatic effects on neurons during and after pharmacological blockage 
of presynaptic transmission are not yet fully understood, and since our aim was to 
approach near physiological conditions during sample preparation, we decided against 
this option. 
In summary, I showed that the hippocampal organotypic slice culture technique applied to 
lethal mouse mutants is a suitable experimental approach for cryo-fixation and 
ultrastructural EM analysis of synaptic parameters in a dense neuronal network. 
 
4.1.2. Studying synaptic vesicle docking using cryo-fixation methods for EM 
 
In recent years it has become evident that conventional chemical fixation methods for EM 
introduce serious problems that confound the study of synaptic vesicle docking at the 
active zone membrane, largely due to artifactual changes induced in cytoskeletal 





arrangements by the cross-linking of proteins and the dehydration of the sample 
(reviewed in Verhage & Sørensen 2008) (See 1.4 Ultrastructural analysis of synaptic 
vesicle docking). Since then, many studies have aimed to prove that cryo-fixation methods 
offer a more realistic view of presynaptic ultrastructure and enable a more reliable 
analysis of synaptic vesicle membrane interactions at active zone release sites. The 
application of high-pressure freezing fixation and freeze substitution prior to plastic 
embedding and three-dimensional electron tomography revealed that synaptic vesicle 
membranes of docked synaptic vesicles are in direct contact with the active zone plasma 
membrane (Siksou et al., 2009). 
Despite the improvements in synaptic ultrastructural preservation resulting from high-
pressure freezing, the imaging of samples at room temperature requires a cryo-
substitution step in which sample water is slowly exchanged for an organic solvent at low 
temperatures and the sample is preserved by fixatives. In the present study, a 
combination of tannic acid and OsO4 was used, which fixes samples during the freeze 
substitution process and deposits a heavy metal precipitate on phospholipid bilayers, 
thereby enhancing membrane contrast for imaging (Giddings, 2003; Jiménez et al., 2009). 
The disadvantages of this dehydration and staining procedures include the potential 
destruction of cytoskeletal elements and the fact that imaging relies on the presence of 
the heavy metal membrane stain that might obscure small structures and thus limits the 
resolution during imaging. 
Alternatively, cryo-preserved samples can be imaged at low temperatures by cryo-
electron tomography, avoiding sample dehydration and staining. One disadvantage of this 
method is, however, that only plunge-frozen samples thinner than 500 nm can be imaged 
directly (e.g. synaptosomes), whereas thicker, high-pressure frozen specimens (e.g. 
organotypic slice cultures) require cryo-sectioning, which introduces severe compression 
artifacts. Moreover, unfixed samples are very beam-sensitive and imaging therefore 
requires a very low electron dose and a high defocus to obtain phase contrast of proteins 
and membranes. However, studies employing cryo-electron tomography after freezing of 
purified synaptosome preparations and organotypic slice cultures indicated that the vast 
majority of synaptic vesicles might not be in direct membrane to membrane contact with 
the active zone, but that the closest vesicles are rather linked to the plasma membrane by 
multiple short filaments, or tethers (Fernández-Busnadiego et al., 2010). These tethered 
vesicles are connected by an average of two or more short filaments to the membrane, a 
number that correlates nicely with the calculated number of SNARE complexes needed to 
overcome the energy barrier for fusion of synaptic vesicles in vivo (Fernández-
Busnadiego et al., 2010; Mohrmann and Sørensen, 2012). Moreover, these short tethers 





disappeared after the treatment of synaptotosomes with tetanus toxin, a molecule that 
cleaves free Synaptobrevin-2, supporting the idea that multiple partially, or fully 
assembled, SNARE complexes link synaptic vesicles to the membrane (Fernández-
Busnadiego et al., 2010). According to this criterion, vesicles in direct membrane contact 
would be classified as fusion intermediates. In the present study, I occasionally observed 
short filamentous structures between vesicles and active zone membranes, but the 
majority of the vesicles appeared to be in direct membrane contact. It is very likely that 
this discrepancy between our electron tomography approach on plastic sections and the 
cryo-electron tomography data is caused by the layer of precipitated stain on the 
phospholipid bilayers in my method. I was unable to quantify the number of short tethers 
in this study. Moreover, I termed vesicles that were in physical contact with the plasma 
membrane "membrane-attached" or "docked" synaptic vesicles, although in reality these 
vesicles might indeed be "tethered" by short tethers to the membrane. 
Another possibility that may account for the lack of membrane-attached synaptic vesicles 
in the cryo-electron tomography study in comparison to my findings might be the 
differences in sample preparation prior to and during the cryo-fixation process. For cryo-
EM, rat synaptosomes were purified in a series of centrifugation steps prior to plunge-
freezing and results were compared with tomograms obtained from high-pressure frozen 
and cryo-sectioned organotypic slice cultures (Fernández-Busnadiego et al., 2010). In my 
preparations, I used 20% BSA dissolved into the culture medium for freezing. I found that 
the addition of BSA enabled excellent ultrastructural preservation over large areas without 
exposing the sample to a dramatic increase in osmolarity. In the study by Fernandez-
Busnadiego and colleagues (2010), organotypic slices were frozen in the presence of 
20% dextran and 5% sucrose after five minutes incubation at room temperature. This 
composition of cryoprotectant for freezing causes an increase of osmolarity to ~600 
mOsm, which could trigger the fusion of primed vesicles and thus could easily reduce the 
number of readily-releasable vesicles in synapses and account for the almost complete 
lack of membrane-attached vesicles. Moreover, the physiological consequences of 
centrifugation during synaptosome preparation, and any potential impact this may have on 
the size of the RRP, is difficult to assess. 
A recent study presented a fusion assay in which large liposomes containing stabilized 
Syntaxin-1/SNAP25 (1:1) complexes and liposomes containing full-length Synaptobrevin-
2, or a deletion mutant (∆84) that prevents interactions at the last hydrophobic layer (+8) 
of the four helical SNARE bundle preceding the C-terminal linker, enabled the capturing of 
different SNARE-dependent docking and fusion intermediates by cryo-electron 
microscopy (Hernandez et al., 2012). In this study Hernandez and colleagues showed that 





in the presence of ∆84 Synaptobrevin-2, liposomes can dock to each other. In this 
conformation the bilayers were described to be tightly held together 'without a resolvable 
space between the membranes' but fusion of liposomes was prohibited. This docked state 
was further described to require partial SNARE complex assembly. These findings 
indicate that in vitro, cryo-electron microscopy techniques can capture physical 
membrane-attachment at a stage in which SNARE complexes are partially engaged. 
However, in vivo partial SNARE complex zippering might be arrested further towards the 
N-terminus by regulatory proteins, potentially explaining the observed gap and the short 
filamentous connections between synaptic vesicle and plasma membranes observed by 
Fernandez-Busnadiego and colleagues (Fernández-Busnadiego et al., 2010). 
In summary, the possibility that electron tomography on plastic sections as employed in 
the present study approaches the limits of resolution when studying synaptic vesicle 
membrane-attachment cannot be excluded. Vesicles distanced less than 5 nm from the 
active zone membrane were therefore separated into two groups: (1) 0-2 nm and (2) 0-4 
nm. The 0-2 nm group contained all vesicles that appeared to be in direct membrane 
contact ("docked"). The 0-4 nm group included vesicles that were close enough for trans-
SNARE interactions to occur (van den Bogaart et al., 2011; Li et al., 2007). The term 
"tethering" is used here primarily to describe membrane-proximal vesicles within 40 nm of 
the active zone that can interact with the membrane by long filaments. This synaptic 
vesicle tethering process has been shown to remain unaffected in Munc13-1/2 DKO 
synapses despite the loss of docked synaptic vesicles, a finding that we were able to 
confirm in the present study (Siksou et al., 2009). 
 
4.2.   A common pool of docked and primed synaptic vesicles? 
 
Early EM studies that investigated the relationship between synaptic vesicle docking and 
priming were performed on chemically fixed wild-type neuron samples and compared the 
number of docked synaptic vesicles in electron micrographs with the number of released 
synaptic vesicles calculated from the measured postsynaptic response after hypertonic 
sucrose application (Murthy and Stevens, 1999; Rosenmund and Stevens, 1996; 
Schikorski and Stevens, 1997; Stevens and Tsujimoto, 1995). In these early studies, the 
number of membrane-attached synaptic vesicles correlated well with the number of 
fusion-competent synaptic vesicles in the sucrose pool. An alternative method to measure 
the RRP size of synaptic terminals is to apply a 20 Hz action potential stimulation protocol 
to successively release fusion-competent vesicles (Rosenmund and Stevens, 1996). 





Combining this protocol with subsequent FM1-43 membrane dye uptake, chemical fixation 
and photoconversion of the dye for electron microscopy, has again revealed a tight 
correlation between the numbers of retrieved and stained synaptic vesicles after pool 
depletion and the number of active zone membrane-attached synaptic vesicles. These 
findings support the hypothesis that the pool of physiological primed or fusion competent 
synaptic vesicles is comprised of morphological docked synaptic vesicles (Murthy and 
Stevens, 1999; Murthy et al., 1997, 2001; Schikorski and Stevens, 2001). Moreover, by 
coupling optical stimulation of neurotransmitter release in C. elegans neuromuscular 
junction synapses with rapid high-pressure freezing and electron microscopic imaging of 
plastic sections, it has been shown that the number of membrane-attached synaptic 
vesicles decreases after a stimulus, leading to the conclusion that morphologically docked 
vesicles are the first to fuse in response to an action potential (Watanabe et al., 2013). 
In the present study, I demonstrated that in tomograms from all control groups analyzed, 
the vast majority of the vesicles within 40 nm of the active zone appeared to be in direct 
physical contact with the active zone membrane. This finding is very important, because it 
provides an explanation why in wild-type synapses the numbers of morphologically 
docked and functionally primed synaptic vesicles correlate well, irrespective of which 
fixation method or docking definition (direct attachment versus 40 nm bin) is applied.  
 
4.3.  The role of the priming proteins Munc13/CAPS in synaptic vesicle 
docking  
 
4.3.1.   Munc13s 
 
First, the role of Munc13s in synaptic vesicle docking was reinvestigated in my 
experimental system. Munc13-1/2 DKO neurons were shown to exhibit a complete loss of 
physiologically primed synaptic vesicles as probed by application of hypertonic sucrose 
solution (Varoqueaux et al., 2002). In the present study, I found that synapses lacking 
both Munc13-1 and -2 are almost completely devoid of membrane-attached synaptic 
vesicles. Only one out of 15 tomograms harbored a total of three docked synaptic 
vesicles. Moreover, twelve synaptic profiles (80%) lacked both docked and closely 
tethered vesicles (0-4 nm). In comparison to control synaptic profiles, the numbers of 
membrane-attached (0-2 nm) and closely tethered (0-4 nm) synaptic vesicles were 
reduced to 4% and 11%, respectively. These findings are in line with previously published 





analyses of synaptic vesicle docking in C. elegans and mouse neurons in the absence of 
UNC-13/Munc13s (Gracheva et al., 2006, 2010; Siksou et al., 2009; Weimer et al., 2006). 
The remaining membrane-attached vesicles seen in the single tomogram may have been 
primed by an alternative priming mechanism. Munc13-independent priming has been 
reported in the mouse neuromuscular junction and in retina photoreceptor ribbon 
synapses, where synaptic vesicle priming and neurotransmitter release occurs even in the 
absence of Munc13 proteins (Cooper et al., 2012; Schmitz et al., 2001; Varoqueaux et al., 
2005). However, no obvious morphological differences, indicative of a non-glutamatergic 
synapse, were observed in comparison to the remaining tomograms. Another explanation 
for the remaining docking could be the presence of an alternative Munc13 isoform in the 
imaged synapse. Munc13-3 mRNA has been detected by in situ hybridization in the 
mouse hippocampus. However the presence of Munc13-3 proteins in the hippocampus 
could not be demonstrated by Western blot analysis (Augustin et al., 1999b). 
Recently, a study employing cryo-electron tomography on purified synaptosomes of 
RIM1 KO mice, a well-established component of the active zone cytoskeleton and an 
interaction partner of Munc13-1 and ubMunc13-2, reported that RIM1 might have a 
critical role in synaptic vesicle docking (Fernández-Busnadiego et al., 2013). As 
mentioned above, docked synaptic vesicles appeared to be in close proximity (<5 nm) to 
the plasma membrane in cryo-electron tomograms and to exhibit multiple short tethers in 
this configuration (Fernández-Busnadiego et al., 2010). In RIM1 KO mice, five out of 
nine tomograms exhibited a vesicle number comparable to wild-type levels within 45 nm 
of the active zone membrane (KO-aligned) whereas the remaining synapses showed a 
decrease in the number of these membrane-proximal vesicles (KO-altered). Moreover, the 
number of synaptic vesicles within 5 nm of the plasma membrane was dramatically 
reduced, and KO-altered synaptic vesicles completely lacked multiple short tethers in the 
docked state. In addition to its roles in localizing Ca2+-channels to the active zone and in 
docking and priming synaptic vesicles in the vicinity of Ca2+-channels, Rim1 has been 
implicated in the trafficking of Munc13s to synaptic targets (Andrews-Zwilling et al., 2006; 
Betz et al., 2001; Han et al., 2011; Kaeser et al., 2011, 2012). Of note, RIM1α KO mice 
exhibit a 60% reduction of combined Munc13 protein levels, whereas the genetic ablation 
of multiple RIM isoforms (Rim1, Rim1, RIM2, RIM2 and RIM2) causes a reduction 
of Munc13 levels by 67% (Andrews-Zwilling et al., 2006; Deng et al., 2011; Kaeser et al., 
2011; Schoch et al., 2002). 
Consistent with these findings, Munc13 levels are also reduced in synaptosomes purified 
from RIM1 KO mice and quantitative analysis of immunofluorescence revealed a 
significant decrease in the frequency of colocalization between Munc13 and the active 





zone protein Bassoon (Fernández-Busnadiego et al., 2013). The described defects in 
vesicle priming and docking observed in RIM KO animals are therefore most likely 
attributable to reduced levels of Munc13s at the active zone. However, as it has been 
published previously, and has been demonstrated in the present study, loss of UNC-
13/Munc13 proteins causes an accumulation of synaptic vesicles close (8-10 nm), but not 
docked, to the active zone, explaining why the number of vesicles within 40 nm of the 
active zone membrane remains unchanged in Munc13-1/2 DKO synapses and a docking 
deficit could not have been detected in electron microscopic analyses using conventional 
chemical fixation (Gracheva et al., 2010; Siksou et al., 2009). The absence of a prominent 
membrane-proximal vesicle accumulation in 44% of RIM1 synaptosomes may indicate 
an additional, Munc13 independent role for RIM proteins in tethering vesicles close to 
release sites in a process upstream of docking/priming (Fernández-Busnadiego et al., 
2013). 
The molecular mechanism by which Munc13s dock/prime synaptic vesicles is not yet fully 
understood. The C-terminally located MUN domain present in all Munc13 isoforms 
includes two MHD domains and is considered essential for Munc13 priming activity (Basu 
et al., 2005; Stevens et al., 2005). The MUN domain mediates Munc13 binding to 
Syntaxin-1 and Munc13s could therefore induce a switch from the closed to an open 
Syntaxin-1 conformation, which would enable and/or accelerate SNARE complex 
nucleation (Betz et al., 1997; Ma et al., 2011, 2013; Sassa et al., 1999). Although the 
interaction between Munc13 and Syntaxin-1 is weak in comparison to the tight binding 
between Munc18-1 and Syntaxin-1, it can accelerate the transformation from Syntaxin-
1/Munc18-1 complexes to fully assembled SNARE complexes in in-vitro assays (Ma et al., 
2011, 2013; Sassa et al., 1999). The expression of a constitutively open form of UNC-64, 
the C. elegans homologue of Syntaxin-1, in the UNC-64/UNC-13 DKO background can 
rescue the massive deficits in neurotransmission and synaptic vesicle docking in cryo-
preserved samples observed in UNC-13 null mutants (Hammarlund et al., 2007; 
Richmond et al., 2001). Crossing the Munc13-1 KO mouse line with a knock-in mouse line 
that expresses the constitutively open form of Syntaxin-1, however, failed to rescue the 
perinatal lethality of Munc13-1 KO mice (Gerber et al., 2008). In C. elegans, loss of UNC-
18 or UNC-64 (Syntaxin-1) was described to result in a loss of docked and membrane-
proximal, or "tethered", synaptic vesicles in cryo-preserved samples, whereas UNC-
13/Munc13-deficient animals were still able to accumulate synaptic vesicles close to the 
release sites, but not to dock these at the membrane as confirmed in the present study 
(Gracheva et al., 2010). These findings indicate that Syntaxin-1/Munc18 interactions may 
tether vesicles close to the membrane, with Munc13s having a downstream role in 





synaptic vesicle docking, possibly by opening Syntaxin-1 for SNARE complex formation 
(Gracheva et al., 2010). However, due to the severe neurodegenerative phenotype of 
Munc18-1 KO mice, I could not perform a docking analysis of Munc18-1 KO synapses in 
my experimental setting. 
 
4.3.2.   CAPS 
 
Next, the role of CAPS proteins in synaptic vesicle docking was investigated by our high 
resolution three-dimensional EM approach. The ultrastructural analysis of synaptic vesicle 
docking revealed that 62% of the sampled synaptic profiles (12 out of 19 tomograms) 
were completely devoid of membrane-attached synaptic vesicles (0-2 nm). Moreover, 
58% of all CAPS-1/2 DKO synaptic profiles (11 out of 19 tomograms) also lacked vesicles 
closely tethered to the active zone membrane (0-4 nm). Electrophysiological analyses of 
autaptic neurons lacking both mammalian CAPS isoforms revealed that 38% of neurons 
measured were completely devoid of primed synaptic vesicles as determined by 
hypertonic sucrose application, whereas in the remaining 64% of the cells, the size of the 
RRP was decreased by 85% in comparison to controls (Jockusch et al., 2007). Due to the 
fact that only subvolumes of presynaptic terminals were tomographically reconstructed, it 
is likely that the number of neurons/synapses capable of priming synaptic vesicles is 
underestimated in the present study. In comparison to control synapses, in tomograms 
from CAPS-1/2 DKO synapses that still harbored membrane-attached synaptic vesicles, 
the number of docked (0-2 nm) and closely tethered (0-4 nm) vesicles was reduced by 
81% and 72%, respectively. The 81% reduction in morphological synaptic vesicle docking 
for CAPS DKO synaptic profiles correlates closely with the observed 85% reduction in the 
RRP size measured by hypertonic sucrose application in release-active autaptic neurons 
(Jockusch et al., 2007). These findings support the hypothesis that functional priming and 
morphological docking are correlates of the same molecular process. No significant 
changes in the basic synaptic morphology of CAPS-deficient neurons were observed, 
therefore an indirect effect of impaired LDCV release, is unlikely to account for the defect 
in synaptic vesicle release. In this context, my data also failed to reveal an accumulation 
of LDCVs in the presynaptic terminals of neurons lacking CAPS proteins, in contrast to 
what has been described for Drosophila neuromuscular junction synapses lacking CAPS 
(Renden et al., 2001). Renden et al., observed that, in addition to the defects observed in 
LDCV secretion, the release of glutamatergic synaptic vesicles at the neuromuscular 
junction was greatly impaired. Since the observed effects on synaptic vesicle release in 
CAPS mutants could be rescued by transgenic expression of rat CAPS in all neurons, but 





not in single motoneurons, the authors speculated that the presynaptic transmission deficit 
was an indirect consequence of the altered release of LDCV cargo (i.e. neuromodulators). 
One possibility to assess whether the observed defects in synaptic vesicle 
docking/priming are indeed indirect would be to analyze CAPS-1/2 DKO neurons in a 
micro-network cell culture system, in which neurons are spread in a slightly higher density 
as compared to the classical autaptic neuron culture, thus allowing two isolated neurons 
to form a combination of autaptic and interneural synapses on an astrocyte island (Liu et 
al., 2013). Similar to the single motoneuron-rescue experiments in Drosophila larvae by 
Renden et al., co-culturing of CAPS-1/2 DKO and wild-type neurons followed by paired 
recordings of autaptic and heterosynaptic responses after stimulation of the CAPS DKO 
cell could give an insight about possible pre- and postsynaptic effects caused by, for 
example, altered LDCV release from neighboring cells. 
Release from mammalian autaptic neurons with no, or dramatically reduced, RRP sizes 
was rescued by viral expression of CAPS-1 or high-frequency stimulation (Jockusch et al., 
2007). Moreover, Ca2+-uncaging in silent CAPS-1/2 DKO neurons revealed that CAPS 
deficient cells were able to release, albeit with a significant delay in comparison to control 
cells (Burgalossi et al., 2010). The latter finding indicates that an increase in intracellular 
Ca2+ can rescue synaptic transmission in CAPS1-/2 DKO neurons, indicating that the 
basic release machinery for synaptic vesicle release is functionally intact. Therefore CAPS 
may have an important function in vesicle priming at low Ca2+-concentrations, and 
elevations in residual intracellular Ca2+ resulting from high-frequency stimulation may 
overcome the CAPS1-/2 DKO phenotype via activation of for example Munc13 proteins, 
which possess multiple Ca2+-sensitive domains (C2B domain, Ca
2+-Calmodulin binding 
site) (Jockusch et al., 2007). In contrast to Munc13-1/2 DKO synapses, synaptic vesicles 
in CAPS-deficient terminals did not accumulate at a distance of 8-10 nm from the active 
zone membrane, but rather appeared to be randomly distributed within 40 nm from the 
active zone membrane. In chemically fixed CAPS-deficient cells, a slight, but not 
statistically significant, decrease in the number of docked vesicles was reported, a 
phenotype attributable to the absence of a membrane-proximal synaptic vesicle 
accumulation (Jockusch et al., 2007). The defect in synaptic vesicle docking in the 
absence of members of the CAPS family could indeed explain the delay in the response 
after Ca2+-uncaging, which likely reflects Ca2+-dependent priming and fusion of newly 
primed vesicles (Burgalossi et al., 2010). 
In addition to the effects of high Ca2+-concentrations on release in CAPS-1/2 DKO cells, 
neurons that exhibited no or dramatically reduced evoked release were found to be 
rescued by treatment with PDBu, a phorbol ester capable of activating Munc13 proteins 





and other proteins via their C1 domain. However, the exact nature of the relationship 
between Munc13 and CAPS proteins in synaptic vesicle priming has yet to be assessed 
experimentally as so far cross-rescue experiments overexpressing Munc13s in CAPS-
deficient cells, and vice versa, failed to rectify the deficit in synaptic vesicle release 
(Jockusch et al., 2007).  
The molecular mechanism underlying CAPS-dependent synaptic vesicle priming is not 
fully understood. CAPS stimulates formation of trans-SNARE complexes from Syntaxin-
1/SNAP25 acceptor and Synaptobrevin-2 donor liposomes in in vitro fusion assays 
(James et al., 2008, 2009, 2010). In these studies, acceleration of trans-SNARE complex 
formation was highly PIP2-dependent and required binding to Syntaxin-1. Recently it was 
shown that CAPS can bind the t-SNAREs SNAP25 and Syntaxin-1 with high affinity in the 
SNARE motif, but that it can interact with Synaptobrevin-2 only weakly at the N-terminus, 
which has been interpreted as a potential role of CAPS to promote N- to C-terminal 
SNARE complex zippering (Daily et al., 2010). The region that promotes SNARE-complex 
assembly corresponds to the MHD domain, which has been proposed to mediate the 
conformational switch from closed to open Syntaxin-1 (Khodthong et al., 2011). Recent 
evidence indicates that CAPS-1 preferentially binds the open form of Syntaxin-1 by 
targeting the full length of the cytoplasmic domain of Syntaxin-1, whereas Munc13-1 
interacts with the first 80 amino acid residues of Syntaxin-1, therefore binding the closed 
conformation of Syntaxin-1 (Parsaud et al., 2013). The authors argue that Munc13-1 
possibly opens Syntaxin-1, which becomes then stabilized by CAPS prior to SNARE 
nucleation, which is in line with previous publications proposing a sequential mode of 
action for Munc13s and CAPS proteins in secretory vesicle priming (Jockusch et al., 2007; 
Liu et al., 2010; Parsaud et al., 2013). LDCV release from mouse chromaffin cells lacking 
CAPS proteins is heavily impaired, however only minor changes in the number of docked 
vesicles had been observed for CAPS-1 KO cells and no differences to control cells for 
CAPS-1/2 DKO cells (Liu et al., 2010a; Speidel et al., 2005). Also overexpression of 
Munc13-1 in chromaffin cells did not change the number of morphologically docked 
LDCVs, but led to an increase in the measured RRP size (Ashery et al., 2000). 
Overexpression of a constitutive open form of Syntaxin-1 in CAPS-1/2 DKO chromaffin 
cells can rescue the reduced electrophysiologically assessed readily-releasable LDCV 
pool size (Liu et al., 2010). In C. elegans, open Syntaxin can rescue the LDCV docking 
deficits observed in UNC-31 (CAPS) and the synaptic vesicle docking and priming deficit 
described for UNC-13 KO worms (Hammarlund et al., 2007, 2008; Richmond et al., 2001). 
All these findings indicate that CAPS proteins have a role in secretory vesicle priming and 
that they are very likely to act in the same molecular pathway as Munc13s. 





In summary, the findings of the present study demonstrate that the observed defects in 
synaptic vesicle priming upon loss of the Munc13 and CAPS proteins correlate nicely with 
an inability to dock synaptic vesicles to the active zone membrane. Therefore functional 
synaptic vesicle priming and morphological synaptic vesicle membrane-attachment may 
indeed describe the same mechanism rendering synaptic vesicles fusion competent. In 
the following, I will therefore use the terms docking and priming interchangeably for 
describing the final membrane-attachment process that renders synaptic vesicles fusion-
competent (docking/priming).  
 
Figure 4.1. The synaptic vesicle cycle at excitatory synapses 
Synaptic vesicles are locally recycled in presynaptic terminals. Synaptic vesicles are filled with the 
neurotransmitter (here e.g. glutamate) (1) and translocated to the active zone. There, synaptic 
vesicles become potentially tethered to the plasma membrane (2) and undergo a Ca
2+
-regulated 
docking/priming process to acquire fusion-competence (3). In response to the arrival of an action 
potential and an increase in Ca
2+
-concentration, docked/primed synaptic vesicles can fuse with the 
plasma membrane (4) and release their neurotransmitter content into the synaptic cleft. 
Neurotransmitter molecules diffuse through the synaptic cleft to mediate receptor ion channel 
opening and allow ion influx generating an excitatory postsynaptic current (EPSC) (5). Synaptic 
vesicle membranes are recycled in a process called endocytosis (6). The best-described pathway 
is clathrin-mediated recycling, in which clathrin-coated vesicles bud off from the membrane, 
become uncoated and fuse with early endosomes (7). Kiss-and-run exocytosis and bulk membrane 
retrieval are possible alternative, clathrin-independent recycling routes. Schematic provided by Dr. 
B. Cooper; adapted from (Jahn and Fasshauer, 2012). 
  





4.4.  A role for all three neuronal SNAREs in synaptic vesicle docking and 
priming 
 
As discussed above, priming by Munc13s and CAPS proteins most likely involves 
interactions with Syntaxin-1 and/or the SNARE complex. Therefore, the individual 
SNAREs and/or trans-interactions between the v-SNARE Synaptobrevin-2 and the t-
SNAREs Syntaxin-1 and SNAP25 have long been predicted to function in synaptic vesicle 
priming or docking (Pevsner et al., 1994). 
Early studies using genetic knock-out strategies or proteolytic cleavage of SNARE 
proteins in neurons from different species including C. elegans, Drosophila, and mice 
revealed severe reductions in measured RRP sizes, but the number of membrane-docked 
synaptic vesicles was unchanged (Broadie et al., 1995; Deák et al., 2004; Gerber et al., 
2008; Hunt et al., 1994; de Wit et al., 2006). Since early studies on KO animals for UNC-
13/Munc13 priming proteins failed to reveal changes in the number of membrane-attached 
synaptic vesicles in neurons in chemically fixed EM samples, it was assumed that 
synaptic vesicle membrane-attachment might be a prerequisite for vesicle priming and 
fusion, but that docking alone is most likely not sufficient to render a vesicle fusion-
competent (Richmond et al., 1999; Varoqueaux et al., 2002). Based on this model, 
priming and SNARE complex nucleation were believed to occur in a post-docking step 
and most likely required the opening of UNC-64/Syntaxin-1 by members of the UNC-
13/Munc13 family (Richmond et al., 2001). Whether partial or full SNARE complex 
formation could indeed be the molecular basis of synaptic vesicle priming and whether a 
semi-zippered SNARE complex could be stabilized sufficiently prior to fusion in such a 
scenario has been often controversially discussed (reviewed in Jahn & Fasshauer 2012; 
Rizo & Südhof 2012). In the present study, I aimed to analyze the effects of genetic 
deletion of the neuronal SNARE proteins Syntaxin-1, SNAP25 and Synaptobrevin-2 on 
synaptic vesicle docking for the first time in the same experimental setting. It has been 
shown that the individual t- and v-SNARE molecules on opposing membrane bilayers start 
interacting with their SNARE motifs at a distance of 8 nm and SNARE zippering arrests at 
a distance of around 2-4 nm, with 2 nm being the thickness of the fully assembled SNARE 
bundle (Li et al., 2007; Poirier et al., 1998; Sutton et al., 1998). Förster resonance energy 
transfer (FRET) signal caused by SNARE complex assembly of t- and v-SNAREs during 
liposome fusion has been calculated to start at a distance smaller than 5 nm between 
membranes (van den Bogaart et al., 2011). With the combination of cryo-fixation, freeze-
substitution and electron tomography used in the present study, I was confident that it 
would be possible to resolve membrane distances smaller than 5 nm (See 4.1.2.). Indeed, 





in my high-resolution electron microscopy analysis of cryo-preserved samples, I found that 
all three neuronal SNARE proteins are involved in the synaptic vesicle docking process, 
since in the absence or upon reduced expression of the individual SNARE proteins, 
synaptic vesicles were greatly impaired in their ability to physically contact the active zone 
plasma membrane in excitatory synapses. Moreover, an accumulation of vesicles close to 
the plasma membrane, but not in direct contact with the active zone was detected in 
Synaptpbrevin-2 and SNAP25 KO neurons. These findings support the idea that synaptic 
vesicle docking/priming is mediated by Munc13 and CAPS proteins and involves (partial) 
SNARE complex assembly. 
 
4.5.   Loss of individual SNARE proteins can be partially compensated 
 
In the present study, I observed docking deficits for neurons lacking the individual SNARE 
proteins. The greatest reduction in synaptic vesicle membrane-attachment was observed 
for SNAP25 KO neurons. 13 out of 25 tomograms from SNAP25 KO synapses (52%) 
were completely devoid of membrane-attached vesicles (0-2 nm) with 7 out of 25 
tomograms (28%) lacking both, physically docked and closely tethered synaptic vesicles 
(0-4 nm). Synapses lacking SNAP25 showed a reduction in the numbers of membrane-
attached and closely tethered vesicles to 21% and 35% of controls, respectively. In low 
density cultures from SNAP25 KO neurons, cells degenerated during culturing, but 
survival was prolonged by plating cells at high densities. In such a continental culture 
setting, it has been described that 20-30% of SNAP25 KO neurons did not exhibit action 
potential- evoked release. In the remaining cells only very small EPSC amplitudes could 
be measured and spontaneous release and the RRP size probed by hypertonic sucrose 
solution was found to be reduced to 14% and 10% of controls, respectively (Bronk et al., 
2007).  
The fact that the pool of readily releasable fusion-competent and docked vesicles as 
described here are not completely absent, but rather reduced, raises the possibility that 
alternative SNARE proteins compensate for the loss of SNAP25 (Bronk et al., 2007). One 
such candidate SNARE molecule is SNAP23, a neuronally expressed SNAP25 
homologue capable of rescuing sucrose-evoked, but not synchronous action potential-
evoked, release in cultured hippocampal neurons (Delgado-Martínez et al., 2007). 
Recently, SNAP23 has been described to reside specifically in postsynaptic terminals, 
where it has a functional role in N-methyl-D-aspartate (NMDA) receptor exocytosis (Suh et 
al., 2010). Consistent with the findings of Suh et al., no specific co-localization was 





detected between the glutamatergic vesicle marker VGLUT1 and SNAP23, which 
appeared rather in apposition to excitatory terminals in organotypic hippocampal slices. 
Based on its localization, it is unlikely that SNAP23 can compensate for SNAP25 and 
account for the remaining docked vesicles observed in SNAP25 KO synapses. Other 
possible candidates and SNAP25 homologues that are expressed in the brain are 
SNAP29 and SNAP47 (Holt et al., 2006; Steegmaier, 1998). SNAP29 lacks the 
membrane anchor present in SNAP25 and SNAP23, but is present on multiple 
membranes and can bind to a broad range of Syntaxins, including Syntaxin-1A 
(Steegmaier, 1998). SNAP29 has, however, been proposed to function as an inhibitor of 
synaptic transmission (Pan et al., 2005). SNAP47 also lacks a membrane anchor, but is 
enriched on intracellular membranes and can form SNARE complexes with 
Synaptobrevin-2 and Syntaxin-1 to mediate proteoliposome fusion in vitro (Holt et al., 
2006). More recently, SNAP-47 has been described to function in postsynaptic AMPA (α-
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor exocytosis during long-
term potentiation (Jurado et al., 2013). It would be interesting to investigate whether 
changes in the expression level or localization of these alternative SNAP25 homologues 
might explain the residual synaptic vesicle docking and neurotransmitter release in 
SNAP25 deficient cells. 
In comparison to controls, Syntaxin-1A / Syntaxin-1BYFP neurons exhibited a reduction in 
the numbers of membrane-attached (0-2 nm) and closely tethered (0-4 nm) vesicles by 
38% and 35%, respectively. Previous electrophysiological analyses in hippocampal 
autaptic neurons of these mutant had revealed a 65% reduction of the RRP size and an 
80% reduction of EPSC size compared to controls (Arancillo et al., 2013). In comparison 
to the severe electrophysiological deficits in terms of the number of primed synaptic 
vesicles, I only detected milder effects on the number of membrane-attached synaptic 
vesicles. This discrepancy can most likely be attributed to the differences in the culture 
system, since organotypic slices were cultured for up to five weeks in a dense neuronal 
network, which is considerably longer than is possible with autaptic cell cultures. It is likely 
that during this extended culture period, compensatory, likely activity-dependent effects 
result in stabilization of the remaining Syntaxin-1BYFP molecules, potentially via cell 
homeostatic mechanisms functioning to protect Syntaxin-1BYFP from degradation. A recent 
study suggested that expression of Syntaxin-2, -3 and -4, which are BoNT/C resistant, can 
rescue neuronal cell death induced by proteolytic cleavage of Syntaxin-1 (Peng et al., 
2013). However, attempts to culture Syntaxin-1A/B DKO neurons in an organotypic slice 
culture system failed in my hands and neurons from this genotype died within the first 





couple of days, indicating that most likely no other Syntaxin isoform can compensate for 
the loss of Syntaxin-1 in neurons in culture. 
The analysis of synaptic vesicle docking in Synaptobrevin-2 KO neurons revealed 
reductions in the numbers of membrane-attached (0-2) and closely tethered (0-4 nm) 
vesicles by 33% and 43%, respectively, compared to control samples. In a mass culture 
system, all Synaptobrevin-2 KO neurons were described to be able to release. However, 
evoked and spontaneous release were strongly impaired and the RRP size measured 
after hypertonic sucrose application was reduced to 10% of control levels (Schoch et al., 
2001). Here, it was noticed that 33% of Synaptobrevin-2 KO synapses seemed to be less 
affected by the loss of the v-SNARE, since they exhibited comparable numbers of 
membrane-attached synaptic vesicles as control synapses, whereas the numbers of 
membrane-attached and closely-tethered vesicles in the remaining KO synapses were 
reduced by 95%. By immunohistochemical stainings, I demonstrated that Synaptobrevin-
1, another Synaptobrevin isoform expressed in the brain (Takamori et al., 2006), has been 
upregulated in glutamatergic synapses in comparison to control slices. In a previous 
study, Synaptobrevin-1 was not detected by Western blot analysis in P0 Synaptobrevin-2 
KO mouse brain homogenates (Schoch et al., 2001). However, in situ hybridization 
experiments mapping the developmental pattern of Synaptobrevin-1 expression in the 
hippocampus have demonstrated that this Synaptobrevin isoform is first expressed at 
around P14 (Allen Developing Mouse Brain Atlas). In the present study, a striking 
increase in the number of glutamatergic synapses that exhibited Synaptobrevin-1 
immunoreactivity from 8% in control to 36% in Synaptobrevin-2 KO organotypicic slices 
was demonstrated. This finding was compelling, since control samples expressed 
Synaptobrevin-1 preferentially at non-glutamatergic synapses, with the majority of 
Synaptobrevin-1 puncta not colocalizing with VGLUT1. The presence of Synaptobrevin-1 
in 36% of all glutamatergic synapses correlated well with the observation that 33% of the 
analyzed tomograms exhibited normal synaptic vesicle docking. It can therefore be 
postulated that loss of Synaptobrevin-2 is at least partially compensated for by an 
upregulation of Synaptobrevin-1. The question as to whether Synaptobrevin-1 can rescue 
the physiological deficits observed in Synaptobrevin-2 KO neurons has not previously 
been addressed to my knowledge. However, it was not possible to detect Synaptobrevin-1 
in all glutamatergic terminals, explaining the presence of Synaptobrevin-2 KO synapses 
that harbored only very low numbers of docked synaptic vesicles. It cannot be excluded 
that additional Synaptobrevin homologues may also compensate for the loss of 
Synaptobrevin-2. A promising candidate is VAMP7, a tetanus toxin-insensitive 
Synaptobrevin-2 homologue that has been shown to reside in presynaptic terminals in the 





brain, e.g. in the hippocampal mossy fiber synapses, and has been implicated in 
asynchronous synaptic vesicle release (Hua et al., 2011b; Muzerelle et al., 2003; 
Scheuber et al., 2006).  
In conclusion, the presence of a small pool of docked synaptic vesicles in the absence of 
the major synaptic SNARE molecules could be attributed to a compensatory effect by 
other SNARE isoforms or homologues. Above all, the majority of SNAP25 KO neurons 
have been shown to degenerate in culture, indicating that survival of the remaining 
neurons depends on an alternative SNARE isoform. Indeed, such a compensatory effect 
appears to operate in Synaptobrevin-2 deficient samples, in which an upregulation of 
Synaptobrevin-1 can rescue normal vesicle docking in a subset of glutamatergic 
synapses.  
 
4.6.  Increased vesicle sizes do not cause the deficiency in synaptic 
vesicle membrane-attachment 
 
In the present study, a significant increase in synaptic vesicle size was detected in 
Munc13-1/2, SNAP25 and Synaptobrevin-2 KO synapses, genotypes that also exhibited 
severe deficits in synaptic vesicle membrane-attachment. To address the possibility that 
synaptic vesicle docking at the active zone is inhibited as a consequence of increased 
vesicle size, the vesicle diameters of membrane-attached synaptic vesicles in KO 
genotypes were measured and compared to those in respective controls. Thereby it could 
be confirmed that synaptic vesicles of a larger diameter were still able to reach the active 
zone membrane in all three mentioned genotypes. Moreover, analysis of synaptic vesicle 
sizes in Synaptobrevin-2 KOPlus (normal docking) and KOMinus synapses (reduced docking) 
revealed that both groups exhibited significant increases in synaptic vesicle volumes. 
Since previous work has shown that short-term treatment of rat synaptosomes with 
tetanus toxin results in smaller synaptic vesicle sizes, the observed increases in vesicle 
size observed in the present study are likely a consequence of altered membrane-
trafficking caused by the permanent block of release (Fernández-Busnadiego et al., 
2010). Docking intermediates formed by large liposomes in in vitro assays have been 
found to be more stable than those of smaller liposomes (Hernandez et al., 2012). If the 
increased synaptic vesicle size displayed by Munc13-1/2 DKO, SNAP25 KO and 
Synaptobrevin-2 KO mutants had a negative impact on the fusogenicity of synaptic 
vesicles, an accumulation, rather than depletion, of docked/primed vesicles at the active 
zone membrane would be expected, in direct contrast to the results of the present study. 





4.7.   Can trans-SNARE complexes be stabilized in vivo? 
 
Based on my data, it can be concluded that the neuronal SNARE proteins play an integral 
role in synaptic vesicle docking/priming in neurons. The findings presented in this study 
are important in the context of the ongoing discussion whether stable completely or 
partially assembled trans-SNARE complexes exist prior to vesicle fusion (reviewed in 
Jahn and Fasshauer 2012; Rizo and Südhof 2012). 
Central to this discussion is the problem that trans-SNARE complexes seem to be difficult 
to capture and to stabilize in vitro. Studies that used reconstituted SNARE complex 
formation assays led to a model according to which the two t-SNAREs Syntaxin-1 and 
SNAP25 form a highly reactive intermediate acceptor complex on the membrane prior to 
Synaptobrevin-2 engagement and full SNARE complex assembly (Fasshauer and 
Margittai, 2004; Pobbati et al., 2006). This t-SNARE acceptor complex has to be stabilized 
in vitro to prevent it from forming a dead-end complex, which results from the interaction 
of two SNARE motifs from two Syntaxin-1 molecules and two SNARE motifs from one 
SNAP25 molecule. Rendering a stable Syntaxin-1/SNAP25 (1:1) complex in vitro can be 
achieved after the addition of a Synaptobrevin-2 peptide that is comprised of the C-
terminal part of the SNARE motif, but lacks its N-terminus (N) (Hernandez et al., 2012). 
There is, however, evidence from liposome and single vesicle fusion assays that indicates 
that different SNARE-mediated docking and fusion intermediates can be distinguished 
and that trans-SNARE complexes may be stabilized prior to membrane fusion (Bowen et 
al., 2004; Cypionka et al., 2009; Kyoung et al., 2011).  
A more physiological approach to demonstrate experimentally the relationship between 
the physiological priming step and molecular SNARE interactions was undertaken by 
Sørensen and colleagues (Sørensen et al., 2006; Walter et al., 2010; Weber et al., 2010; 
Wiederhold et al., 2010). In these studies, mutations were introduced at different positions 
within the SNARE motifs of SNAP25 and Synaptobrevin-2 and the physiological effects 
were tested by overexpression of the respective constructs in chromaffin cells and/or 
neurons from respective null mutants. The authors consistently demonstrated that 
prevention of C-terminal SNARE zippering, by mutation of amino acid residues in the last 
hydrophobic C-terminal layers of the SNARE motif, decreases the ability of membranes to 
fuse both in vitro and in vivo. Abolishing N-terminal SNARE interactions, however, 
diminished the secretory vesicle priming efficiency in chromaffin cells with only minor 
effects in neurons. In this model, N-terminal interactions of the SNAREs define the primed 
synaptic vesicle state, whereas full C-terminal SNARE zippering is required for triggering 





membrane fusion. These findings imply that stable partially N-terminal assembled SNARE 
complexes might indeed underlie the primed synaptic vesicle state. A recent study using 
the Synaptobrevin-2 C-terminal residue deletion mutant 84 in a liposome fusion assay 
demonstrated that liposome docking, defined by direct bilayer-bilayer contact, was 
unaffected in cryo-electron micrographs, whereas fusion was greatly abolished in vitro 
(Hernandez et al., 2012). The fact that N-terminal SNARE interactions allow vesicle 
priming (Sørensen et al., 2006; Walter et al., 2010; Weber et al., 2010; Wiederhold et al., 
2010) and docking (Hernandez et al., 2012) supports the hypothesis that partial SNARE 
assembly underlies the docked vesicle state.  
Taken together, there is evidence to support the hypothesis that stable neuronal trans-
SNARE complexes exist at an intermediate step prior to vesicle fusion. Consistent with 
this view, my data demonstrate a loss of membrane-attached synaptic vesicles within 0-4 
nm of the active zone membrane in SNARE-deficient neurons. The finding that 
interruption of SNARE zippering at the level of the last hydrophobic layers preceding the 
linker to the TMRs arrests vesicles in a primed/docked state, but prevents membrane 
fusion, appears to strengthen the validity of this model. It is therefore very likely that 
(partial) SNARE complex assembly is the molecular mechanism underlying synaptic 
vesicle docking and priming. 
 
4.8.  Can partially assembled trans-SNARE complexes be stabilized by 
Synaptotagmin-1 or Complexins? 
 
In the present study, it was demonstrated that Munc13 and CAPS proteins prime synaptic 
vesicles by enabling them to dock to the plasma membrane in a SNARE-dependent 
manner. In this docked/primed and fusion-competent synaptic vesicle state, neuronal 
SNARE proteins possibly form (partially) assembled SNARE complexes in order to secure 
fast C-terminal SNARE motif zippering in the presence of Ca2+ to trigger membrane 
fusion. In vitro, stabilization of the Syntaxin-1/SNAP25 (1:1) acceptor complex can be 
achieved by the presence of the Synaptobrevin-2 N, which will bind to the C-terminal 
SNARE motives of SNAP25 and Syntaxin-1, but leaves a free N-terminal binding site for 
full length Synaptobrevin-2 (Hernandez et al., 2012). Upon full-length Synaptobrevin-2 
engagement, zippering of the SNARE complex has been shown to slow down during the 
replacement of the first N-terminal layers of Synaptobrevin-2 N, but then rapidly resume 
towards the C-terminus (Hernandez et al., 2012). Whether, and if so, how partially 
assembled SNARE complexes are stabilized in vivo remains unclear.  





Prime candidates for performing such a role are Synaptotagmin-1 and Complexins, based 
on their ability to interact with the SNARE complex. Complexins can bind via a central α-
helix to the assembled SNARE complex in a groove formed by the SNARE motifs of 
Syntaxin-1 and Synaptobrevin-2 (Chen et al., 2002). Previous analyses from Complexin-
1/2 DKO and Complexin-1/2/3 TKO mice revealed a reduction in evoked release, but no 
corresponding changes in RRP size, thus resulting in a decreased vesicular release 
probability (Reim et al., 2001; Xue et al., 2007, 2008).  
Moreover, genetic deletion of the major mouse Complexin isoforms had no impact on the 
mEPSC frequency in these studies. Based on these findings, it has been proposed that 
binding of Complexins to the SNARE complex might facilitate synaptic vesicle release 
(reviewed in Brose 2008). In the present study, Complexin-1/2/3 TKO neurons exhibited 
no significant changes in the number of membrane-attached synaptic vesicles in 
comparison to controls, correlating well to the unaltered RRP sizes measured 
electrophysiologically (Reim et al., 2001; Xue et al., 2007, 2008). However, recent studies 
described a decrease in the RRP and EPSC size and a massive increase in the mEPSC 
frequency after lentiviral knock-down of Complexins in mammalian mass neuron culture 
systems, prompting the authors to propose that Complexins function to clamp synaptic 
vesicles in a primed state prior to fusion, potentially by stabilizing SNARE complexes (Cao 
et al., 2013; Kaeser-Woo et al., 2012; Tang et al., 2006; Yang et al., 2010). This model is 
supported by data obtained from C. elegans Complexin null mutants, which revealed a 
severe reduction in evoked release and in the number of docked vesicles, a phenotype 
most likely explained by an increase in spontaneous fusion events in the absence of 
inhibitory clamping-functions (Hobson et al., 2011). The discrepancy between knock-down 
and the full knockout approaches can be explained by the introduction of a compensatory 
mechanism, that arises in response to long-term loss of Complexins, and ultimately 
reduces vesicular release probability in order to compensate for the absence of a fusion-
clamp and to provide a stable pool size. Alternatively, the knock-down approach could 
introduce false effects by inducing off-target effects of the RNAi, or a transient 
upregulation, or stabilization, of other molecular components of the release machinery to 
compensate for the decrease in neurotransmission caused by the loss of Complexins, 
thus explaining the increased mEPSC frequency. Moreover it has been shown that the 
increase in mEPSC frequency is highly Ca2+-dependent, allowing the possibility that 
differences between the knock-down and knockout approach might be related to 
differences in Ca2+-concentrations used between studies (Neher, 2010; Yang et al., 2010). 
It is becoming increasingly evident that different functional domains of Complexins could 
mediate a subtle interplay between facilitory and inhibitory effects on release (Cho et al., 





2010; Li et al., 2011; Xue et al., 2007, 2009, 2010). However, my data clearly support a 
facilitatory role for Complexins in neurotransmitter release, since an inhibitory clamping 
function would potentially result in a decrease in the number of membrane-attached 
synaptic vesicles as observed in C. elegans (Hobson et al., 2011).  
Synaptotagmin-1 has also been proposed to function in clamping synaptic vesicles, either 
alone, or in concert with Complexins, in addition to its role as Ca2+-sensor for release. In 
mass, micronetwork or organotypic slice cultures, Synaptotagmin-1 KO neurons exhibit an 
increase in the mEPSC and mIPSC frequency (Kerr et al., 2008; Liu et al., 2009; Xu et al., 
2009). However, in autaptic neurons, such an increase has not yet been detected 
(Geppert et al., 1994; Liu et al., 2009). In various experimental settings, the genetic 
deletion of Synaptotagmins results in small, but rarely significant, decreases in the RRP 
size as measured by application of hypertonic sucrose solution or by Ca2+-uncaging 
(Burgalossi et al., 2010; Geppert et al., 1994; Jorgensen et al., 1995; Liu et al., 2009; 
Tang et al., 2006; Xu et al., 2009). In the present study, a decrease in the number of 
membrane-attached synaptic vesicles was detected in Synaptotagmin-1 KO synapses, 
indicating a reduction in the RRP of fusion-competent synaptic vesicles. A decrease in the 
number of membrane-proximal (0-40 nm) synaptic vesicles was detected whereas the 
general distribution of synaptic vesicles in the terminal appeared unchanged. Based on 
these findings, it cannot be excluded that Synaptotagmins may play a regulatory role in 
clamping synaptic vesicles prior to release, since an increase in spontaneous release 
would likely be observed as a decrease in the number of docked/functionally primed 
synaptic vesicles at any given point in time as it has been described for C.elegans 
Complexin null mutants (Hobson et al., 2011). However, the molecular mechanism 
underlying such a clamping function has yet to be solved. 
 
4.9. A regulatory, but not essential role of Synaptotagmin-1 in synaptic 
vesicle docking/ priming 
 
The precise molecular function of Synaptotagmin-1 prior to, or during, Ca2+-triggering has 
not yet been fully understood. However, two different models have recently been 
proposed (reviewed in Jahn and Fasshauer, 2012; Vennekate et al., 2012). Firstly, 
Synaptotagmin-1 could modulate synaptic vesicle priming prior to Ca2+-evoked fusion by 
stabilizing partially assembled SNARE complexes, thereby acting as a fusion clamp by 
preventing full SNARE complex assembly (See 4.8.). According to this model, 
Synaptotagmin-1 would respond to increases in intracellular Ca2+-concentrations by 





triggering C-terminal zippering of the SNARE complex by either (1) displacing Complexins 
from the partially assembled SNARE complex, (2) unclamping the SNARE complex, or (3) 
binding to the plasma membrane in trans, thereby destabilizing the bilayer and potentially 
inducing positive membrane curvature to help to overcome the energy barrier for fusion 
(Hui et al., 2009; Martens et al., 2007; Radhakrishnan et al., 2009). This model, which 
assumes at least partial SNARE complex assembly in the docked/primed synaptic vesicle 
state prior to synaptic vesicle fusion, is supported by the findings presented in this study. 
Since all three components of the neuronal SNARE complex are required for efficient 
synaptic vesicle docking/priming, it can be concluded that trans-SNARE interactions prior 
to vesicle fusion are likely to form the molecular basis of synaptic vesicle docking. In the 
present study, it is demonstrated that in Synaptotagmin-1 KO neurons, synaptic vesicle 
docking in glutamatergic synapses is only slightly reduced. Moreover, the general 
distribution of synaptic vesicles is unaffected by the loss of Synaptotamin-1 KO and the 
vast majority of the vesicles within 40 nm of the active zone still reside in physical contact 
with the plasma membrane. However, the observed decrease in the number of membrane 
proximal vesicle numbers appears compatible with Synaptotagmin-1 performing a 
clamping function. Taken together, these findings indicate that Synaptotagmin-1, though 
not essential for synaptic vesicle docking/priming in neurons, might perform a regulatory 
function in this process. 
A second alternative model has recently been proposed according to which 
Synaptotagmin-1 performs an essential role in tethering/docking synaptic vesicles to the 
plasma membrane prior SNARE complex assembly (van den Bogaart et al., 2011; Jahn 
and Fasshauer, 2012; Vennekate et al., 2012). Ca2+-triggering by Synaptotagmin-1 would 
then result in Ca2+-dependent penetration of Synaptotagmin-1 into the plasma membrane, 
which would decrease the distance between the vesicle and plasma membrane bilayers, 
and would thereby bring t- and v-SNAREs into interactive range for SNARE complex 
formation. The docked/primed state of a synaptic vesicle would be defined by Ca2+-
independent Synaptotagmin-1 interactions with t-SNARE acceptor complexes and/or with 
PIP2 at the plasma membrane. Experimental support for this model comes mainly from in 
vitro studies. In the presence of Ca2+, a cytoplasmic stretch of Synaptotagmin-1 containing 
both C2 domains (C2A and C2B) can cluster liposomes at a distance of 3-5 nm measured 
after cryo-electron microscopy, which would correspond roughly to the calculated size of a 
single Ca2+-bound C2 domain oriented perpendicularly between the two membranes (e.g. 
vesicle and plasma membrane) (Araç et al., 2006; Seven et al., 2013). Recently, it was 
shown that Ca2+-unbound Synaptotagmin-1 could tether vesicles in a ~5-28 nm distance 
from the active zone membrane and in response to elevated Ca2+ levels reduce the 





vesicle distance to below 5 nm by Ca2+-dependent PIP2 interactions, triggering SNARE 
nucleation and subsequent membrane fusion (van den Bogaart et al., 2011). 
Studies assessing the role of Synaptotagmin-1 in secretory vesicle docking aimed at 
providing evidence for this alternative model in a more physiological environment often 
produced rather controversial results. In Drosophila and C. elegans neuromuscular 
junction synapses, the absence of Synaptotagmin-1 results in a dramatic reduction in the 
total number of synaptic vesicles and in fewer docked vesicles per terminal, whereas no 
effects on vesicle numbers or the RRP size were originally observed in mouse presynaptic 
terminals (Geppert et al., 1994; Jorgensen et al., 1995; Reist et al., 1998). Other studies, 
however, have reported that lack of Synaptotagmin-1 in C.elegans, Drosophila and mouse 
neurons causes a decrease in total presynaptic vesicle numbers in addition to a docking 
deficit, most likely as a result of impaired vesicle recycling (Liu et al., 2009; Reist et al., 
1998; Yu et al., 2013). In the present study, a slight decrease in the synaptic vesicle 
terminal and cluster density in synapses was observed, a potential result of altered 
membrane recycling in the absence of Synaptotagmin-1. However, in mammalian 
hippocampal culture systems lacking Synaptotagmin-1, hypertonic sucrose solution 
application or Ca2-uncaging experiments revealed little, or no, change in the measured 
size of the RRP, therefore questioning an essential role of Synaptotagmin-1 in the 
synaptic vesicle priming step (Burgalossi et al., 2010; Geppert et al., 1994; Jorgensen et 
al., 1995; Liu et al., 2009; Xu et al., 2009). One recent study indicated a decrease in the 
RRP size in Synaptotagmin-1 KO dissociated hippocampal neuron cultures, which was 
accompanied by a decrease in the number of synaptic vesicles in presynaptic terminals 
and in the number of morphologically docked vesicles after high-pressure freezing, freeze-
substitution and electron tomographic analysis (Liu et al., 2009). 
Another study has proposed that Synaptotagmin-1 might indeed function in LDCV docking 
in mouse chromaffin cells (de Wit et al., 2009). Previous work by de Wit and colleagues 
indicated that a reduction of Syntaxin-1 protein levels by proteolytic cleavage with BoNT/C 
coupled with a complete genetic KO of the Syntaxin-1 binding partner and key regulator of 
secretory vesicle release, Munc18-1, results in a robust LDCV docking-defect in 
chemically fixed chromaffin cells with corresponding reductions in the RRP size (Gulyás-
Kovács et al., 2007; Toonen et al., 2006; Voets et al., 2001; de Wit et al., 2006, 2009). 
Based on these findings, de Wit and colleagues tried to solve the molecular pathway 
underlying LDCV docking in chromaffin cells by performing cross-rescue experiments in 
mouse mutants, ultimately proposing a molecular scenario for secretory vesicle docking 
that argues against a role of the fully assembled SNARE complex in LDCV docking (de 
Wit et al., 2009). In this study, de Wit and colleagues observed, in addition to the docking 





defects upon Syntaxin-1 and Munc18-1 pertubation, a deficiency in LDCV docking in 
mutants lacking the second t-SNARE SNAP25, for which docking deficits were not 
previously reported, or the Ca2+-sensor Synaptotagmin-1 (Sørensen et al., 2003; de Wit et 
al., 2009). The conclusion of the authors was that SNAP25/Syntaxin-1 acceptor 
complexes on the plasma membrane act in concert with Synaptotagmin-1 on the vesicle 
surface to promote LDCV docking. Since Synaptobrevin-2 KO chromaffin cells failed to 
reveal a decrease in the number of docked LDCVs in previous studies, de Wit and 
colleagues proposed that SNARE complex formation occurs downstream of LDCV 
membrane-attachment (Borisovska et al., 2005; Gerber et al., 2008; de Wit et al., 2009). 
However, in contrast to neuronal synapses, which possess spatially and molecularly 
defined active zones, LDCV secretion from chromaffin cells is not restricted to specialized 
release sites, but rather occurs over the entire plasma membrane. As shown by de Wit 
and colleagues, loss of Munc18-1, Syntaxin-1, SNAP25 and Synaptotagmin-1 resulted in 
a loss of membrane-attached LDCVs as analyzed in two-dimensional electron 
micrographs after chemical and high-pressure freezing fixation (de Wit et al., 2009). 
However, in this study LDCVs did not only fail to dock to the plasma-membrane, but KO 
chromaffin cells exhibited also a change in the cumulative vesicle distribution within the 
first 100 nm of the plasma membrane, raising the possibility that the docking deficit might 
rather be a result of an inability of LDCVs to be transported and tethered to the plasma 
membrane. Moreover, a recent study using high-pressure freezing fixation for electron 
microscopic analysis of LDCV docking in PC12 cells revealed that proteolytic cleavage of 
Synaptobrevin-2 results in a decrease of membrane-attached LDCVs, with no major 
changes in the total number of vesicles close to the plasma membrane (Wu et al., 2012), 
whereas in contrast, genetic deletion of Synaptobrevin-2 in chromaffin cells has been 
previously shown to result in a significant increase in the number of LDCVs per chromaffin 
cell profile in electron micrographs and even in a slight, but not significant increase in the 
number of docked LDCVs (Gerber et al., 2008). 
It is very likely that the discrepancy between the data for LDCV docking in chromaffin cells 
and synaptic vesicle docking presented here arises from differences in sample 
preparation and in docking definitions applied between studies. To date, none of the 
studies analyzing LDCV docking in chromaffin cells have employed electron tomography 
to resolve fine differences in membrane distances between LDCVs and the plasma 
membrane, but rather focused on gross changes in the vesicle distribution throughout the 
cell. Following our model and taking in vitro data into account, it is possible that in 
chromaffin cells Synaptotagmin-1 has an important role in tethering LDCVs close to the 
plasma membrane (e.g. 5-28 nm) in a Ca2+-independent manner, e.g. by interactions with 





the t-SNARE acceptor complex or PIP2 in a process upstream of LDCV membrane-
attachment and SNARE-complex formation (van den Bogaart et al., 2011; de Wit et al., 
2009). This would explain the decrease in membrane-proximal LDCVs seen in SNAP25, 
Syntaxin-1 and Synaptotagmin-1 KO chromaffin cells and could also explain why the loss 
of Synaptotagmin-1 introduces a significant decrease in the number of membrane 
proximal (0-40 nm) synaptic vesicles in our experimental setting. In a second step, 
downstream of LDCV tethering, LDCVs might then become physically docked/primed to 
the plasma membrane as a result of SNARE complex formation. Due to the technical 
limitations imposed by chemical fixation and conventional two-dimensional electron 
microscopy, past studies investigating LDCV docking in chromaffin cells have been 
unable to resolve small (<5 nm) distances between vesicle and plasma membranes. This 
would explain why genetic deletion of CAPS and Synaptobrevin-2 in chromaffin cells 
introduces major physiological deficits in the RRP size, when so far no major reductions in 
the number of docked LDCVs have been described (Borisovska et al., 2005; Gerber et al., 
2008; Liu et al., 2008, 2010; Speidel et al., 2005). This argument is supported by the fact 
that proteolytic cleavage of the individual SNAREs in PC12 cells results in a docking 
deficit of LDCVs close to the membrane, with no changes in the LDCV distribution further 
away from the membrane analyzed after high-pressure freezing fixation (Wu et al. 2012). 
In the present study, an accumulation of LDCVs in presynaptic terminals of 
Synaptobrevin-2 KO synapses was detected, which was even more dramatic than that 
observed for SNAP25 and Syntaxin-1 deficient neurons. In these genotypes, LDCVs were 
able to come in close proximity to the plasma membrane (<40 nm), a phenomenon that 
was hardly ever observed in control synapses, but vesicles were never in physical plasma 
membrane contact. 
In summary, I propose that the following processes occur sequentially prior to vesicle 
fusion: (1) Ca2-independent interactions between Synaptotagmin-1 and the t-SNAREs 
SNAP25 and Syntaxin-1, possibly in a PIP2 dependent manner, tether secretory vesicles 
close to the plasma membrane (5-28 nm). This interaction, although potentially crucial for 
LDCV release in chromaffin cells, may be less critical in neuronal synapses due to the 
dense active zone protein network, which might be able to employ alternative 
mechanisms to tether vesicles close to the plasma membrane. Moreover, CAPS proteins 
might be involved in the first tethering step since KO mice lack a prominent accumulation 
of tethered vesicles close to the plasma membrane. (2) In this membrane-proximal state 
of vesicles, members of the Munc13 and/or CAPS protein family can prime synaptic 
vesicles for fusion by initiating or accelerating SNARE complex assembly. The 
interactions between t- and v-SNAREs in trans requires vesicles to be within 5 nm of the 





plasma membrane, therefore physiologically primed vesicles appear as membrane-
attached or docked. At this stage, Synaptotagmin-1 interactions with the SNARE complex 
might have a role in clamping vesicles in a release-competent state prior to fusion and 
Complexins might stabilize partially-assembled SNARE-complexes to secure a fast 
response after the arrival of an action potential. (3) Ca2-triggering would then be mediated 
by Synaptotgamin-1, which could act by destabilizing the membranes, by inducing 
membrane curvature to trigger fusion or by displacing another fusion clamp to initiate and 
synchronize full zippering of multiple SNARE complexes.  
Essentially, the data presented in this study support a model according to which synaptic 
vesicles require trans-SNARE interactions for membrane-attachment. Synaptotagmin-1 
might have an upstream regulatory or tethering function in this process. This model does 
not differ by much from the mechanism proposed by Mohrmann and Sorensen (2012), 
according to which Synaptotagmin-1/t-SNARE interactions "dock" synaptic vesicles to the 
plasma membrane and Munc13s can then "prime" vesicles to initiate SNARE complex 
formation. As it was demonstrated here, priming by Munc13s and CAPS proteins results 
in final membrane-attachment (<5 nm), which was termed "docking" and whose detection 
requires cryo-fixation and high-resolution three-dimensional electron microscopy 
techniques. Loss of Munc13s, SNAP25 and Synaptobrevin-2 causes a severe 
accumulation of vesicles close to the plasma membrane, possibly "tethered" to the 
release site by interactions with the active zone cytoskeleton in proximity of the membrane 
(5-10 nm). The initiation of this tethering could be performed by Synaptotagmin-1, since 
Ca2+-unbound Synaptotagmin-1 has been shown to tether liposomes within this range (i.e. 
5-28 nm) (van den Bogaart et al., 2011). 
 






Figure 4.1. Molecular mechanisms of synaptic vesicle docking/priming 
A sequential model of synaptic vesicle membrane interactions at the active zone. In wild-type 
synapses, RIM proteins might initiate tethering of synaptic vesicles close to the plasma membrane 
(Fernández-Busnadiego et al., 2013). CAPS and/or Synaptotagmin-1 (dark green) could mediate 
this synaptic vesicle tethering step via Ca
2
-independent, PIP2-dependent interactions with the 
plasma membrane (grey circle) and/or the t-SNARE acceptor complex (not shown). Munc13 and 
CAPS initiate docking/priming of synaptic vesicles in a final membrane-attachment process. The 
synaptic vesicle docking/ priming step depends on the individual neuronal SNARE proteins 
Synaptobrevin-2 (blue), Syntaxin-1 (light green), SNAP25 (red) and possibly requires at least 
partial SNARE complex formation. Synatptotagmins and Complexins might stabilize partially-
arrested SNARE complexes prior to fusion. Model is not drawn to scale. Molecule schematics are 
taken from Jahn and Fasshauer 2012. 
 
4.10. Enlarged synaptic vesicles in Synaptobrevin-1, SNAP25 and Munc13 
 KO synapses 
 
Throughout the study, I noticed a significant increase in the vesicle diameter in synapses 
lacking either Munc13 proteins, or the SNARE proteins Synaptobrevin-2 or SNAP25. This 
increase in the vesicle size assessed by three-dimensional analysis of electron 
tomograms was accompanied by an accumulation of large vacuolar endosomal structures 
in two-dimensional electron micrographs in the aforementioned genotypes. Moreover, 
synapses from Syntaxin-1A / Syntaxin-1BYFP samples exhibited more endosomes per 
synaptic profile, despite normal synaptic vesicle sizes. The latter discrepancy is likely due 
to the fact that I was not investigating a full Syntaxin-1A/B DKO, but was rather studying a 
reduction in Syntaxin-1 levels in hypomorphic conditions. In SNAP25 and Synaptobrevin-2 





KO slices, I detected an increase in the size of VGLUT1 positive puncta, which might be 
associated to the respective increase in the measured synaptic vesicle volumes for these 
genotypes. The increase in vesicle size is unlikely to result from an increase in vesicular 
neurotransmitter content, since the mEPSC amplitudes were unchanged, or even slightly 
decreased, in Synaptobrevin-2 and SNAP25 KO mice, respectively (Bronk et al., 2007; 
Schoch et al., 2001). However, recent data implicating SNARE proteins in postsynaptic 
receptor trafficking/exocytosis emphasize the need for caution when estimating vesicular 
quantal sizes by analysis of mEPSCs in SNARE-deletion mutants (Jurado et al., 2013). 
Indeed, it is likely that the observed increases in vesicle size are correlated to altered 
presynaptic membrane recycling in the absence of synaptic vesicle fusion. This coupling 
of exo-and endocytotic processes is thought to be largely Ca2+ and SNARE protein 
dependent (Deák et al., 2004; Hosoi et al., 2009; Koo et al., 2011; Peng et al., 2013; Wu 
et al., 2009; Xu et al., 2013). Early studies proposed that Synaptobrevin-2 could be 
involved in a fast endocytosis process in hippocampal synapses, since genetic deletion of 
Synaptobrevin-2 causes an increase in synaptic vesicle sizes (Deák et al., 2004). The 
observed defects in endocytosis are most likely caused by an inability of Synaptobrevin-2 
to interact normally with its endocytic adaptors AP180 and clathrin assembly lymphoid 
myeloid leukemia (CALM). AP180 KO mice exhibited retention of Synaptobrevin-2, but not 
VGLUT1, in the plasma membranes and an increase in synaptic vesicle sizes comparable 
with that observed in Synaptobrevin-2 KO synapses in the present study (Koo et al., 
2011).  
SNAP25 and Syntaxin-1 were shown to interact with intersectin and dynamin, 
respectively, both molecules involved in synaptic membrane recycling (Galas et al., 2000; 
Okamoto et al., 1999). A recent study proposed a mechanism according to which the 
observed cell death after genetic deletion or proteolytic cleavage of Syntaxin-1 and 
SNAP25 is most likely caused by a defect in t-SNARE dependent membrane recycling 
processes rather than by the defects observed in exocytosis (Peng et al., 2013). 
Interestingly, a SNAP25 knock-in mouse line carrying a mutation that abolishes protein 
kinase C-dependent phosphorylation of SNAP25 (SNAP25S187A) results in a reduction of 
presynaptic SNAP25 levels accompanied by a significant increase in the size of 
glutamatergic terminals in the striatum as assessed by VGLUT1 immunolabeling and 
electron microscopy (Nakata et al., 2012). Moreover, these mice commonly exhibited 
seizures and neurons with the knock-in mutation presented an accumulation of α-
Synuclein in presynaptic terminals, a feature associated with a range of 
neurodegenerative diseases (α-Synucleinopathies), including Parkinson's disease. 
Interestingly, these α-Synuclein accumulations seem to reside at the periactive zone, a 





canonical site of endocytosis, indicating a relationship between altered endocytosis and 
SNAP25 expression levels in the synapse (Nakata et al. 2012). Taken together, the data 
presented here support the hypothesis that SNAP25 plays a role in presynaptic 
membrane recycling. 
In the Calyx of Held synapse, a large, highly specialized synapse in the auditory pathway, 
exo- and endocytosis can be monitored by membrane capacitance measurements made 
at the presynaptic terminals (reviewed in Schneggenburger and Forsythe 2006). During 
high synaptic activity, e.g. upon by high-frequency stimulation, the pool of fusion-
competent vesicles has to be constantly refilled while action potential-triggered fusion 
remains ongoing. The rate of this constant refilling of the RRP has been shown to be 
diminished when endocytosis is pharmacologically blocked or when the SNARE proteins 
Synaptobrevin, SNAP25 and Syntaxin were proteolytically cleaved (Hosoi et al., 2009; Xu 
et al., 2013). One interpretation of these findings was that the rate of RRP refilling is most 
likely not limited by the number of presynaptic vesicles present, but rather by the speed by 
which key players of the molecular release machinery (i.e. SNAREs, Synaptotagmins, and 
vesicular neurotransmitter transporter) can be cleared from active zone release sites 
and/or recycled into release-competent synaptic vesicles (Hosoi et al., 2009). 
The 28% increase in vesicle volume observed in Munc13-1/2 DKO samples is more 
difficult to explain, since so far no defects in endocytosis have been observed in these 
mice (Varoqueaux et al., 2002). Synapses lacking all Munc13 isoforms are completely 
silent, therefore exo-endocytosis coupling cannot be measured by capacitance 
measurements or by stimulation of FM dye uptake into vesicles. One possible explanation 
for the observed increase in synaptic vesicle volume could be that a constant block of 
neurotransmitter release prevents important vesicular proteins (i.e. Synaptotagmin-1, 
Synaptobrevin-2) needed for endocytosis from ever reaching the plasma membrane, a 
hypothesis which would be difficult to test experimentally in Munc13-1/2 DKO mice that 
die at birth and whose neurons are completely silent (Diril et al., 2006; Koo et al., 2011; 
Varoqueaux et al., 2002). However, it has been proposed that in hippocampal and Calyx 
of Held synapses, an increase in Ca2+-concentrations not only triggers release, but also 
endocytosis of a "readily-retrievable pool" of vesicles (Hua et al., 2011a; Wu et al., 2009). 
In the Calyx of Held, the Ca2+-dependence of endocytosis has been linked to Calmodulin, 
a Ca2+-dependent regulator of Munc13s (Wu et al., 2009). Indeed, Calmodulin inhibitors 
induce a defect in RRP refilling, which may be attributable to a slower rate of endocytosis 
(Sakaba and Neher, 2001; Wu et al., 2009). Interestingly, a recently published mouse line 
expressing a Ca2+-Calmodulin insensitive Munc13-1 variant exhibited a comparable 
decrease in the rate of synaptic vesicle replenishment into the RRP during high activity in 





the Calyx of Held, indicating that Munc13-1 might be the major target in Ca2+-Calmodulin 
dependent presynaptic plasticity processes (Lipstein et al., 2013).  
The results of the present study support the possibility that Munc13s function in both 
synaptic vesicle priming and in coupling exo- and endocytosis at the active zone. Ca2+-
Calmodulin/Munc13 interactions during high synaptic activity might then potentiate the 
rate of pool refilling by boosting fast endocytosis and therefore fast release machinery and 
membrane recycling during release. Indeed, Munc13s may be interesting candidates for 
such a function due to their central position at the active zone and their interactions with 
RIM proteins, which link Munc13s and vesicles in close proximity of Ca2+-channels (Han et 
al., 2011; Kaeser et al., 2011). Moreover, it has recently been shown that synaptosomes 
lacking RIM1α, a major Munc13-1 and ubMunc13-2 binding partner at the active zone, 
exhibited a 26% increase in synaptic vesicle volumes, which closely correlates with the 
28% increase observed in Munc13-1/2 DKO synaptic profiles in the present study 
(Fernández-Busnadiego et al., 2013). RIM1α KO mice are viable, despite exhibiting 
defects in synaptic vesicle priming/docking, and a 60% decrease in Munc13 levels 
(Andrews-Zwilling et al., 2006; Deng et al., 2011; Han et al., 2011; Schoch et al., 2002). 
These findings indicate that the interaction between Munc13s, RIM proteins and 
potentially Ca2+- channels at the active zone might have a direct role in mediating exo- 
and endocytosis coupling. 
 
4.11.   A Munc13-1 conditional KO mouse line 
 
The aim of the second part of the present study was to generate a Munc13-1 conditional 
KO mouse line. Munc13-1 conventional KO mice exhibit severe impairments in synaptic 
transmission in glutamatergic synapses, causing death of the animals at birth (Augustin et 
al., 1999a). Within the last years it became evident that Munc13s are not only essential for 
priming synaptic vesicles under basal conditions, but also serve as important modulators 
of synaptic vesicle release through a wide range of molecular interactions with second 
messengers (Ca2+, DAG) in the presynaptic terminal (Lipstein et al., 2013; Rhee et al., 
2002). Moreover, it has been shown that Munc13s play a crucial role in presynaptic short- 
and long-term plasticity processes in a variety of excitatory neuron types (e.g. Calyx of 
Held, hippocampal mossy fiber synapse) (Breustedt et al., 2010; Chen et al., 2013; 
Lipstein et al., 2013; Yang and Calakos, 2011; Zhao et al., 2012a, 2012b). The majority of 
these studies revealed a dominant role of Munc13-1 in the investigated neuron types, a 
problem that required elaborated approaches to study the role of Munc13-1 in 





physiological networks, e.g. in organotypic slice culture systems or by viral overexpression 
of dominant-negative Munc13-1 constructs in vivo (Chen et al., 2013; Yang and Calakos, 
2011; Zhao et al., 2012a, 2012b). With the help of a Munc13-1 CKO mouse line, it will not 
only be possible to assess the consequences of Munc13-1 loss in vivo, but also to study 
the functions of Munc13-2 and -3 in the absence of Munc13-1. Mice carrying a genetic 
deletion for Munc13-2, -3 or for both of these isoforms are viable and fertile indicating that 
Munc13-1 can compensate for their loss and to a large extent maintain adequate synaptic 
transmission in the affected synapses (Augustin et al., 2001; Chen et al., 2013; 
Varoqueaux et al., 2002).  
In the present study, I was able to generate Munc13-1 CKO mice and demonstrate that 
homozygously floxed animals from that line are viable and fertile. Moreover, viral 
expression of the Cre-recombinase protein in dissociated neurons successfully induces 
Cre-mediated deletion of exon 21 in the Munc13-1 gene, tested by PCR. In addition, 
Western blot analysis demonstrated the absence of Munc13-1 protein in Cre-recombinase 
expressing cultures, and of truncation products capable of exerting dominant-negative 
effects. Preliminary electrophysiological experiments in Cre-recombinase expressing 
autaptic cultures revealed significant reductions in EPSC amplitudes and RRP sizes in 
response to hypertonic sucrose solution by ~80%. To test whether Cre-mediated excision 
can take place in vivo, I started to cross the floxed Munc13-1 allele into a mouse line 
expressing Cre-recombinase under the adenoviral Ella promotor, which is expected to 
excise exon 21 of Munc13-1 in all neurons at an early developmental time-point (Lakso et 
al., 1996). Genotyping of the first offspring from these breeding pairs by PCR revealed the 
presence of heterozygous mice, carrying one Munc13-1 WT and one Munc13-1 Cre allele. 
Litters from double heterozygous breeding pairs are expected to contain mice which will 
carry two Munc13-1 Cre alleles and that will hopefully phenotypically resemble full 
Munc13-1 KO mice (Augustin et al., 1999a). Additionally, the floxed Munc13-1 allele will 
be crossed into a Munc13-2/3 DKO genetic background. This mouse line can be used to 
completely shut down synaptic transmission in a subset of neurons or at different 
developmental time-points, depending on the choice of promoter controlling Cre-
recombinase expression in specific mouse lines (Kaartinen and Nagy, 2001). Moreover, in 
these genetic backgrounds viral overexpression of Munc13 constructs carrying mutations 
in crucial regulatory domains (e.g. C2B, C1) in vivo can help to understand their respective 
functions in plasticity processes in defined, mature neuronal networks that have been 
difficult to study in culture (e.g. Calyx of Held).  





5.    Summary 
 
In the present study, a combination of organotypic slice culture, cryo-fixation and three-
dimensional electron tomographic microscopy was employed to analyse synaptic vesicle 
docking in the absence of key proteins mediating neurotransmitter release. In this 
experimental setting, loss of priming proteins from the Munc13 and CAPS family caused 
an almost complete absence of docked synaptic vesicles. In both cases, reductions in the 
number of membrane-attached synaptic vesicles correlated well with previously observed 
physiological deficits in synaptic vesicle priming.  
These findings indicate that morphological synaptic vesicle docking and functional priming 
are correlates of the same molecular process. Genetic deletion, or reduced expression, of 
the individual SNARE proteins Synaptobrevin-2, SNAP25 and Syntaxin-1 resulted in a 
decreased number of membrane-attached synaptic vesicles, indicating that (partial) 
SNARE complex assembly underlies the molecular mechanism of synaptic vesicle 
docking and priming. Moreover, my data indicate that upregulation of Synaptobrevin-1 
may partially compensate for the loss of Synaptobrevin-2 function in docking/priming in a 
subset of glutamatergic synapses. This finding supports the hypothesis that residual 
release observed in neurons after genetic deletion of SNARE proteins is mediated by 
alternative SNARE homologues. Genetic deletion of Munc13s results in an almost 
complete depletion of release-competent (docked/primed) synaptic vesicles, consistent 
with the view that Munc13s initiate synaptic vesicle docking/priming, possibly via their 
interaction with the t-SNARE Syntaxin-1. However, the precise stage at which SNARE-
complex assembly is arrested in Munc13-deficient synapses could not be identified in this 
study. 
Loss of the Ca2+-sensor Synaptotagmin-1 caused a decrease in total and membrane-
attached synaptic vesicles. However, the reductions were not as dramatic as it would 
have been expected for a molecule that was formerly proposed to be the vesicular partner 
in vesicle docking. Based on our findings, Synaptotagmin-1 might have a role (1) in 
tethering synaptic vesicles to the plasma membrane prior to final membrane-attachment 
or (2) in clamping synaptic vesicles in a fusion-competent state until the arrival of the 
Ca2+-signal for triggering fusion. Genetic deletion of Complexin caused no significant 
changes in the number of docked synaptic vesicles, a result that provides support for a 
facilitatory, rather than inhibitory, role of Complexins prior to synaptic vesicle fusion.  
Synapses lacking Munc13 priming proteins, or the SNARE proteins Synaptobrevin-2 or 
SNAP25, exhibited increased synaptic vesicle sizes, indicating that the key components of 





the synaptic release machinery might also play an important role in presynaptic 
membrane or protein recycling. 
In a second project, I generated a conditional Munc13-1 knock-out mouse line, which will 
be used to study the role of Munc13-1 in defined neuronal networks in vivo. Moreover, it 
will allow the function of other Munc13 isoforms (bMunc13-2, ubMunc13-2 and Munc13-3) 
to be studied in synapses which are otherwise dominated by Munc13-1. In this study, I 
demonstrate that homozygously floxed mice are viable and fertile and that after lentiviral 
Cre-recombinase expression in dissociated hippocampal neuron cultures, Munc13-1 
protein levels are undetectable by Western blot analysis. Cre-recombinase expressing 
autaptic neurons exhibit a massive reduction in the EPSC and RRP sizes as described for 






6.    Supplementary Figures 
 
Figure S1 Light microcopic analysis of SNAP23 and VGLUT1 immunoreactivity in SNAP25 KO 
organotypic hippocampal slices 
 
Confocal laser scanning micrographs reveal a punctate pattern of SNAP23 immunoreactivity in neuropil 
from organotypic hippocampal slices (A; white framed region enlarged in B, C). SNAP23 
immunolabelling (shown with the 'fire' LUT to illustrate relative signal intensities) are not localized to 
VGLUT1-immunoreactive presynapses (white outlines; B). Merged SNAP23 (green) and VGLUT1 (red) 
channels (C).  Data as in panels A-C, but from SNAP25 KO organotypic hippocampal slices (D-F). 
Normalized spatial density of punctate SNAP23 signals (G). Normalized spatial density of VGLUT1 
immunoreactivity (H). Normalized mean area of VGLUT1 signals (I). G-I: Control (gray) and SNAP25 
KO (red): N=2, n=18; (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. Scale bar: A,D, 10 µm; . C,F, 
2 µm. 







Figure S2 Light microcopic analysis of Syb-1 and VGLUT1 immunoreactivity in Syb-2 KO 
organotypic hippocampal slices 
 
Confocal laser scanning micrographs of Syb-1 immunoreactivity in neuropil from organotypic 
hippocampal slices (A; white framed region enlarged in B, C). Syb-1 signals (shown with the 'fire' LUT 
to reveal relative signal intensities) are occasionally localized to VGLUT1-immunoreactive presynapses 
(white outlines; B). Merged Syb-1 (green) and VGLUT1 (red) channels (C).  Data as in panels A-C, but 
from Synaptobrevin-2 (Syb-2) KO organotypic hippocampal slices (D-F). Normalized spatial density of 
Syb-1 signals (G). Normalized spatial density of VGLUT1 immunoreactivity (H). Normalized mean area 
of VGLUT1 signals (I). The proportion of glutamatergic terminals in which Syb-1 is detected (J). G-J: 
Control (gray) and Syb-2 KO (blue): N=2, n=27; (Mean + SEM), P<0.001: ***; P<0.01: **; P<0.05: *. 
Scale bar: A,D, 10 µm; . C,F, 2 µm. 
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